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BACKGROUND: Childhood traumatic experiences, including physical and sexual 
abuse, antipathy, and neglect, are significantly associated with higher risk of 
developing both mental disorders and medical conditions.  
 
AIM: To elucidate the effects of childhood trauma on health, especially mental 
health, taking into account some literature-selected biological, psychological, and 
social correlates. 
 
METHODS: Investigations were conducted in three different sample groups: (1) a 
group of First Episode Psychosis (FEP) patients belonging to the “Genetics, 
Endophenotypes and Treatment: Understanding early Psychosis” (GET UP) 
Research Project; (2) a group of hepatitis C patients included in the "Chronic 
Inflammation and Depression” Research Project; and (3) a sample of healthy 
subjects. In these three samples, childhood traumatic experiences were evaluated 
by the Childhood Experience of Care and Abuse Questionnaire (CECA) 
questionnaire (Bifulco et al., 2005): physical punishments, sexual unwanted 
experiences, loss, separation, antipathy, and neglect were investigated. HPA axis 
functioning, cannabis use, and glucose metabolism were investigated as potentially 
involved biological correlates. HPA axis functioning was estimated by measuring 
salivary cortisol levels, as both diurnal cortisol levels and Cortisol Awakening 
Response (CAR). The Cannabis Experiences Questionnaire (CEQ) (Barkus et al., 
2006) evaluated cannabis use. The concentrations of C-peptide, Ghrelin, GIP, GLP-
1, Glucagon, Insulin, Leptin, PAI-1, Resistin and Visfatin were determined using 
Bio-PlexPro™ Human Diabetes Assays (Bio-Rad, CA, USA). Coping strategies, 
age, gender, education, socio-economic status, and recent severe stressful life 
events were taken into account as potentially involved psychosocial correlates. 
 
RESULTS: (1) Significant associations between severe sexual abuse and a 
diagnosis of affective psychosis and between childhood trauma, severe sexual abuse 
in particular, and lifetime cannabis use were found in FEP subjects. No gender 
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difference was detected. Moreover, C-peptide and insulin levels were found 
increased in traumatized FEP subjects. Indeed, we found that C-peptide was higher 
in patients who experienced childhood trauma (with or without severe life events), 
while Insulin was higher in patients who reported childhood trauma (with no 
mention of severe recent stressful life events), in comparison to FEP subjects 
without traumatic events. (2) In subjects affected by Hepatitis C, childhood trauma, 
parental antipathy, and neglect were found significantly associated with higher 
levels of depressive and anxious symptomatology and with greater emotional 
distress. Exploring different types of trauma, we found that subjects with a history 
of physical punishments demonstrated significantly increased levels of depression, 
emotional distress, and fatigue in comparison with subjects not recalling this 
history. An even stronger association was found between sexual unwanted 
experiences and levels of depression, anxiety, and emotional distress. Healthy 
subjects (3) with a history of childhood trauma showed higher lifetime frequency 
of positive psychotic-like symptomatology, while maternal antipathy was 
significantly associated with lower lifetime frequency of negative symptoms and 
lower levels of distress in response to depressive symptoms. Lifetime cannabis use 
and salivary cortisol levels were explored as potentially mediating factors, but no 
mediational effect was found. Finally, higher insulin levels were significantly 
associated in healthy subjects with physical abuse and childhood trauma plus severe 
life events (SLEs); Body Mass Index (BMI), which was also significantly 
associated with higher insulin levels, completely mediated the association with 
physical abuse, while childhood trauma plus SLEs and BMI gave independent 
contributions to higher insulin levels. Higher PAI-1 levels were found in subjects 
reporting childhood trauma and SLEs. Finally, physical abuse, severe sexual abuse 
and childhood trauma plus SLEs were found significantly associated with higher 
C-peptide levels. BMI completely mediated the association between physical abuse 
and C-Peptide, while severe sexual abuse or childhood trauma plus SLEs and BMI 
independently contributed to C-Peptide levels. 
 
CONCLUSION: Our findings confirmed the detrimental consequences of 
childhood trauma, even at non-clinical level. On the other side, some of our results 
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Childhood traumatic experiences represent a compound phenomenon, which 
includes physical, sexual, and psychological abuse, and neglect, strikes one child 
out of 100 in Italy, and is significantly associated with higher risk of developing 
both mental disorders and medical conditions. The overall aim of this PhD thesis is 
to investigate the effects of childhood trauma on mental health, taking into account 
some literature-selected biological, psychological, and social correlates. In details, 
in chapter 1, the definition of childhood traumatic experiences is given and the 
magnitude of the phenomenon reported, focusing on worldwide, European and 
Italian lifetime prevalence rates. Moreover, a brief review of the evidence 
supporting the well-established association between childhood trauma and the 
increased risk of developing severe mental disorders (such as psychosis and mood 
disorders) and medical conditions (like metabolic syndrome, diabetes, and obesity) 
is reported. The chapter closes with the description of the known biological (HPA 
axis, cannabis, and epigenetics- here a systematic review on the relationship 
between childhood trauma and epigenetics published in 2017 is presented), 
psychological (believes, dissociation, and attachment), and social (gender and 
poverty) correlates of the association between childhood trauma and severe mental 
disorder.  
Based on this background, the impact of childhood trauma on mental health in 
relation with several biopsychosocial features has been investigated in three 
different sample groups: a group of subjects affected by First Episode Psychosis 
(FEP) (chapter 2), a group of subjects affected by hepatitis C (chapter 3), thus 
characterized by a state of chronic inflammation and inclined to develop depression, 
and a sample of healthy subjects (chapter 4).  
Chapter 2 includes the description of the “Genetics, Endophenotypes and 
Treatment: Understanding early Psychosis” (GET UP) Research Project by Ruggeri 
and collaborators, within whose framework two studies were conducted.  The first, 
published in 2017 in the British Journal of Psychiatry (Tomassi et al., 2017) aimed 
to investigate in a large sample of FEP patients the influence of childhood trauma 
on diagnosis and lifetime cannabis use. The second, next to be submitted soon, 
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explored the association between childhood traumatic experiences and glucose 
metabolic biomarkers in early psychosis. In both cases, methods are fully described, 
results reported, and findings discussed.  
In chapter 3, I reviewed the literature regarding depression and inflammation, 
paying particular attention to the role of peripheral pro-inflammatory cytokines and 
to the known association between inflammatory chronic medical conditions (such 
as hepatitis C) and depression. Afterwards, the "Chronic inflammation and 
Depression” Research Project by Tosato and collaborators is described. Then, some 
preliminary findings about hepatitis C, depression, and risk and resilience factors 
(a special focus is kept on childhood trauma), recently presented in a symposium at 
the 6° European Association of Psychosomatic Medicine Conference held in June 
2018 in Verona, are reported and discussed.  
Finally, the “Healthy Subjects” Research Project by Tosato and collaborators is 
illustrated in chapter 4. Two studies were conducted using data from this project. 
The first one is actually under review. It aimed to investigate the association 
between childhood trauma and psychotic-like experiences in healthy subjects, also 
taking into account some potentially mediating factors such as lifetime cannabis use 
and salivary cortisol levels. The second study is also under review. It aimed to 
explore the association of childhood traumatic experiences and altered glucose 
metabolism. In both cases, methods are fully described, results reported, and 
findings discussed.  
 
In general, we found several significant effects of childhood traumatic experiences 
on mental health in all sample groups and we confirmed the detrimental 
consequences of trauma, even at non-clinical level. On the other side, some of our 
findings evoked a potential increased resilience in subjects with a history of 
childhood traumatic experiences. It seems therefore to suggest an alternative 
starting point for future research on childhood adversities, which in our opinion, 
























1.1 DEFINITION AND MAGNITUDE OF THE PHENOMENON 
 
Childhood trauma is a complex and heterogeneous phenomenon, significantly 
conditioned and modulated by bio-psycho-sociocultural elements. The World 
Health Organization defines childhood trauma as (WHO, 1999):  
 
‘‘Child maltreatment is the abuse and neglect of people under 18 years of age. It 
includes all forms of physical and/or emotional ill-treatment, sexual abuse, neglect 
or negligent treatment or commercial or other exploitation, resulting in actual or 
potential harm to the child’s health, survival, development or dignity in the context 
of a relationship of responsibility, trust or power. Four types of child maltreatment 
are generally recognized: physical abuse, sexual abuse, psychological (or 
emotional or mental) abuse, and neglect.’’ 
 
In scientific literature, definitions of childhood trauma are heterogeneous: some 
focus on adults’ behaviors regardless of the outcome, while others consider abuse 
to take place if there is harm or the threat of harm to the child. Some require the 
harm to the child to be intended for the act to be defined as abusive, while others 
consider as abused also those children inadvertently harmed through the actions of 
an adult (WHO 2002). Finally, the question remains whether the experience of 
abuse should be understood as a dichotomous event (which may or may not occur) 
or whether it should be seen in a dimensional, rather than a categorical context, 
characterized by distinct qualitative elements, such as frequency of occurrence, 
severity of the act, and duration in time. Taking into consideration the 1999 WHO 
definition, this thesis will be focusing on the main four types of maltreatments: 
physical abuse, sexual abuse, psychological abuse (or antipathy), and neglect. 
Physical abuse of a child is defined as those acts of commission by a caregiver that 
cause actual or potential physical harm. Sexual abuse includes those acts where a 
caregiver uses a child for sexual gratification. Emotional abuse (or antipathy) can 
be defined as the lack of a caring and supportive environment, and includes: acts 
restricting child’s movements, denigration, ridicule, threats and intimidation, 
discrimination, rejection, and other nonphysical forms of hostile treatment. Neglect 
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refers to the failure of a parent to provide for the development of the child in one or 
more of the following areas: health, education, emotional development, nutrition, 
shelter and safe living conditions. Neglect can occur only in cases where reasonable 
resources are available to the family and it is thus distinguished from circumstances 
of poverty (WHO, 2002). To investigate the presence of childhood traumatic 
experiences, I chose the CECA questionnaire (Bifulco et al., 2005), because it is an 
internationally validated instrument and one of the most applied in this field of 
research. I have described the questionnaire thoroughly in more than one section of 
this thesis (see pages 64, 65, 81, 111, 115, 116, 149, 150, 163, 164). The instrument 
is based on retrospective reports of past events and may therefore imply the risk of 
recalling bias. Concurrent mental health factors may influence the reporting of 
traumatic childhood experiences (Colman et al., 2016). Studies that use 
retrospective reporting (such as the CECA-Q) to estimate associations between 
childhood adversity and adult outcomes associated with mental health may be 
biased. On one side, reliance on the retrospective reporting of abuse might then 
increase the risk of recall bias in studies investigating a sample of psychotic patients 
(Howard, 1993; Young et al., 2001 in Fisher et al., 2011). On the other side, the 
reliability of patients affected by psychosis in referring trauma has been clearly 
demonstrated (Fisher et al., 2011): their reports were shown to be independent from 
symptomatology, stable over the course of time (test-retest reliability), similar when 
obtained by different assessment instruments and generally consistent with other 
sources of information (concurrent validity). It has also been proven that 
retrospective recall yields to an underestimation of the phenomenon, rather than an 
overestimation (Hardt & Rutter, 2004). Depressed mood may also increase the 
likelihood of recall of negative experiences (Jorm et al., 1992; Mechanic et al., 
1998; Mandelli et al.,2015), though several studies sustain a certain reliability in 
retrospective evaluation of adverse life events (Bifulco et al., 2002; Hardt et al., 
2004; Dube et al., 2004). We investigated the history of childhood trauma in healthy 
subjects and in subjects affected by hepatitis C (in this case, the assessment on 
childhood trauma was performed at baseline, and at that time point, none of the 
participants was depressed). Even if present a recall bias due to an altered mood, it 
did not affect our data.  Ideally, though, the validity of retrospective self-reports of 
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childhood abuse should be established by comparison with social services’ records 
of corroborated abuse. However, the approval to obtain corroboration of childhood 
abuse reports from social services’ records was not available for the studies 
included in this thesis. Nevertheless, these would probably not have been useful 
anyway for the majority of cases as very few incidents of abuse are ever reported 
to the authorities (Hardt et al., 2004). Other forms of corroboration (eg, family 
reports, documentation by different professionals) (Fergusson et al., 1996; Heim et 
al., 2012) could be be useful and should therefore be included in future research. A 
more accurate assessment of traumatic childhood experiences would be obviously 
obtained by prospective, longitudinal study designs (Widom et al., 2007), which 
unfortunately lack on feasibility and are very expensive in terms of both time and 
resources. 
  
Every year, about 41,000 children under age 15 are victims of homicide worldwide. 
More deaths from child maltreatment go unreported — since they are incorrectly 
documented as due to other causes. Figure 1 shows global lifetime prevalence of 
childhood trauma (WHO, 2014).  
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In the United States, 1.2% of children are victims of maltreatments. Among these, 
10.0% and 7.0% are victims of physical abuse and sexual abuse, respectively, 11% 
reports psychological abuse, 60.0% neglect; in Canada the prevalence of child 
maltreatment is equal to 1.0%; physical, sexual and psychological abuse are 
reported respectively in 23.0%, 17.0% and 11.0% of cases, while 38.0% of subjects 
reports being neglected. In Australia, 0.7% of children are victims of abuse: the 
abuse is physical in 28.0% of cases, sexual in 10.0%, psychological in 34.0%; 
negligence affects 34.0% of children who are victims of maltreatments (Gilbert et 
al., 2009). Within the European Region, 852 children under the age of 15 die every 
year in because of maltreatments. The highest rate of maltreatment-related deaths 
is found in children under age of four. Nine per cent of European children are 
victims of sexual abuse (13.4% of girls and 5.7% of boys); 12-23% are victims of 
physical violence, 15-30% are psychologically abused, and 9% are neglected 
(WHO, 2013, 2014).  According to a recent national survey conducted in 2015, 
maltreated youths (0-17 years of age) followed by Social Services in Italy are 
91,000 (CISMAI-TDH, 2015).  
In Italy, almost one children out of 100 (9.5‰) is victim of maltreatments: among 
those in charge to Social Services, 6.9% and 4.2% refers to be victim of physical 
and sexual abuse respectively, 13.7% reports a psychological abuse, while 47.0% 
relates neglect, both physical and emotional (CISMAI-TDH, 2015). Girls or female 
teenagers (11-17 years of age) and foreign children (20‰ vs 8.5‰ of Italian 
children) appear to be the most affected (CISMAI-TDH, 2015).  
In 1924, The Declaration of the Rights of the Child, also known as the Geneva 
Declaration of the Rights of the Child, was adopted by the League of Nations (UN, 
1924). It was the first document promoting child rights approved by an inter-
governmental institution (Buck, 2014); it was adopted by the United Nations in 
1946 and implemented in 1959 (UN, 1959). On 20 November 1959, the UN General 
Assembly adopted a Declaration of the Rights of the Child, based on the structure 
and contents of the 1924 original, with ten principles, and followed in 1989 by the 
Convention on the Rights of the Child (UN, 1989). Currently 196 countries are 
parties to the treaty. The United States signed the convention in 1995, but they have 
not ratified it yet.  
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When searching on Pubmed for Childhood Trauma AND Psychosis, 519 papers 
were found, most of them published starting from the late nineties, the oldest one 
printed in 1962. Looking at them carefully, it is worth noting that the very first work 
concerning the association between trauma during childhood and psychosis is 
actually dated 1996. Since then the research on this field has been spreading as 
showed in figure 2, which displays results by the searching “Childhood Trauma 
AND Mental Health”.  
 
Figure 2: “Childhood Trauma AND Mental Health” searching results  
 
It is therefore possible to affirm that only quite recently, since the nineties, 
childhood has been world widely entitled to special care and assistance. Similarly, 























































































































































Childhood trauma and mental health
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1.2 THE ASSOCIATION WITH SEVERE MENTAL DISORDERS 
 
Childhood trauma has serious consequences. The effects can be immediate: victims 
can suffer serious injuries or die. The consequences can also last a lifetime. Adults 
who were abused or neglected as children have a higher risk of perpetrating or being 
a victim of violence, developing mental disorders (including psychosis), becoming 
obese, using tobacco, drugs, and alcohol (WHO, 2015). Childhood trauma has in 
fact been globally associated with the development of health problems, specifically 
with mental and neurological disorders (OR=2.3) (WHO, 2014), as well as with 
social and behavioral problems (e.g. low life satisfaction: OR=2.4; prostitution: 
OR=2.5), and impaired cognitive performance (e.g poor academic performance: 
OR= 1.3; cognitive impairment: OR=1.8). Childhood traumatic experiences have 
been widely proven to be associated with the development of severe mental 
disorders, such as schizophrenia and mood disorders (Read et al., 2005; Conus et 
al., 2010; Alvarez et al., 2011). In the general population, subjects recalling a 
history of childhood trauma (within their first 17 years of life) show an increased 
risk to undergo psychotic like experiences in their adulthood (OR 2.78; 95% CI 
2.34–3.31) (Varese et al., 2012a). On the other hand, subjects with a diagnosis of 
severe mental disorder show an increased rate of past childhood trauma, with the 
rate size varying according to the type of exposure and perpetrator, up to the 47% 
of cases (Alvarez et al., 2011). A diagnosis of schizophrenia has been associated 
with a higher frequency of traumatic experiences during childhood. Female affected 
subjects showed rates of sexual abuse and physical abuse equal to 47.7% and 47.8% 
respectively, while males referred sexual abuse in 28.3% and physical abuse in 
50.1% of cases (Read et al., 2005). A recent systematic review (Bonoldi et al., 2013) 
summarized evidence regarding the prevalence of childhood traumatic experiences 
in subjects affected by psychosis, and found that 26% and 39% of patients were 
sexually and physically abused when children, respectively. Moreover, first episode 
psychosis (FEP) patients showed a two-fold higher prevalence (85.7% vs 38.7%) 
of childhood trauma when compared with healthy controls (Mondelli et al., 2010). 
Severe sexual abuse was reported in 15.0-18.2% of FEP subjects (Neria et al., 2002; 
Fisher et al., 2010), while severe physical abuse was recalled in 15.2–21.6% (Fisher 
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et al., 2010; Neria et al., 2002). Similarly, childhood trauma has been proven a 
relevant risk factor for developing depression in adulthood (Zavaschi et al., 2006; 
Chapman et al., 2004; Kendler et al., 2004). A recent systematic review and meta-
analysis (Mandelli et al., 2015) showed a strong association between emotional 
abuse (OR = 2.78), or neglect (OR = 2.75), or sexual abuse (OR = 2.42) and 
depression. A significant association was also found for physical abuse (OR = 1.98). 
Moreover, exposure to childhood traumatic experiences has been found to be 
associated with a two-fold risk of both recurrent and persistent depression (Nanni 
et al., 2011). They predict lifetime suicide attempts in treatment-resistant depression 
patients (OR 2.79; 95% CI 1.14-6.84) (Tunnard et al., 2014) and they have been 
related to the presence of psychotic features in mood disorders (Gaudiano & 
Zimmerman, 2010).  
 
In recent years, findings have converged in support of a negative impact of 
childhood adversity on illness’ features, outcome and course of severe mental 
disorders, across diagnostic boundaries (Alvarez et al., 2011; Aas et al., 2016). 
Patients suffering from schizophrenia and with a history of child abuse have, in fact, 
in comparison with unexposed affected subjects, a younger age of onset (on average 
their onset occurs four years earlier), with an earlier first admission, and a double 
hospitalization rate (Alvarez et al., 2011). Childhood trauma has been also 
associated to a more severe symptomatology with dissociative characteristics, a 
worse cognitive performance, and a more deteriorated social-relational functioning 
with a lower quality of life (Alvarez et al., 2011). Moreover, being affected by 
schizophrenia and having undergone traumatic experiences during childhood has 
been associated with more severe positive symptoms (i.e. commenting voices, ideas 
of reference, experiences of insertion and reading of thought and paranoid ideation) 
(Read et al., 2005).  
The presence of childhood traumatic experiences has been associated with greater 
suicidality. One out of two (50%) exposed subjects also affected by a severe mental 
disorder, regardless of the type of trauma, have at least one suicide attempt in their 
life against 26% of the unexposed subjects (Alvarez et al., 2011). If we consider 
child sexual abuse, the percentage of patients attempting suicide rises to 69% 
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among subjects affected by schizophrenia (vs. 21% in unexposed) and to 73% of 
individuals suffering from mood disorders (vs 34% in unexposed) (Alvarez et al., 
2011; Daruy-Filho et al., 2011). Finally, in patients with a diagnosis of both 
schizophrenia and mood disorder, the presence of childhood traumatic experiences 
has been associated with a higher risk of drug use (Daruy-Filho et al., 2011). 
 
It is worth mentioning that even though the association between childhood 
traumatic experiences and mental disorders appear strong (Varese et al., 2012a), 
traumatized children do not develop a clinically significant disorder in the majority 
of cases (Matheson et al., 2013). There is evidence that protective factors can 
modify the negative effects of early adverse life circumstances leading people to 
select functional environments (Werner, 2004, 1992). The term resilience derives 
from the Latin word “resalio” (i.e. jump or rebound) and found its first application 
in mathematical and physical sciences, where it indicates the property of a material 
to resume the original shape after having suffered a stroke. Thereafter, the term was 
introduced and used in psychology, and the first longitudinal resilience study began 
in 1955. In psychology, resilience refers to a "dynamic process that includes a 
positive adaptation to a significantly adverse context ". It is therefore not a quality 
of the person, but a process, a phenomenon, which occurs due to the interaction 
between a set of external and internal resources, which can vary over time and 
within which the subject is only one of the involved elements. Protective factors 
towards stress have previously been classified into three categories: 
1) Protective factors related to the individual (cognitive, emotional, and relational 
skills): children defined as "resilient" demonstrate in challenging situations to 
possess good adaptive skills, combining spirit of initiative and the ability to seek 
help. They seem to be characterized by a facilitating and affectionate temperament; 
they maintain a locus of internal control (with a good sense of self-efficacy) and an 
integral self-esteem. 
2) Family protective factors (heat, family cohesion, support, and openness to 
dialogue): a family defined as protective should ensure the presence of at least one 
adult representing a stable emotional reference, capable of eliciting a sense of 
founded trust in the child and, as such, representing a valid identification model. 
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Furthermore, families with a strong religious belief seem to be more protective in 
difficult times; in fact, they represent a source of stability and provide a shared 
meaning to cope with in front of an adverse reality. 
3) Community-related protective factors (social network, significant leisure-time 
activities, education): in this case, a role of primary importance seems to be played 
by the school. The presence, in fact, of a reference teacher, able to advise and 
support, appears to be strongly protective in demanding situations. 
To sum up, protective resilient factors can be attributed to the individual itself, as 
temperamental characteristics that easily elicit positive responses from caregivers 
and/or good communication and problem solving skills, or lie within the family 
(caregivers providing positive role models) and in the community (teachers, caring 
neighbors and peers) (Werner, 2004). A primary role has also been theorized for 
contextual and cultural factors (Ungar, 2013) and resilience has been defined as the 
capacity of both individuals and their environments to interact to overcome 
childhood adversities (Ungar & Liebenberg, 2011). Political processes, funding, 
and cultural norms contribute significantly to make it more or less likely a positive 
adaptation (Leadbeater et al., 2005). It is therefore possible to postulate that subjects 
that endured childhood maltreatments, whether surrounded by a supportive 
relational and social context, could also cope with it in an adaptive way (Ungar, 
2013; Ungar & Liebenberg, 2011).  
 
Vulnerability, on the other hand, is what in a system determines an increased risk 
of negative consequences deriving from stressful events or situations. In the late 
1970s, Zubin and Spring (Zubin & Spring, 1977) conceptualized the so-called 
"stress-vulnerability model" for schizophrenia. The model postulates that the 
vulnerability to psychosis is acquired through a genetic predisposition, which is a 
necessary condition, but not sufficient for the development of the disease. In order 
for the disorder to become manifest clinically, in fact, additional pathogenic factors 
must intervene, with a triggering effect on the onset of the disease. Psychosocial 
stimuli, particularly in early stages of life, would therefore have a profound impact 
in determining the risk of developing a mental disorder, contributing to increase (or 
reduce) the effects of an innate vulnerability (Luthar et al., 2006). The concept of 
20 
 
“risk” always maintains the characteristic of probability, and not of certainty, of 
causing harm (Luthar et al., 2006). Risk can be internal (such as genetic 
predisposition or organic pathologies) or external to the individual (family or 
related societies). Evidence has shown that a biological risk for severe mental 
disorders exist, mainly due to genetic vulnerability: with regards to schizophrenia, 
studies on twins have estimated an inheritability of the disorder equal to 60-80% 
(Sullivan et al., 2003), while for mood disorders the estimate is equal to 6-80% 
(Wray & Gottesman, 2012). Alongside the genetic vulnerability, it is also possible 
to identify a risk component due to elements defined as "environmental". In 
schizophrenia it has been hypothesized that environmental risk factors may have a 
relative weight of 60% in determining the vulnerability to the disorder. Worth 
mentioning, as now supported by clear scientific evidence, are: childhood traumatic 
experiences, growing in urban environment, migrant status, high levels of maternal 
stress during the perinatal period (pregnancy and childbirth), the advanced paternal 
age, obstetric complications, and the use of drugs (particularly cannabinoids) in 
adolescence (Schmitt et al., 2014). With regard to mood disorders, childhood 
traumatic experiences, obstetric complications (Schmitt et al., 2014), recent 
stressful life events and poorly supportive socio-family contexts appear to be the 
significant environmental risk factors involved. 
 
Any reasonable theory that aimed to explain how childhood traumatic experiences 
might favor later on the development of a severe mental disorder should therefore 
take into account the integrated bio-psycho-social paradigm. Several paradigms, 
often integrated, have been developed focusing on diverse elements such as the 
stress response system, including the hypothalamus-pituitary-adrenal (HPA) axis, 
cognitive models and schemas, and environmental factors (Larkin & Read, 2008).  
Great attention has been paid to the effects of childhood trauma on brain 
development, in particular with respect to the potential damage caused by early 
adversities to the stress response system (Read et al., 2005). The Traumagenic 
Neurodevelopmental (TN) Model, a recent evolution of the original 
conceptualization of the "stress-vulnerability model" for schizophrenia (Zubin & 
Spring, 1977) represents a genuinely integrated bio-psycho-social approach. 
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According to this model, early traumatic events would be able to determine an 
activation of the hypothalamic-pituitary-adrenal axis, a system involved with a role 
of primary importance in the mechanisms of stress response. In case of abnormal 
and/or prolonged in time exposure to the trauma, a dis-regulation of the HPA axis 
itself could take place. The consequence would be the establishment of a condition 
of emotional hyper-reactivity to the stressors of everyday life, which would 
represent an element of vulnerability (Van Winkel et al., 2008). 
From a psychological point of view, the association between childhood trauma and 
severe mental disorders has been mainly explored in light of cognitive processes 
and meaning attribution, dissociative phenomena, and attachment theory. The 
cognitive models proposed are numerous (Larkin & Read, 2008): their common 
element appears to be the presence of cognitive-behavioral patterns, acquired 
during childhood, determined by traumatic experiences, and responsible for the 
increased vulnerability. The experience of abuse would lead, in fact, to the shaping 
of negative believes about oneself, the others and the world, such as "I am 
vulnerable", "others are unreliable" and "the world is threatening/dangerous", 
which would then condition the reading of reality and daily events and would 





1.3 THE ASSOCIATION WITH MEDICAL CONDITIONS:  
Metabolic syndrome, diabetes, and obesity 
 
There is strong evidence indicating that traumatic experiences during critical 
periods of brain development, such as childhood, can cause long-term, persistent 
effects on behaviour, increasing the likelihood to negative health outcomes. 
Childhood trauma has been demonstrated to increase the vulnerability for several 
medical conditions, including metabolic disorders and type 2 diabetes (Huffhines 
et al., 2016, Miller et al., 2011).  
The physiological response to stress involves the activation of multiple biological 
systems, comprising the endocrine, metabolic, and immune systems; whereas the 
acute stress activate adaptive mechanisms, (McEwen, 2003) the long term exposure 
to stress is associated with long lasting physiological dysregulation, eventually 
leading to enhanced vulnerability to several kind of diseases (Juster et al., 2010). 
Confirming the long-term effects of early life stress on the body, several studies 
(Danese et al., 2009; Dich et al., 2015) have linked childhood trauma to detrimental 
changes in physiological functions. For instance, it has been shown that victims of 
childhood sexual and physical abuse are more likely to be obese or to show three 
or even more symptoms of metabolic syndrome when compared with non-victims 
(Danese & Tan, 2014). Moreover, it was showed that exposure to maltreatment is 
associated with higher levels of several biomarkers related to metabolism, including 
high glycated hemoglobin (Danese et al., 2009). Finally, evidence suggests that 
subjects who reported an exposure of childhood trauma had an increased risk of the 
32% to develop later in life type 2 diabetes (Huang et al., 2015) and of the 20-50% 





1.4 BIOLOGICAL CORRELATES OF THE ASSOCIATION BETWEEN 
CHILDHOOD TRAUMA AND SEVERE MENTAL DISORDERS  
HPA axis, cannabis, and epigenetics 
 
HPA axis functioning, cannabis consumption, and epigenetics are some among the 
biological correlates that have been investigated to better understand the association 
between being traumatized as children and the later development of a severe mental 
disorder.   
 
1.4.1 HPA AXIS 
An altered HPA axis functioning has been found significantly associated with both 
childhood trauma and psychosis. HPA axis is a key element of the body system that 
modulates the response to stress (Lupien et al., 2009): in physiological conditions, 
corticotrophin releasing hormone (CRH) and vasopressin (AVP) are synthetized in 
the hypothalamic paraventricular nucleus (PVN). Once released into the portal 
circulation, they reach the pituitary gland and activate the secretion of 
adrenocorticotropic hormone (ACTH), which in turn finally stimulates the secretion 
of glucocorticoids, including cortisol, from adrenal glands. Cortisol then binds its 
receptors (glucocorticoid receptors or GR and mineralcorticoid receptor or MR) in 
multiple target tissues, including the Central Nervous System and the HPA axis 
itself, and it is responsible for a negative feedback of both ACTH and CRH 
secretion (Pariante & Lightman, 2008). In case, however, of prolonged stimulation 
this homeostatic mechanism may fail. A flattening of the daily curve of cortisol 
values was observed with a significant increase in the evening values in association 
to a chronic stimulation by pro-inflammatory cytokines (Raison et al., 2010a). A 
chronic stimulation of the HPA axis can be responsible for its malfunction through 
an inhibitory effect on GR receptors. It has been demonstrated that pro-
inflammatory cytokines can reduce the functionality of GR receptors: cytokines 
were shown to inhibit both cytoplasm-nucleus translocation and DNA binding, and 
were proven to influence the expression of receptors’ isoforms, stimulating the 
production of a relatively inert isoform (Pace et al., 2007). It would result in 
increased levels of circulating corticosteroid hormones, due to an altered HPA 
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cortisol-axis negative feedback mechanism and mediated, at least in part, by 
glucocorticoid receptor resistance. Both HPA axis hyper- (Danese et al., 2007, 
2008, 2009) and hypo-activation (Lupien et al., 2009) and hyper- (Heim et al., 2000) 
and hypo-reactivity to stress (Klaassens et al., 2009; Carpenter et al., 2007) have 
been significantly associated to childhood traumatic experiences. HPA-axis 
dysfunction was also proven significantly associated to severe mental disorders 
themselves (both psychosis and depression). HPA-axis hyperactivity, characterized 
by high cortisol levels in basal condition, and a blunted HPA axis response to stress 
(hypo-reactivity), were in fact both found to characterized psychosis (Borges et al., 
2013). Similarly, hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis 
with cortisol hyper-secretion (Pariante & Lightman, 2008; Pariante & Miller, 2001) 
and glucocorticoid resistance (Carvalho et al., 2010) can be consistently identified 
in depressed patients. Whether HPA axis dysfunction mediates the trauma-severe 
mental disorder association or represents a trait of illness is still a matter of debate. 
Nonetheless, several findings (Danese et al., 2007, 2008, 2009) indicate that 
abnormalities in the stress response system, and the subsequent increased 
inflammation, originate in childhood and might be considered a ‘biological scar’ of 
the early exposure to high levels of stress (Baumeister et al., 2016). 
 
1.4.2 CANNABIS 
Cannabis consumption has been found significantly associated with both childhood 
trauma and psychosis. On one side, childhood traumatic experiences has been 
associated with a higher risk of substance use (including cannabis) in adolescence 
and early adulthood in the general population (Madruga et al., 2011). Subjects 
recalling childhood trauma are in fact more prone to use cannabis: they may develop 
depressive symptoms and try to self-medicate and/or they often live in 
disadvantaged environments, where it is easier to get addicted (Houston et al., 
2011). On the other side, the association between cannabis consumption and 
psychotic symptoms is well established in literature, even in the general population 
(Rössler et al., 2011: Moore et al., 2007; Henquet et al., 2005).  It is worth 
mentioning that childhood trauma has been hypothesized to have a role in 
modulating and moderating the association between cannabis use and the later 
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development of psychosis (Houston et al., 2011). The risk for psychosis has been 
in fact found significantly higher in those who were exposed to both childhood 
trauma and cannabis use compared to those exposed to only one of the two. The 
strength of this association was found to be dose-dependent, with higher rates of 
psychosis as the frequency and severity of traumatic experiences increase (Konings 
et al., 2011). Despite clear evidence of association between trauma, cannabis, and 
psychosis, available evidence does not elucidate whether childhood traumatic 
experiences and cannabis use represent vulnerability factors for psychosis or 
environmental stressors that trigger the disorder acting on a pre-existing 
vulnerability. Traumatic experiences and cannabis use could both be vulnerability 
agents, which decrease the subject’s resilience in response to other stressors (i.e., 
migration) and lead to psychosis. They might represent two different environmental 
stressors, acting (in an additive or in a multiplicative way) on another type 
(genetic?) of vulnerability. Finally, childhood trauma could enhance vulnerability 
and cannabis use acts as an exacerbating agent, or alternatively, vice versa.  
 
1.4.3 EPIGENETICS 
Epigenetics has been demonstrated to take a part in transducing environmental 
experiences in both genome and brain structure modifications, potentially 
underlining the association between childhood trauma (CT) and the development 
of psychosis (Heim & Nemeroff, 2001). Epigenetic modifications, like cytosine 
residues methylation, histone modifications and non-coding RNAs (Chuang and 
Jones, 2007), determine whether a DNA region is compacted and transcriptionally 
repressed/silent or open and transcriptionally active. CT could thus influence gene 
expression and individuals’ capacity of adaptation through epigenetic modifications 
(Korosi et al., 2012). It is not yet possible neither to draw definitive conclusion 
about the epigenetic modifications due to CT, nor does to clarify why only a subset 
of people exposed to CT develop a psychosis while the majority does not. 
Furthermore, it stands unclear among subjects affected by psychosis, to what extent 
the observed epigenetic modifications are to be ascribable to the CT rather than to 
the psychosis itself. The main aim of the present review, published in 2017 in 
Neuroscience and Biobehavioral Reviews (Tomassi & Tosato, 2017), was then to 
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summarize the evidence relating to the specific epigenetic and gene expression 
modifications associated with CT in both subjects affected by FEP and healthy 
samples. Since we aimed also to explore the relative role of psychosis itself in 
determining these modifications, evidence about FEP and epigenetics/gene 




Search strategy and selection criteria  
Based on previous works (Aas et al., 2012; Bifulco et al., 2005), we defined CT as 
the experience of sexual or physical abuse, neglect, parental loss or separation. We 
considered healthy subjects those non-affected by any psychiatric disorder. We 
performed a literature search on PubMed, last updated in December 2016.  
Original searches were done for experimental studies using the following search 
terms: “childhood trauma” OR “child abuse” OR “ABUSE*” OR “childhood sexual 
abuse” OR “childhood physical abuse” OR “neglect” “childhood parental loss” OR 
“childhood separation” in combination with the following terms: “DNA 
methylation” OR “histone modification” OR “microRNA” OR “gene expression” 
OR “genome wide methylation” OR “genome wide gene expression”; and 
specifically for the main aim in combination with “first episode psychosis”. Finally, 
for the secondary aim searches were done using the following search terms: “DNA 
methylation” OR “histone modification” OR “microRNA” OR “gene expression” 
OR “genome wide methylation” OR “genome wide gene expression” in 
combination with “first episode psychosis”. The database search was restricted to 
human studies, English language papers. Cross-references from all included articles 
were also screened. Unpublished studies, conference abstracts or poster 
presentations were not included. The search yielded a total of 2966 potentially 
relevant records. After excluding duplicated studies and those that clearly did not 
pertain to our topic of interest (n=2776), basing on the review of titles or abstracts, 
the full text of the remaining studies (n=190) was assessed for eligibility. Once 
removed non-pertinent articles, 41 studies were included (figure 3). Articles were 
screened and selected by me and checked by my supervisior. 
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Table 1: List of included studies and their main characteristics   






Gender M   
N(%) 
Alexander et al., 2014  German healthy adults with early trauma 
200  
Cases N=-- 
23.7 (2.8); 18-30 100 (50) 
Peripheral 
blood 
Beach et al., 2011  
Sexually abused by Iowa Adoptee Study 
(IAS) 






Beach et al., 2010  
Sexually and Physically abused by Iowa 
Adoptee Study (IAS) 
192 35-69 96(50) 
Peripheral 
blood 
Bick et al., 2012  Foster placed adolescents 
9 
Cases N=4 
23.7 (2.8) 5 (55.5) 
Peripheral 
blood 
Cecil et al., 2016  
Maltreated adolescents from the High risk 
inner city (London) sample 
124 
Cases N=84 
16-24  58 (47) Buccal cells 
Duman & Canli, 2015  
Caucasian males 
(CT as a continuous by CTQ) 
105 
Cases N=-- 
28.5 (13.8); 18-77 105 (100) 
Peripheral 
blood 
Di Nicola et al., 2013 
FEP patients with a history of 
loss/separation/CSA/CPA. 
24 28.1(1.1) 16(66.7) 
Peripheral 
blood 
Fusté et al., 2013  FEP patients  
28 
Cases* N=14 
Schizophreniform disorder (N=3), 
psychosis NAS (N=7), BD (N=4) 
25.2 (5.5); 17-40 7 (50) 
Peripheral 
blood 
Gouvea et al., 2016  Antipsychotic naïve  FEP patients  
142 
Cases* N=69 
(N=53 FEP SCZ) 
(N=16 FEP w mania) 
*26.3 (7.5) FEP w 
SCZ 





Guillemin et al., 2014  




25 (1)* 0 (0) 
Peripheral 
blood 
Houtepen et al., 2016 
Healthy individuals w CT 
(CT as a continuous by CTQ) 
69 (discovery sample) 




Janusek et al., 2016  
American African men w CT 
(CT as a continuous by CTQ) 
33 20.2 (2.3); 18-25 34 (100) 
Peripheral 
blood 
Khulan et al., 2014  Separated from parents Finland males 
166 
Cases* N=83 








Klengel et al., 2013  
Adult subjects with an history of CSA and 
CPA 
 
By 3 different cohorts 
1) Grady trauma project Cohort 
2) Conte Center Cohort 
3) Third cohort (from Metha et al., 2011) 
1) cases N=30 with ≥2 CT; 
controls N=46 
 
2)N=56 with ≥2 CT 
 
3) 129 individuals (CA + risk 
allele, N = 40; CA + protective 
genotype, N = 15; no CA + risk 
allele, N = 60; no CA + protective 
genotype, N = 14) 
1) cases: 41.5 (11.7); 














Kumsta et al., 2016  
Romanian adoptees with an (1) extended (6-43 
months) or (2) limited (<6 months) experience 
of deprivation 
49 
Cases N=16 (1) and 
N=17 (2) 
15 (--) 
7 (43.7) (1) 
9 (52.9) (2) 
Buccal cells 




*28.1 (7.9) *8 (25) 
Peripheral 
blood 
Lee et al., 2012  FEP patients  
52 
Cases* N=26 
SCZ N=16 (61.5%), 
Schizoaffective disorder N=1 (3.8%), 
Schizophreniform disorder N=8 
(30.8%), 
Delusional disorder N=1 (3.8%) 
*29.1 (5.1) *15 (5.3) 
Peripheral 
blood 
Levine et al., 2015  




73.2 (9.5); 51-95 51 (44.7) 
Peripheral 
blood 
Misiak et al., 2015  
First Episode Schizophrenia (FES) subjects 
with CT (FES+) 
94 




*25.2 (4.17) 42 (44.7) 
Peripheral 
blood 
Mondelli et al., 2011  Childhood traumatized FEP subjs 
79 
N=49 FEP (9 w CT) 
FEP 28.2 (0.9) 




Naumova et al., 2012  Institutionalized children 
28 
Cases N=14 
8.25 (--); 7-10 19 (67.8) 
Peripheral 
blood 













Noto et al., 2016  Antipsychotic naïve  FEP patients  
251 
Cases* N=174 
SCZ (53.2 %),  
schizophreniform disorders (17.4 %),  
brief psychotic disorders (12.0 %), 
psychosis NAS (10.9 %),   
psychotic mania (6.5 %). 
* 26.19 (7.56); 16-40  *(62.2) 
Peripheral 
blood 
Ota et al., 2015  Antipsychotic naïve  FEP patients  
146 
Cases* N=73 
SCZ (60.9%),  
schizophreniform disorder (17.2%),  
brief psychotic disorder(14.1%) 
 psychosis NAS (7.8%) 
*26.1 (7.4) *45 (61.6) 
Peripheral 
blood 




schizophreniform disorder (21.3%) 
brief psychotic disorder (12.7%)  
psychosis NAS (6.4%) 
*25.4 (8.0) *32 (62.7) 
Peripheral 
blood 
Provençal et al., 2014  









Provençal et al., 2013  









Radtke et al., 2015  Maltreated volunteers 46 11-21 18 (39.1) 
Peripheral 
blood 
Romens et al., 2015  Physically maltreated children 
56 
Cases N=18 
11-14 30 (53.6) 
Peripheral 
blood 




*25.9 (7.4) *39 (59.1) 
Peripheral 
blood 
Schwaiger et al., 2016  
Healthy individuals w CT 




*52.6 (5.5) *10 (33.3) 
Peripheral 
blood 
Shields et al., 2016 
Women reporting physical/sexual Childhood 




*52.8 (--); 43-78 0 (0) 
Peripheral 
blood 
Smearman et al., 2016  
Traumatized African American 
(CT as a continuous by CTQ)  
389 
Cases N=189 









Suderman et al., 2014  




45 (--) 40 (100) 
Peripheral 
blood 
Tyrka et al., 2012  
Adults with parental death or 
desertion/childhood maltreatment 
99 27.3 (10.4); 18-59 41(41.4) 
Peripheral 
blood 
Van der Knaap et al., 2015  
Dutch Adolescents from the Tracking 
Adolescents’ Individual Lives Survey 





16.2 (--) -- 
Peripheral 
blood 
Van der Knaap et al., 2014 
Dutch Adolescents from the Tracking 
Adolescents’ Individual Lives Survey 





16.1 (--); 14-18 232 (49.5) 
Peripheral 
blood 
Vijayendran et al., 2012  









Wankerl et al., 2014  German healthy adults with early trauma 
133 
Cases N=-- 
23.8 (3.05); 18-30 70 (52.6) 
Peripheral 
blood 
Weder et al., 2014  




10.2 (--); 5-14 80 (42) Saliva 
Yang et al., 2013  
Maltreated children (physically/ 
















Epigenetic modifications/gene expression and CT in FEP  
 
Only one study (Misiak et al., 2015) investigated genome wide DNA methylation 
patterns in patients affected by first-episode schizophrenia with a history of CT, 
collected using Early Trauma Inventory Self Report–Short Form (ETISR-SF) 
(Bremner et al., 2000). Methylation of two repetitive DNA sequences (long 
interspersed element–1 or LINE–1 and B–melanoma antigen or BAGE) was 
assessed using fasting whole peripheral blood samples. Emotional abuse and total 
trauma score predicted lower LINE–1 methylation in subjects with CT in 
comparison with those without CT. Conversely, no significant differences were 
found in BAGE methylation between groups.  
We did not find any article exploring gene target DNA methylation, histone 
modifications, non-coding RNAs or genome wide gene expression in FEP subjects 
with history of CT.  
Two articles (Di Nicola et al., 2013; Mondelli et al., 2011) investigated gene targets 
gene expression profile in FEP, and assessed CT using a modified version of 
Childhood Experience of Care and Abuse (CECA) Questionnaire (Bifulco et al., 
2005). Peripheral blood samples were collected and RNA isolation performed. The 
first study (Di Nicola et al., 2013) found no differences in IL1a, IL1b, IL6, IL8, 
MCP-1, VEGF, EGF,INF-γ and TNFa gene expression between subjects with and 
without CT, while the second (Mondelli et al., 2011) found a negative correlation 
between BDNF gene expression and the number of CT. No significant differences 























Gene(s) Results  
Di Nicola et al., 2013 Gene target gene expression 
IL1a, IL1b, IL6, IL8, MCP-1, VEGF, 
EGF,INF-γ, and TNFa 
NO  significant difference between 
groups 
Misiak et al., 2015 LINE-1 and BAGE methylation Surrogate measure of global DNA  ↓ LINE-1  in association with CT  







Epigenetics modifications/gene expression and CT in healthy samples  
 
Genome wide DNA methylation 
Eleven different studies conducted a genome wide DNA methylation analysis in 
healthy samples with reference to CT: three studies (Cecil et al., 2016; Houtepen et 
al., 2016; Weder et al., 2014) used the Childhood Trauma Questionnaire (CTQ) 
(Bernstein et al., 2003; Bernstein & Fink, 1998)  to explore the presence of CT 
(emotional, sexual and physical abuse; emotional and physical neglect), three (Bick 
et al., 2012; Khulan et al., 2014; Naumova et al., 2012) focused on parental 
separation only, three (Guillemin et al., 2014; Suderman et al., 2014; Yang et al., 
2013) defined the presence of CT (physical and sexual abuse; neglect) on the basis 
of different types of reporting (self-report, family- and school-report), one (Kumsta 
et al., 2016) considered severe early life deprivation (abuse and neglect), and one 
(Provençal et al., 2014) focused on physical abuse only. In seven studies (Bick et 
al., 2012; Guillemin et al., 2014; Houtepen et al., 2016; Khulan et al., 2014; 
Naumova et al., 2012; Provençal et al., 2014; Suderman et al., 2014) out of eleven, 
DNA was extracted from whole peripheral blood samples, in two (Kumsta et al., 
2016, Cecil et al., 2016) from buccal cell samples and in the remaining two studies 
(Weder et al., 2014; Yang et al., 2013) DNA was obtained from saliva. Main 











Bick et al., 2012 
Genome wide 
DNA methylation 
13 500 genes 
180/27 000 differentially methylated CpGs sites between groups.  
Involved 173 genes: 72/173 ↑ and 101/173 ↓ in cases w history of foster care; many involved in 
immune system functioning, inflammatory response, cell cycle, cell development and 
differentiation.  





34 Differentially Methylated Probes (DMP) for Physical abuse: top ranked cg20000641 ↑ located in 
the promoter region of PSEN2 
7 DMP for Sexual abuse: top ranked cg17106653  ↑ located in the promoter region of glutamate 
receptor gene GRIN2D 
118 DMP for Physical neglect: top ranked cg00691266 ↓ in the body of EVPL 
20 for all 3 maltreatment types: top ranked cg08796898 ↑ located in the promoter region of 
HUWE1; top ranked cg10494379 (↓) located in the body of CC2D2A 
Guillemin at el., 2014 
Genome wide 
DNA methylation 
20 318 genes 
430  Differentially Methylated Gene Promoters (DMGP) in association with childhood chronic 
physical aggression: 77 ↑ and 353 ↓ 
25 genes promoters most significantly different; among them NR3C1↓ 
74 functional categories enriched in cell signalling and interaction, inflammatory response and 
behaviour 





NO significant differences between groups  





NO significant differences between groups 





A  ~ 600bp Differentially Methylated Region (DMR), including 9 CpGs, found in chromosome 10 ↑ 












14 000 genes 
914/26 214 differentially methylated CpGs sites between groups: 815/914 ↑ in the institutionalized 
group comparing with controls.  
Involved 838 gene promoters: 744/838 ↑ (control of cellular signalling system and immune 
response) and 94 ↓ (in the institutionalized, many of these genes play a critical role in the 
development and function of the brain. 
Provencal et al., 2014 
Genome wide 
DNA methylation 
20 000 genes 
 
448 DMGP in association with childhood chronic physical aggression: 171 ↑  and 277 ↓  
60 genes promoters most significantly different; among them SLC6A3↑ 
Suderman et al., 2014 
Genome wide 
DNA methylation 
20 533 genes 
997 DMGP in association with CT: 311 ↑ and 686 ↓, affecting 1141  genes 
169/1141 enriched in regulatory functions  134/169 ↓  
230/1141 enriched in developmental functions  172/230 ↓   
125/1141 enriched in cell surface receptor linked signal transduction  46/125 ↓ 
Weder et al., 2014 
Genome wide 
DNA methylation 
> 485 000 
probes 
NO significant differences between groups  
Yang et al., 2013 
Genome wide 
DNA methylation 
> 485 000 
probes 
2868 differentially methylated CpGs sites (on all 23 chr) in association with abuse/maltreatment: ↑ 
methylation values at sites with ↓ methylation values, and ↓ methylation at sites with ↑ methylation 
values. 45 (2%) CpG sites were in 3=UTR regions, 213 (7%) in 5=UTR regions, 848 (30%) were 
promoter-associated; 524 (18%) were in intergenic regions; and 1238 (43%) were on the gene body  
8 genes had signifıcant methylation differences: CCDC85C, FANK1, FRG1, TMED2, WNT3A, 
PTPRN2, SLC29A4, and PTPRN. 
↓ at cg04111177 CpG site on the body of the NR3C1 gene 
 









Gene target methylation 
Eighteen studies (Alexander et al., 2014; Beach et al., 2011, 2010; Duman & Canli, 
2015; Houtepen et al., 2016; Janusek et al., 2016; Klengel et al., 2013; Provençal et 
al., 2013; Radtke et al., 2015; Romens et al., 2015; Shields et al., 2016; Smearman 
et al., 2016; Tyrka et al., 2012; Van der Knaap et al., 2015, 2014;  Vijayendran et 
al., 2012; Wankler et al., 2014; Weder et al., 2014) investigated whether the 
presence of CT would influence gene target methylation: ten (Alexander et al., 
2014; Duman & Canli, 2015; Houtepen et al., 2016; Janusek et al., 2016; Klengel 
et al., 2013; Smearman et al., 2016; Tyrka et al., 2012; Van der Knaap et al., 2015; 
Wankler et al., 2014; Weder et al., 2014) applied the CTQ (Bernstein et al., 2003; 
Bernstein and Fink, 1998), seven (Beach et al., 2011, 2010; Provençal et al., 2013; 
Romens et al., 2015; Shields et al., 2016; Van der Knaap et al., 2014, Vijayendran 
et al., 2012) defined the presence of CT (sexual and physical abuse) on the basis of 
different types of reporting (self-report, Child Protective Service- and school-
report), and one (Radtke et al., 2015) used a German version of the Modified 
Adverse Childhood Experience (MACE) interview (physical and sexual abuse; 
physical and emotional neglect). Only in one study (Weder et al., 2014) out of 18, 
DNA was obtained from saliva, while in the others DNA was extracted from whole 




Table 4: Childhood Trauma and gene target methylation in healthy subjects 
Authors  Epigenetic assessment Gene(s) Results  
Alexander et al., 2014 Gene target methylation SLC6A4 (83 CpG sites) NO significant difference between groups 
Beach et al., 2011 Gene target methylation SLC6A4 (71 CpG sites) ↑(overall mean) in sexually abused females 
Beach et al., 2010 Gene target methylation SLC6A4 (26 CpG sites) ↑(overall mean) in abused; ↑at CpG1 and 3 in abused females  
Duman & Canli, 2015 Gene target methylation 
SLC6A4 (2 upstream 
amplicons; 79 CpGs sites) 
NO significant difference between groups 
Van der Knaap et al., 
2015 
Gene target methylation SLC6A4 NO significant difference between groups 
Vijayendran et al., 2012 Gene target methylation SLC6A4 (16 CpG sites) Methylation of cg22584138 and cg05016953 was influenced by sex abuse history. 
Wankerl et al., 2014 Gene target methylation SLC6A4 (83 CpG sites) NO significant difference between groups 
Weder et al., 2014 Gene target methylation SLC6A4 (16 CpG sites) NO significant difference between groups 
    
Radtke et al., 2015 Gene target methylation NR3C1  (exon 1F) (41 CpGs) 
NO significant difference between groups in average methylation.  
↑ in maltreated at cg17860381 







Shields et al., 2016 Gene target methylation 
NR3C1 (promoter region, 
CpG island shore) 
↑ in abused, w a clear dose – response relation 
Tyrka et al., 2012 Gene target methylation NR3C1 (exon 1F) (13 CpGs) 
↑  at CpG 1 in subjects with loss;  
↑  at CpG 3 in maltreated and in subjects with loss 
Van der Knaap et al., 
2014 
Gene target methylation 
NR3C1 (3 amplicons and 
exon 1F) 
↑ in amplicon 1, 2 (which includes exon 1F ) and 3 in traumatized  
Weder et al., 2014 Gene target methylation 
NR3C1 (promoter region, 41 
CpGs) 
↓in maltreated 
    
Klengel et al., 2013 Gene target methylation 
FKBP5 (glucocorticoid 
response element or GRE) 
↓at intron 7 in CA exposed – risk allele carriers  
Weder et al., 2014 Gene target methylation 
FKBP5 (both body and 
promoter region, 34 CpG 
sites) 
↓in maltreated 
    
Provençal et al., 2013 Gene target methylation 
IL-1a, IL-6, IL-4, IL-10, and 
IL-8 
48 (↑ or ↓) methylated regions (none in the promoters of the target genes) 
associated with physical aggression 
↓ IL-6 (involved a region 2042 bp upstream and close to the IL-6 transcription start 
site TSS) 







    
Provençal et al., 2013 Gene target methylation NFkB1, NFAT5, and STAT6 
66 (37+19+10) differentially (↑ or ↓) methylated regions associated with physical 
aggression 
Houtepen et al., 2016 Gene target methylation KITLG ↑ in cg27512205 in association with CT 
Smearman et al., 2016 Gene target methylation OXTR (18 CpGs) ↑ in cg04523291 and cg02192228 in association with CT 
Weder et al., 2014 Gene target methylation 
BDNF (gene body, 77 CpG 
sites) 
↓ in maltreated;  
 








The most explored genes were: SLC6A4 (Alexander et al., 2014; Beach et al., 2011, 
2010; Duman & Canli, 2015; Van der Knaap et al., 2015; Vijayendran et al., 2012; 
Wankler et al., 2014; Weder et al., 2014), NR3C1 (Radtke et al., 2015; Romens et 
al., 2015; Shields et al., 2016; Tyrka et al., 2012; Van der Knaap et al., 2014; Weder 
et al., 2014), FKBP5 (Klengel et al., 2013; Weder et al., 2014), and  IL-1a, IL-6, 
IL-4, IL-10 and IL-8 genes (Janusek et al., 2016; Provençal et al., 2013). A single 
study analyzed KITLG (Houtepen et al., 2016), one explored OXTR (Smearman et 
al., 2016), one BDNF (Weder et al., 2014), and one NFkB1, NFAT5 and STAT6 
(Provençal et al., 2013).  
Five studies (Alexander et al., 2014; Duman & Canli, 2015; Van der Knaap et al., 
2015; Wankler et al., 2014; Weder et al., 2014) out of the eight exploring SLC6A4 
methylation found no significant differences between subjects with and without CT. 
The remaining studies (Beach et al., 2011, 2010; Vijayendran et al., 2012) showed 
a significant influence of CT on SLC6A4 methylation. An association was found 
between changes in SLC6A4 methylation (specifically at CpG residues 
cg22584138 and cg05016953) and sexual abuse (Vijayendran et al., 2012). 
Moreover, a hyper-methylation of SLC6A4 characterized sexually and/or 
physically abused women (Beach et al., 2011, 2010): they showed both an overall 
hyper-methylation early in the promoter region (CpG1-17) (Beach et al., 2011) and 
at CpG1 (cg25586514) and CpG3 (cg25586527) (Beach et al., 2010) in comparison 
with non-abused. 
Six studies (Radtke et al., 2015; Romens et al., 2015; Shields et al., 2016; Tyrka et 
al., 2012; Van der Knaap et al., 2014; Weder et al., 2014) investigated DNA 
methylation of NR3C1 in relation to CT, and five of them (Radtke et al., 2015; 
Romens et al., 2015; Shields et al., 2016; Tyrka et al., 2012; Van der Knaap et al., 
2014) found an hyper-methylation in traumatized subjects. Women most frequently 
physically abused showed significantly higher mean percent methylation levels in 
comparison with non-abused (Shields et al., 2016). A dose–response relation was 
observed and a trend of increasing methylation levels resulted significantly 
associated with increased severity of abuse. CT was also shown to increase 
methylation levels at specific single CpGs sites in exon 1F of NR3C1: hyper-
methylation was demonstrated at CpGs 3, 6 and 7 in maltreated children (Romens 
 
 
et al., 2015), at CpGs 1 and 3 in children whose mother and/or father had died 
(Tyrka et al., 2012); in amplicon 2 (which covers Exon1F ) in sexual abused 
adolescents (Van der Knaap et al., 2014) and at cg17860381 in maltreated children 
(Radtke et al., 2015).  Conversely, a sixth study (Weder et al., 2014) showed reverse 
results, finding a significant hypo-methylation at NR3C1 promoter region in 
association with maltreatment.   
Associations between CT and hypo-methylation of FKBP5 (Klengel et al., 2013; 
Weder et al., 2014), IL-6 (Provençal et al., 2013; Janusek et al., 2016) and BDNF 
(Weder et al., 2014) and between CT and hyper-methylation of KITLG (Houtepen 
et al., 2016) and OXTR (Smearman et al., 2016) were also found. Finally, 66 
differentially methylated regions (both hyper-methylated and hypo-methylated) 
were demonstrated in physically abused subjects involving NFkB1, NFAT5 and 
STAT6 genes (Provençal et al., 2013) in comparison with non-abused.  
 
Histone modifications 
We did not find any article exploring this issue.  
 
Non-coding RNA 
Four studies (Bick et al., 2012; Guillemin at el., 2014; Provençal et al., 2014; 
Suderman et al., 2014) explored the methylation of non-coding RNA genes in 
healthy subjects with reference to CT. Two of them (Guillemin at el., 2014; 
Suderman et al., 2014) defined the presence of CT (physical and sexual abuse; 
neglect) on the basis of reporting (self- and school-report), one (Bick et al., 2012) 
focused on parental separation, and one (Provençal et al., 2014) on physical abuse. 
In all four, DNA was extracted from whole peripheral blood samples. Main findings 





Table 5: Childhood Trauma and microRNA methylation in healthy samples 
 
↑ = hyper-methylated; ↓ = hypo-methylated 
  
Authors  Epigenetic assessment Gene(s) Results  
Bick et al., 2012 microRNA methylation 110 microRNA   NO significant differences between groups  
Guillemin at el., 2014 microRNA methylation 400 microRNA   NO significant differences between groups  
Provencal et al., 2014 microRNA methylation 400 microRNA   
12  differentially methylated microRNA promoters in association with childhood chronic physical 
aggression: 2 ↑ and 10 ↓  







Genome wide gene expression 
Only one study (Schwaiger et al., 2016) investigated genome wide gene expression 
profile in traumatized healthy subjects. CT was defined by a German version of CTQ 
(Bernstein et al., 2003; Wingenfeld et al., 2010) and included emotional, sexual and 
physical abuse, emotional and physical neglect. Peripheral blood samples were used for 
gene expression analysis. The study explored differences in gene expression following 
stress exposure (induced by the Trier Social Stress Test paradigm) between trauma and 
no-trauma groups. Out of the 405 transcripts differently expressed at 45’ post stress, 77 
were up-regulated and 69 down-regulated in the traumatized group, and conversely they 
did not change their expression in the non-traumatized subjects. Out of the 608 transcripts 
differentially regulated between the groups at 180’ post-stress, 141 were upregulated and 
86 down-regulated in the CT group and did not change their expression in the non-CT 
group. Among differentially expressed genes, several were involved in hormone activity, 
as steroid binding.  
 
Gene target gene expression 
Three studies (Duman & Canli, 2015; Levine et al., 2015; Wankerl et al., 2014) examined 
gene target gene expression differences between healthy subjects with and without CT.  
Two studies (Duman & Canli, 2015; Wankerl et al., 2014) applied CTQ (Bernstein et al., 
2003; Wingenfeld et al., 2010) while the third (Levine et al., 2015) relied on self-report 
of physical abuse. In all 3 studies, peripheral blood samples were used. Main findings are 
summarized in Table 6.  
Table 7 highlights the strongest findings, based on reproducibility, about epigenetic 
modifications/gene expression in association with CT in both FEP and healthy subjects. 
Notably, replicated findings are not available for methylation and CT in FEP, nor for gene 




Table 6: Childhood Trauma and Gene target gene expression in healthy sample 
↑ = hyper-expressed; ↓ = hypo-expressed 
 
Table 7: Most replicated epigenetic /gene expression modifications in association with CT in both First-Episode of Psychosis and Healthy 
Subjects 
 




Gene(s) Results  
Duman & Canli, 
2015 
Gene target gene 
expression 
SLC6A4 and NR3C1 
NO significant difference between groups for both SCL6A4 and 
NR3C1 
Levine et al., 2015 
Gene target gene 
expression 
IL1B, IL8, and PTGS2 ↑ pro – inflammatory gene expression in traumatized 
Wankerl et al., 2014 
Gene target gene 
expression 
SLC6A4 ↓ in maltreated 
Gene target Methylation in association with CT 
Gene  ↓ or  ↑ Sample group N of study 
SLC6A4 ↑ Healthy subjects 2 (Beach et al., 2011, 2010) 
NR3C1 ↑ Healthy subjects 
5 (Radtke et al., 2015; Romens et al., 2015; Shields et al., 2016; Tyrka et 
al., 2012; Van der Knaap et al., 2014) 
FKBP5 ↓ Healthy subjects 2 ( Klengel et al., 2013; Weder et al., 2014) 








Epigenetics modifications/gene expression in FEP 
 
Genome wide DNA methylation 
Only one study (Nishioka et al., 2013) investigated DNA methylation profile in 
peripheral blood samples from subjects affected by FEP. Among the 27 578 CpG 
sites analyzed, the overall DNA methylation level resulted significantly lower in 
patients in comparison with healthy controls. Hypo-methylation was found at 603 
CpG sites: 589 genes resulted involved, mostly related to nucleotide and 
transcription factor binding.  
 
Gene target methylation  
A single target gene was considered: GCH1. Peripheral blood specimens were 
analyzed. Investigating a total of 37 CpG sites ( Ota et al., 2014), both higher mean 
methylation levels and significant hyper-methylation at 4 CpGs were found in FEP 
subjects: specifically at CpG13, CpG15, CpG16, and CpG21.  
 
Histone modifications  
We did not find any article exploring this issue.  
 
Non-coding RNA  
We did not find any article exploring this issue.  
 
Genome wide gene expression 
Two studies (Kuzman et al., 2009; Lee et al., 2012) investigated genome wide gene 
expression profile in FEP subjects in comparison with healthy controls. RNA was 
extracted from peripheral blood samples. One-hundred and eighty genes were found 
to be significantly differently expressed (115 up-regulated and 65 down-regulated) 
in FEP when compared with healthy controls (Kuzman et al., 2009). Out of these 
180, a subset of genes was selected to be tested as potential markers of FEP: catenin 
gene, CTNNB1, RYBP, RFN10, SLC2A3, zinc metallopeptidase gene, NLN-1, 
MYO1C and DAAM2. Patients showed significantly increased expression of 
 
 
SLC2A3 and DAAM2 and decreased expression of NLN-1 and MYO1C in 
comparison with healthy controls. Moreover, a transcriptomic signature of FEP, 
basing on a 400 genes transcriptomics, was identified and confirmed by three 
different techniques (Lee et al., 2012).  
 
Gene target gene expression 
Finally, six studies (Fusté et al., 2013; Gouvea et al., 2016; Noto et al., 2016; Ota 
et al., 2015, 2014; Santoro et al., 2015) explored gene target gene expression 
differences between FEP and healthy controls. Peripheral blood samples were used 
for gene expression analysis. Twenty-five different genes were investigated: 
COMT,TNF, DISC1, PAFAH1B1, NDEL1, MBP, AKT1, DGCR8, DICER1, 
DROSHA, UFD1L, DGCR2, ABAT, TSPO, CHRNA7, CHRNB1, CHRNE, 
GABRR2, GCH1, GCHFR, TACR2, NRG1, SP1, SP3 and SP4. Three studies 
(Gouvea et al., 2016; Ota et al., 2015; Santoro et al., 2015) analyzed the same panel 
of 12 target genes (COMT, TNF, DISC1, PAFAH1B1, NDEL1, MBP, AKT1, 
DGCR8, DICER1, DROSHA, UFD1L and DGCR2), one (Noto et al., 2016) 
explored a subset of nine target genes from the same panel (COMT, TNF, DISC1, 
NDEL1, MBP,  AKT1, DICER1, DROSHA, and UFD1L), one (Ota et al., 2014) 
focused on 11 genes (COMT, ABAT, TSPO, CHRNA7, CHRNB1, CHRNE, 
GABRR2, GCH1, GCHFR, TACR2 and NRG1) and one study (Fusté et al., 2013) 
examined SP1, SP3 and SP4. FEP patients showed significantly hyper-expression 
of MBP, NDEL1 (Gouvea et al., 2016; Noto et al., 2016; Ota et al., 2015), AKT1 
and DICER1 (Gouvea et al., 2016) and hypo-expression of COMT, DISC1, 
DROSHA (Noto et al., 2016) and GCH1 (Ota et al., 2014) when compared with 
healthy controls.  
 












Gene(s) Results  




27 578 CpG sites (72·5% inside CpG 
islands), 14 475 genes 
↓  mean levels at all CpG sites in FEP vs healthy controls (HC) 
↓  mean levels at CpG sites inside CpG islands in FEP vs HC 
↓ at 603 CpG sites (covering 589 genes and located in 96·4% of cases 
inside CpG islands)  in FEP vs HC 
Top ranked involved genes: CLDN12 and BCDIN3.  
Enrichment of genes related to the nuclear lumen, to nucleotide binding 
and transcription factor binding (both genders). Enrichment of 
mitochondrion-related  genes  (female only).  
    
Ota et al., 2014 
Gene target 
methylation 
GCH1 promoter region (37 CpGs) 
↑ mean levels in FEP vs HC 
↑ at CpG13, 15, 16 and 21 in FEP vs  HC 
    




22 283 probes, 11 000 genes 
180 gene differently expressed in FEP vs HC: ↓ 115/180, ↑ 65/180  
Genes with altered expression included genes from different functional 
groups: transcription/RNA processing, ubiquitin, lipid/glucose/protein 
metabolism, signal transduction and cytoskeleton. 
↑ SLC2A3 and DAAM2  in FEP vs HC; ↓ neurolysin 1 and myosin C  in 
FEP vs HC  
Lee et al., 2012 
Genome wide 
gene expression 
400 genes  
Found a blood-based, gene expression “signature” that classified FEP from 
HC 









↑ = hyper-methylated/expressed; ↓ = hypo-methylated/expressed 
 
  
Fusté et al., 2013 
Gene target gene 
expression 
SP1, SP3, and SP4 NO  significant difference between FEP and HC 
Gouvea et al., 2016 
Gene target gene 
expression 
COMT, TNF, DISC1, PAFAH1B1, 
NDEL1, MBP, AKT1, DGCR8, DICER1, 
DROSHA, UFD1L, and DGCR2 
↑ MBP and NDEL1 in FEP (both SCZ and BD) vs HC 
↑ AKT1 and DICER1 in FEP BD vs  HC 
Noto et al., 2016 
Gene target gene 
expression 
COMT,  TNF, DISC1, NDEL1, MBP,  
AKT1, DICER1, DROSHA, and UFD1L 
↑  MBP and NDEL1 in FEP vs  HC 
↓ DROSHA, COMT, and DISC1 in FEP vs  HC 
Ota et al., 2015 
Gene target gene 
expression 
COMT, TNF, DISC1, PAFAH1B1, 
NDEL1, MBP, AKT1, DGCR8, DICER1, 
DROSHA, UFD1L, and DGCR2 
↑ MBP and NDEL1 in FEP vs HC 
Ota et al., 2014 
Gene target gene 
expression 
COMT, ABAT, TSPO, CHRNA7, 
CHRNB1, CHRNE, GABRR2, GCH1, 
GCHFR, TACR2, and NRG1 
↓ GCH1 in FEP vs HC 
Santoro et al., 
2015 
Gene target gene 
expression 
COMT, TNF, DISC1, PAFAH1B1, 
NDEL1, MBP, AKT1, DGCR8, DICER1, 
DROSHA, UFD1L, and DGCR2 








CT might profoundly influence epigenetic programming (McGowan 2013). 
Environmental mediation of the epigenome, and aberrant epigenetic regulation, 
could therefore provide a mechanism for the gene-environment interaction 
underlying psychosis. The principal aim of the present review was to summarize 
the evidence relating to the epigenetic modifications associated with CT in both 
subjects affected by FEP and healthy samples. Despite the known impact of CT on 
people with psychosis and the attention paid recently to epigenetics and gene 
expression, available studies were only three. The existing evidence is therefore 
very limited and no definitive conclusions can be drawn from these findings. 
Waiting for more robust evidence, findings regarding specific modifications 
associated with CT in FEP indicate that CT entails global DNA hypo-methylation 
(Misiak et al., 2015) and reduced BDNF gene expression (Mondelli et al., 2011). 
CT-associated lower DNA methylation could have a functional relevance to gene 
regulation and/or be responsible for genomic instability, which has been previously 
observed in schizophrenia (Shimabukuro et al., 2007; Smith et al., 2010). A similar 
global DNA hypo-methylation was also found in FEP subjects (Nishioka et al., 
2013) when compared with controls, not taking into account the presence of CT. 
Further investigations are therefore required to elucidate whether the global hypo-
methylation is to be considered as an epigenetic consequence of CT or a trait of 
psychosis. Reduced BDNF mRNA levels associated with CT in FEP (Mondelli et 
al., 2011) could result in altered neuroplasticity, since FEP subjects were also 
characterized by a smaller left hippocampal volume. Conversely, no association 
was found between CT and BDNF gene expression in healthy subjects (Mondelli 
et al., 2011), standing unclear whether the reduced BDNF gene expression is to be 
ascribable to a specific effect of CT, independently from the presence of psychosis. 
We need for large, well-designed case-control studies enrolling FEP both with and 
without CT to generate biologically relevant information on epigenetic and gene 
expression modifications.   
Findings about CT and epigenetic modifications in healthy subjects could 
potentially help to shed some light on biological vulnerability factors for psychosis, 
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especially when conducted in children and adolescents not (or not yet) affected by. 
Genome wide DNA methylation studies in children and adolescents (Bick et al., 
2012; Cecil et al., 2016; Kumsta et al., 2016; Naumova et al., 2012; Yang et al., 
2013) showed that differently methylated genes associated with CT were enriched 
in: neurotoxin metabolism (Kumsta et al., 2016), central nervous system 
development (Cecil et al., 2016; Naumova et al., 2012; Yang et al., 2013), plasticity 
and degeneration, DNA repair mechanisms, neuronal signaling and interaction 
(Cecil et al., 2016; Naumova et al., 2012), immune system and inflammatory 
response (Bick et al., 2012; Naumova et al., 2012). In adults, differently methylated 
(Guillemin et al., 2014; Provençal et al., 2014; Suderman et al., 2014) or expressed 
(Schwaiger et al., 2016) genes associated with CT were enriched in: regulation of 
chromatin and histone modification, regulation of transcription factor binding, 
development of multicellular organismal (Suderman et al., 2014), cell signaling 
(Guillemin et al., 2014; Provençal et al., 2014; Schwaiger et al., 2016; Suderman et 
al., 2014), and inflammatory response (Guillemin et al., 2014; Provençal et al., 
2014; Schwaiger et al., 2016). Alterations in any of these processes might be 
responsible for an increased vulnerability for psychosis because each of them refer 
to several pathological models of schizophrenia (Sullivan 2012). The connection 
between methylation and gene transcription, and between mRNA levels and protein 
are critical to the hypotheses assuming biological changes as a consequence of CT. 
A significant hyper-methylation of SLC6A4, NR3C1, KITLG and OXTR promoter 
regions was found in association with CT in healthy subjects. A hyper-methylation 
of the gene promoter region is usually associated with a reduced gene expression 
due to a closer chromatin structure (Schübeler 2015). Thus, it is possible to 
speculate that CT led to a significant reduction in SLC6A4, NR3C1, KITLG and 
OXTR gene expression, with a subsequent dysfunction of serotonergic 
neurotransmission (SLC6A4), stress-reactivity (NR3C1, KITLG) and social 
behavior and bonding (OXTR). In line with this hypothesis, CT was found 
associated in healthy subjects with a reduced SLC6A4 gene expression (Wankerl et 
al., 2014), while to date no evidence supports a reduced NR3C1, KITLG and OXTR 
gene expression in association with CT. A significant gene promoter hypo-
methylation of FKBP5 (Klengel et al., 2013; Weder et al., 2014) and IL-6 (Janusek 
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et al., 2016; Provençal et al., 2013) was also reported in association with CT in 
healthy subjects leading hypothetically to an increased transcriptional gene 
expression (Schübeler 2015). FKBP5 is an important functional regulator of the 
stress hormone system. It down-regulates the glucocorticoid receptor (GR) complex 
activity, decreasing ligand binding and impeding complex translocation to the 
nucleus (Scammell et al., 2001; Wochnik et al., 2005). In normal condition, GR 
activation mediates the cessation of the stress response once removed the stimulus 
(Binder 2009). A CT-dependent hypo-methylation in the FKBP5 promoter region 
(Klengel et al., 2013; Weder et al., 2014) might therefore be linked to an increased 
gene transcription and to an enhanced GR complex activity down-regulation. It 
could in turn result in a long-term dysregulation of the stress hormone system and 
entails effects on brain areas associated with stress regulation. IL-6 is a pro-
inflammatory cytokine. IL-6 promoter region hypo-methylation significantly 
associated with CT (Janusek et al., 2016; Provençal et al., 2013) might result in 
higher gene expression, and thus contribute to create a pro-inflammatory, stress-
vulnerable phenotype. Finally, BDNF gene was found significantly hypo-
methylated within its body in healthy subjects with CT (Weder et al., 2014). Being 
methylation within gene bodies positively correlated with gene expression (Portela 
and Esteller, 2010), CT could thus be associated with reduced BDNF gene 
transcription. Significantly increased pro–inflammatory genes gene expression 
(including IL1B, IL8 and PTGS2) was also demonstrated in association with CT 
(Levine et al., 2015), in line once more with the hypothesis of a CT-related 
dysfunction of the stress response system. 
Finally, significant differences in terms of miRNAs methylation between healthy 
subjects with and without CT were observed (Provençal et al., 2014; Suderman et 
al., 2014). MiRNAs are small, non-coding RNA molecules. Despite the poor 
understanding of miRNAs expression regulation, it appears reasonable that 
epigenetics (e.g. methylation) could control miRNAs transcription (Chuang and 
Jones, 2007). In turn, miRNAs would exert their epigenetic regulatory function by 
binding target mRNAs, down-regulating mRNAs translation, finally repressing 
mRNAs expression. Difference in this regulatory function could thus be implicated 
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in the enhanced vulnerability for psychosis observed in subjects with a history of 
CT. 
Aiming to explore the relative role of psychosis itself in determining epigenetic 
modifications, we finally reviewed the available knowledge concerning these 
modifications in FEP. As discussed above, a global DNA hypo-methylation was 
not only found in FEP subjects with CT (Misiak et al., 2015) but also in FEP 
subjects when compared with controls, without taking into account the presence of 
CT (Nishioka et al., 2013). This last finding appears in line with previous results 
(Melas et al., 2012; Shimabukuro et al., 2007) which demonstrated global DNA 
hypo-methylation in schizophrenia. It stands therefore unclear whether the global 
hypo-methylation is to be considered as an epigenetic consequence of CT or a trait 
of psychosis. Genome wide DNA methylation and genome wide gene expression 
studies showed that differently methylated  or differently expressed  genes in FEP, 
when compare with healthy controls, were related to nucleotide and transcription 
factor binding, mitochondrion functioning, lipid/glucose/protein metabolism, 
signal transduction and RNA processing. Such alterations could be considered both 
a direct (expression of a true biological difference) and an indirect (for example 
related to environmental exposures) manifestation of the psychosis. FEP subjects 
showed a significantly increased methylation and reduced GCH1 gene expression 
(Ota et al., 2014). GCH1 is located in chromosome 14 and it is involved in the 
tetrahydrobiopterin (BH4) production, which in turn, as a cofactor enzyme, plays 
an important role in the synthesis of dopamine and serotonin (Richardson et al., 
2005). Therefore, GCH1 altered methylation and expression, observed in FEP could 
potentially entail a neurotransmission dysfunction. Finally, MPB, NDEL1, AKT1 
and DICER1 were found hyper-expressed, while DROSHA, COMT, and DISC1 
resulted hypo-expressed in FEP in comparison with healthy controls. They are all 
involved in a variety of CNS functions including neurodevelopment, plasticity and 
neurotransmission (Gouvea et al., 2016; Noto et al., 2016). Notably, none of the 
studies investigating epigenetic modifications in FEP, explore the potential role of 
environmental exposures, such as CT.  
In conclusion, childhood trauma appears associated in both FEP and healthy 
samples with a variety of epigenetics modifications and seems linked to specific 
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gene expression profiles. Some alterations observed in FEP are most probably 
ascribable to the psychosis itself, rather than to CT, while some other modifications 
found in healthy subjects could represent vulnerability factors for psychosis. 
However, the understanding of how, at a biological level, childhood trauma is 





1.5 PSYCHO-SOCIAL CORRELATES OF THE ASSOCIATION 
BETWEEN CHILDHOOD TRAUMATIC EXPERIENCES AND SEVERE 
MENTAL DISORDERS  
 
As aforementioned, from a psychological point of view, the association between 
childhood traumatic experiences and severe mental disorders has been mainly 
explored in light of cognitive processes and meaning attribution, dissociative 
phenomena, and attachment theory.  
Garety et al. (2001) have suggested that childhood traumatic experiences can bias 
attributions of cause towards external sources, eliciting the development of negative 
schemas about the self and others, and in doing so, contributing to the development 
of paranoid delusions. The cognitive models proposed to underline the association 
between childhood traumatic experiences and severe mental disorders have been 
numerous (Larkin & Read, 2008): their common element appears to be the presence 
of cognitive-behavioral patterns, acquired during childhood, determined by 
traumatic experiences, and responsible for the increased vulnerability. The 
experience of abuse would lead, in fact, to the shaping of negative believes about 
oneself, the others and the world, such as "I am vulnerable", "others are unreliable" 
and "the world is threatening/dangerous", which would then condition the reading 
of reality and daily events and would facilitate the development of a severe mental 
disorder (Larkin & Read, 2008).  
Dissociation can be defined as "a disruption in the usually integrated functions of 
consciousness, memory, identity, or perception of the environment" (American 
Psychiatric Association, 2000). It has been suggested to mediate, albeit partially, 
the relationship between trauma and subsequent psychopathology (Gershuny et al., 
2004) and has been shown to account for the association between sexual abuse and 
hallucinations (Perona-Garcelán et al., 2012; Varese et al., 2012b; Chu & Dill, 
1990). A dissociative response to childhood trauma can be considered, within the 
framework of the traumagenic neurodevelopmental model, as the first step of the 
pathway to psychosis (i.e. hallucinations, delusions and dissociative symptoms) 
(Read et al., 2001). Causing impaired reality testing, dissociation can in fact favor 
the experience of psychotic experiences, particularly hallucinations (Kilcommons 
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& Morrison, 2005), in subjects coping from trauma, particularly regarding sexual 
abuse (Varese et al., 2012b). The concept of ‘Self’ described as “…an organized 
and interactive system of thoughts, feelings, identities, and motives that (1) is born 
of self-reflexivity and language, (2) people attribute to themselves, and (3) 
characterizes specific human beings” (Owens, 2003), may be important in relation 
to dissociation and psychosis vulnerability. Several assumptions have been 
theorized, as for example: “…dissociative detachment renders individuals 
vulnerable to psychosis not only because it deprives them of external anchors... In 
addition, it robs them of internal anchors - the sense of being connected to one's 
body, a sense of self or identity, and one's own actions. The result may be not only 
profoundly impaired reality-testing but also severe confusion, disorganization, and 
disorientation” (Allen et al., 1997). Particular attention has been paid to the so-
called self-concept clarity (Campbell et al., 1996, 2003) defined as “the extent to 
which the contents of the self-concept, i.e. the totality of an individual's thoughts 
and feelings with reference to himself as an object (Rosenberg, 1979), are clearly 
and confidently defined, internally consistent, and temporally stable” (Campbell et 
al., 1996). 
There is emerging evidence that evokes a role of self-concept clarity within the 
childhood trauma – dissociation – psychosis pathway, suggesting that levels of 
trauma-related dissociation would be inversely associated with self-concept 
integration (Lutz & Ross, 2003; Pollack et al., 2001). 
 
Childhood traumatic experiences have been strongly associated (OR=41.2) with the 
development of an insecure attachment style (WHO, 2014). Insecure attachment 
styles, both anxious (preoccupied) and avoidant (dismissing), characterized by 
difficulties in trusting others, have also been suggested to represent a factor 
potentially favoring a paranoid attributional style (Bentall & Fernyhough, 2008). 
This hypothesis is line with findings showing significant association between being 
raised in institutional care and paranoia (Bentall et al., 2012), and between insecure 
attachment styles and subclinical paranoia in a non-clinical sample (Pickering et al., 
2008). The attachment theory concerns infant emotional bonding and supposes that 
over time, the child’s perception of the interaction with their primary caregivers 
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would affect the formation of internal working models of the self and others 
(Bowlby, 1973). The development of secure attachment occurs when a positive 
working model is formed. In this case, a feeling of security and safety is established 
and the caregiver is perceived as responsive, accessible, and trustworthy (Bowlby, 
1973). Conversely, adverse interactions lead to negative working models of others 
as unpredictable (anxious/ambivalent) and unavailable (anxious/avoidant) (Gamble 
& Roberts, 2005). Internal working models have been interpreted as archetypes, 
applied throughout a lifetime and shaping individuals’ understanding and 
anticipation of others' behaviour (Bowlby, 1973). Four different attachment styles 
have been outlined (Hazan & Shaver, 1987, Bartholomew & Horowitz, 1991): the 
secure, the preoccupied, the dismissing, and the fearful style. An individual with a 
secure attachment style have a positive view of others and the self. The anxious 
style (preoccupied) reflects a positive view of others and a negative view of the self. 
Individuals seeks to gain approval and acceptance from others, feeling unworthy of 
love. On the opposite, the avoidant (dismissing) attachment style reflects a negative 
view of others and a positive view of the self. Individuals perceived others as 
untrustworthy and rejecting, and although feeling worthy of love, they avoid close 
relationships. Finally, the fearful attachment style reflects a negative view of both 
others and the self: individuals feels unworthy of love and avoids relationships to 
protect against rejection. Insecure attachment styles may act to increase the 
likelihood of mental health difficulties compared to patterns of secure attachment 
(Sroufe, 2005) 
 
Finally, several social correlates, including gender and socio-economic status, also 
seem to be involved within the association between childhood trauma and severe 
mental disorder. On one side, a gender difference in stress reactivity has been 
hypothesized. Women have in fact been shown to be more susceptible to the 
negative consequences of stress in general (Myin-Germeys et al., 2004) and of early 
traumatic experiences, in particular (Myin-Germeys et al., 2007). A recent study, 
described a significant association between childhood sexual abuse and depressive 
symptoms in women but not in men, and suggested that maltreatments may have a 
gender effect on the development of mental disorders (Haug et al., 2015). Finally, 
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although this issue will not be further discussed in this thesis, poverty has to be 
mentioned as a potential mediator of the association between childhood trauma and 
psychosis. Poverty and mistreatment of children go hand in hand. Although there is 
no evidence which shows that poverty causes child maltreatment, poverty and child 
maltreatment share many similar risk factors, and frequently overlap (Jütte et al., 
2014). Moreover, number of studies using varied measures of maltreatment and 
adult economic outcomes support a specific association between child maltreatment 
and a range of poverty-related outcomes (Bywaters et al., 2016 – JFR Report): 
mistreated children are more likely to live in poverty in their adulthood. On the 
other side, it cannot be denied the importance of poverty as a variable adversely 
influencing health. In Bridging the Gaps, the World Health Organization (1995) 
states, ‘The world’s most ruthless killer and the greatest cause of suffering on earth 
is extreme poverty.’ It is a well-recognized fact that poverty has important 
implications for health, and can be considered both a determinant and a 
consequence of poor mental health (Langner & Michael, 1963). Subjects living in 
disadvantaged circumstances have been demonstrated to suffer disproportionately 
from common mental disorders and their adverse consequences (Patel et al., 2010; 
Campion et al., 2013; Melzer et al., 2004; Patel & Kleinman, 2003). A systematic 
review showed that the vast majority (70%) of the 115 included studies reported a 
significant and positive association between poverty and mental disorders (Lund et 
al., 2010). Low socio-economic status, lower educational and lower social 
achievement levels, social isolation, economic deprivation and financial debt, 
stressful, unrewarding and de-personalizing work or unemployment, dangerous 
environments, and poor marital relationships, can be considered among the social 
determinants mostly involved (Allen et al., 2014; Murali & Oyebode, 2004). Once 
again, a significant gender-related difference appears to subsist: being equal the 
level of household income, women show higher prevalence of mental disorder than 
men (McManus et al., 2007). 
The relationship between poverty and mental disorder is complex. Two main 
hypotheses have been proposed: social causation (‘breeder’) and social selection 
(‘drift’). The social causation hypothesis asserts that experiencing greater socio-
economic adversities, typical of lower-class living conditions, increases the risk of 
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subsequent mental illness. According instead to the social selection/drift 
hypothesis, mental health can influence socioeconomic achievement and lead 
people to drift down the occupational and social scale, into the lower social class, 

































2.1 THE GET UP PROJECT RESEARCH 
 
The Genetics, Endophenotypes and Treatment: Understanding early Psychosis – 
(GET UP) was a large research program, which aims to compare, at 9 months, the 
effectiveness of a multi-component psychosocial intervention versus treatment as 
usual (TAU) in a cohort of patients with FEP (Ruggeri et al., 2012). They and their 
family members were recruited from all public community mental health centers 
(CMHCs) located in two entire regions of Italy (Veneto and Emilia Romagna), and 
in the cities of Florence, Milan and Bolzano. GET UP research Program was 
constituted by four partner projects including “Psychosis early Intervention and 
Assessment of Needs and Outcome” (GET UP PIANO) Trial and “Genetic data 
Utilization and Implementation of Targeted drug Administration in the clinical 
Routine” (GET UP GUITAR) Project.  
The GET UP PIANO Trial had a pragmatic cluster randomized controlled design. 
The randomized units (clusters) were the CMHCs, and the units of observation were 
the centers’ patients and their family members. Patients in the experimental group 
received TAU plus: 1) cognitive behavioral therapy sessions, 2) psycho-educational 
sessions for family members, and 3) case management. Patient enrolment took 
place over a 1-year period. Several psychopathological, psychological, functioning, 
and service use variables, including the presence of childhood traumatic 
experiences, were assessed at baseline and at 9-months follow-up.  
Several studies were performed exploring data from the GET UP Research 
Program. With reference to childhood traumatic experiences, the effects of early 
adversity were investigated in first-episode psychosis patients in terms of diagnosis 
and lifetime cannabis use (Tomassi et al., 2017), clinical and functional profiles 
(Ritunnano et al, under review), and glucose metabolism (Tosato et al., in 






2.2 THE INFLUENCE OF CHILDHOOD TRAUMA ON DIAGNOSIS AND 
SUBSTANCE USE IN FIRST-EPISODE PSYCHOSIS 
 
Childhood trauma has been associated with first-episode psychosis (Fisher et al., 
2010; Mondelli et al., 2010), affective dysfunction (Nanni et al., 1011; Tunnard et 
al., 2014; Gaudiano & Zimmerman, 2010; Upthegrove et al., 2015), and substance 
use (Madruga et al., 2011; Houston et al., 2011; Konings et al., 2011). In a recent 
case-control study, first-episode psychosis (FEP) patients showed a prevalence of 
physical abuse of 14.0% – 15.2% and a prevalence of sexual abuse of 18.2% (Fisher 
et al., 2010). In another sample of FEP patients, two-fold higher rates of childhood 
trauma were reported in cases compared with controls (Mondelli et al., 2010).  
Exposure to childhood trauma was found to be associated with a two-fold risk of 
both recurrent and persistent depression (Nanni et al., 2011); it predicts lifetime 
suicide attempts in treatment-resistant depression patients (OR 2.79; 95% CI 1.14-
6.84) (Tunnard et al., 2014), and it has been related to the presence of psychotic 
features in mood disorders (Gaudiano & Zimmerman, 2010).  
Finally, childhood trauma has been associated with a higher risk of substance use 
in adolescence and early adulthood in the general population (OR 3.83; 95% 
CI1.29–11.30) (Madruga et al., 2011) and might also have a role in modulating and 
moderating the association between cannabis use and the later development of 
psychosis (Houston et al., 2011). The risk for psychosis is higher in those who have 
been exposed to both childhood trauma and cannabis use compared to those 
exposed to only one of the two. The strength of this association was found to be 
dose-dependent, with higher rates of psychosis as the frequency and severity of 
traumatic experiences increase (Konings et al., 2011).  
Based on the above literature on first-episode psychosis, childhood trauma, 
affective dysfunction, and cannabis use, we aimed to verify, in a large 
epidemiologically representative sample of FEP patients, whether subjects who had 
experienced childhood trauma, when compared with those who had not, show: 1) a 
psychosis onset characterized by a higher rate of affective psychosis and 2) an 






This study, published in 2017 in the British Journal of Psychiatry (Tomassi et al., 
2017) was conducted within the framework of the “Genetics Endophenotypes and 
Treatment: Understanding early Psychosis - Psychosis early Intervention and 
Assessment of Needs and Outcome” (GET UP PIANO) Trial. As aforementioned, 
the GET UP PIANO Trial was a large, multicenter, randomized, controlled trial 
comparing an add-on multi-element psychosocial early intervention with ‘routine 
care’ for subjects affected by FEP and their relatives, provided within Italian public 
mental health services. Detailed information on the study design, sample 
recruitment, and clinical assessment has been reported elsewhere (Ruggeri et al., 
2012). 
The GET PIANO Trial (Ruggeri et al., 2015) was proposed to all community mental 
health centres (CMHCs) located across two northern Italian regions (Veneto and 
Emilia-Romagna) and the urban areas of Florence, Milan, and Bolzano, covering 
an area of 9,951,306 inhabitants. Of 126 CMHCs, 117 (92.8%, covering 9,304,093 
inhabitants) participated. The trial was approved by the Ethics Committees of the 
coordinating center (Azienda Ospedaliera Universitaria Integrata di Verona) and 
each participating unit and was registered with ClinicalTrials.gov (NCT01436331). 
 
Subjects 
All CMHC professionals were asked to refer potential psychosis cases at first 
contact during the index period (Apr 1, 2010-Mar 31, 2011) to the study team. 
Immediately thereafter, a screening questionnaire for psychosis (Jablensky et al., 
1992) was administered. The inclusion criteria to ascertain FEP were: (a) age 18–
54 years; (b) residence within the catchment areas of CMHCs; (c) presence of at 
least 1 of the following symptoms: hallucinations, delusions, qualitative speech 
disorder, qualitative psychomotor disorder, or bizarre or grossly inappropriate 
behavior; or 2 of the following symptoms: loss of interest, initiative, and drive; 
social withdrawal; episodic severe excitement; purposeless destructiveness; 
overwhelming fear; or marked self-neglect; and (d) first lifetime contact with 
CMHCs, prompted by these symptoms. 
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Exclusion criteria were: (a) antipsychotic medication (>3 months) prescribed for an 
identical or similar mental disorder ; (b) mental disorders due to a general medical 
condition; (c) moderate-to-severe mental retardation assessed by clinical functional 
assessment; and (d) psychiatric diagnosis other than ICD-10 for psychosis. 
Since FEP is generally a phase of high diagnostic instability, the specific ICD-10 
codes for psychosis (F1x.4; F1x.5; F1x.7; F20–29; F30.2, F31.2, F31.5, F31.6, 
F32.3, F33.3) were assigned at 9 months. The best-estimate ICD-10 diagnoses were 
made by consensus by a panel of clinicians by taking into account all available 
information gathered in the 9-month follow-up period, as required to apply the Item 
Group Checklist (IGC) of the Schedule for Clinical Assessment in Neuropsychiatry 
(SCAN) (Wing et al., 1990).  
Eligible FEP patients, identified as those who were sufficiently clinically stable, 
gave written informed consent (Ruggeri et al., 2015). 
 
Assessment 
All FEP patients were assessed by 17 independent researchers who underwent 
specific training on the use of the standardized instruments and an inter-rater 
reliability exercise to determine consistency of evaluations between investigators. 
Information about childhood trauma and substance use was collected using the 
Childhood Experience of Care and Abuse-Questionnaire version (CECA-Q) 
(Bifulco et al., 2005) and the Cannabis Experiences Questionnaire (Barkus et al., 
2006), respectively. 
Based on previous literature (Bifulco et al., 2005; Aas et al., 2012), severe sexual 
abuse (SSA) has been defined as “an experience that had to meet at least two of the 
following criteria: the individual knew the perpetrator; the perpetrator was a 
relative; the perpetrator lived in the same household; the unwanted sexual 
experience occurred more than once; the perpetrator touched the child’s genitals; 
the perpetrator forced the child to touch their genitals; the abuse involved 
intercourse.” Severe physical abuse (SPA) has been defined as “a repeated exposure 
to physical violence from parental figures before age 16 that had to meet at least 
two of the following criteria: the abuse consisted of being hit with a belt or stick or 
being punched or kicked; the abuse resulted in an injury, including broken limbs, 
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black eyes, or bruising; the perpetrator was considered to be out of control.” 
Separation has been defined as a detachment from at least one living relative longer 
than 6 months within the first 17 years of life; loss was defined as the death of one 
or both parents during the subjects’ childhood. Subjects were defined as 
“traumatized” if they had experienced at least one trauma: severe sexual abuse, 
severe physical abuse, separation, and/or loss. 
Lifetime substance use, including several types of drugs, was assessed by the 
Cannabis Experiences Questionnaire (Barkus et al., 2006). Subjects were stratified 
into two groups: those who had never used substances and those who had used 
substances at least once in their life.  
 
Description of the sample 
Within the GET UP PIANO Trial, 444 FEP patients identified at the intake with a 
confirmed ICD-10 diagnosis of psychosis at 9 months were assessed. Out of them, 
345 (77.7%) [(57.7% male, mean age 29.8 years (SD ± 9.7)] FEP subjects agreed 
to be interviewed on childhood traumatic experiences and represented the sample 
of the present study. Socio-demographic features and clinical characteristics of the 
sample are shown in Table 9. No significant differences were found with regard to 
socio-demographic or clinical characteristics between subjects who completed the 
CECA-Q and those who did not (data available from the authors), with the 
exception of non-Italian nationality, which was more frequent among those who did 





Table 9: Socio-demographics of patients assessed with CECA-Q (n=345)   






Age at first contact with services, mean (SD) 29.8 (9.7) 
Educational level, n (%) 
Low (primary–middle school) 








Marital status, n (%) 
Unmarried 






































Among the 345 FEP subjects who completed the CECA-Q, 80 (23.2%) received an 
ICD-10 code for affective psychoses, while 265 (76.8%) received an ICD-10 code 
for non-affective psychoses (N=96, 27.8% of schizophrenia; N=169, 49.0% of non-
affective, non-schizophrenic psychosis). 
Regarding childhood trauma, in the 345 FEP subjects, 8.5% experienced severe 
sexual abuse during their childhood, 14.3% reported severe physical abuse, and 
20.4% was separated for more than 6 months from at least one of the parental 
figures and/or lost one of their parents. Thus overall, 37.1% had had at least one 
traumatic experience during their childhood. 
In terms of lifetime substance use, 43.3% out of the 345 FEP subjects reported 
cannabis use, 20.0% referred cocaine use, and 6.3% recalled heroin use. When 
looking at combined lifetime use, we found, as expected, that the totality (100.0%) 
of subjects who referred a lifetime use of heroin had both cocaine and cannabis 
lifetime use. Similarly, subjects who reported a lifetime use of cocaine also had a 
lifetime cannabis use in the 96.3% of cases. Finally, among those with a cannabis 
lifetime use, 52.3% related an exclusive use of cannabis. 
 
Statistical analysis 
The association between categorical variables was evaluated by chi-square or 
Fisher’s exact test, where appropriate. Adjustment for gender was performed in 
univariate logistic regression models, with specific types of traumas as dependent 
variables and diagnosis and substance misuse as independent variables, 
respectively. Interaction between gender and trauma was controlled for in all 





Childhood trauma and diagnosis  
As shown in Figure 4, the overall rate of affective psychosis detected in traumatized 
and non-traumatized subjects was around 24.0% in both groups (23.6% vs 23.8%, 
respectively; p=1.00). Analysing the specific types of traumas, we found a 
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significant association between severe childhood sexual abuse and affective 
psychosis (Χ2=4.9, p=0.040). In particular, 41.7% of subjects who reported severe 
sexual abuse had an affective psychosis compared with 21.6% of non-sexually 
abused subjects; this finding remained significant after adjusting for gender 
(OR=2.2, CI 95% 1.1–6.2; p=0.03). The interaction between gender and trauma was 
not significant. In contrast, the percentage of affective psychosis was lower in 
patients with severe physical abuse than in those without it (15.6% vs 23.7%; 
p=0.25), although this difference was not significant. Moreover, no significant 
difference was found in terms of diagnosis between subjects with a history of 






Figure 4: Association between childhood traumatic experiences and diagnosis   
 
§Childhood trauma (at least 1 among severe sexual abuse; severe physical abuse; loss/separation): 72 out of 
194 (56%) subjects with information available  
 Severe sexual abuse: 24 out of 283 (82%) subjects with information available  
 Severe physical abuse: 45 out of 315 (91%) subjects with information available  





Childhood trauma and substance use 
Concerning cannabis, about one-half (53.6%) of subjects with traumatic 
experiences during childhood had lifetime cannabis use compared with 34.2% of 
those without traumatic experiences (p=0.013) (Figure 5). In particular, cannabis 
use was significantly more frequent among patients reporting severe sexual abuse 
compared with those who did not report severe sexual abuse (68.2% vs 41.0%, 
respectively; p=0.023). This finding remained significant after adjusting for gender 
(OR=4.6 CI 95% 1.7-12.5; p=0.003). The interaction between gender and trauma 
was not significant. On the contrary, no significant association was found between 









§Childhood trauma (at least 1 among severe sexual abuse; severe physical abuse; loss/separation): 69 subjects 
out of 180 (52%) with information available 
Severe sexual abuse:22 subjects out of 261 (76%) with information available  
Severe physical abuse:43 subjects out of 280 (81%) with information available  





Regarding heroin, no significant difference in lifetime use was found between 
traumatized and non-traumatized patients (6.3% vs 5.2%, respectively; p=0.74). 
Instead, severely sexually abused participants reported significantly higher lifetime 
heroin use compared with non-sexually abused subjects (20.0% vs 4.6%, p=0.020). 
This finding remained significant after adjusting for gender (OR=12.6 CI 95% 2.7-
58.1; p=0.001). Similarly, physically abused individuals reported substantially 
higher heroin lifetime use when compared with non-physically abused subjects 
(14.6% vs 4.7%, p=0.030). This finding remained significant after adjusting for 
gender (OR=3.7 CI 95% 1.2-11.3; p=0.020). The interaction between gender and 
trauma was not significant. In contrast, no significant association was found 
between loss/separation and lifetime heroin use (7.9% in exposed vs 6% in non-
exposed; p=0.71).  
Lastly, no significant difference in lifetime cocaine use (23.4% vs 15.8%; p=0.30) 
was found between traumatized and non-traumatized subjects. In particular, no 
significant association was found between severe sexual abuse or loss/separation 
and lifetime use of cocaine. Conversely, severely physically abused participants 
showed higher lifetime cocaine use in comparison with non-physically abused 
patients (31.7% vs 17.4%, p=0.050). This finding gained significance after 
adjusting for gender (OR=2.3 CI 95% 1.1-4.9; p=0.040). The interaction between 
gender and trauma was not significant. 
Overall, severely abused individuals showed a significantly higher frequency of 
lifetime substance use (i.e., cannabis, cocaine, or heroin) than non-abused 




This is the first study to investigate the relationship between childhood trauma and 
affective psychosis in a large FEP sample recruited in a ‘real world’ setting. As 
hypothesized, we found a significant association between affective psychosis and 




In the present study, the frequency of sexual and physical abuse was substantially 
lower than in previous FEP studies (Fisher et al., 2010; Neria et al., 2002). In fact, 
severe sexual abuse was reported in 8.5% of our subjects versus 15.0-18.2% in 
previous works (Neria et al., 2002; Fisher et al., 2010), and similarly, severe 
physical abuse was reported in 14.3% versus 15.2–21.6% (Fisher et al., 2010; Neria 
et al., 2002). Variability in the prevalence of abuse has been widely described 
before. Methodological issues, such as heterogeneity of definition, sample size, and 
demographic and social context issues, have been also identified as possible reasons 
for this variability (Fisher & Craig, 2008). The use of a “severe” abuse category, 
instead of the “abuse” one, might account for differences with other studies. Rates 
of sexual and physical abuse in our sample were 10.6% and 28.6%, respectively. 
Regarding sexual abuse, our rate remains substantially lower than others (Neria et 
al., 2002; Fisher et al., 2010). In contrast, the prevalence of physical abuse is 
basically in line with the literature. The surge of the rate of physical abuse in our 
sample might depend on the inclusion in this category of physical punishments (i.e., 
open-handed smacks) and maltreatments (such as punches and kicks), even when 
occurring once in a lifetime. The social acceptability of corporal punishments as a 
method of education and their consequent high frequency within Italian families 
might therefore explain the data. 
Overall, the lower percentage of abused patients in our sample is consistent with a 
survey carried out in the Italian general population, in which eight children out of 
1000 were reported to be victims of maltreatments; specifically, among minors 
under the care of Child Services, 4.2% was sexually abused, while 6.9% 
experienced physical maltreatment (CISMAI-TDH, 2015). When compared with 
rates from the WHO Global Status Violence Prevention, a discrepancy comes to 
light with Italian rates, which are substantially lower, and other high-income 
countries’ rates (WHO, 2014). In the US, the prevalence of sexual abuse and 
physical maltreatment was 7.0% and 10.0%, respectively; in Canada the prevalence 
was 7.0% and 23.0%, in Australia it was equal to 10.0% and 28.0%, respectively. 
These differences might be due to a more cohesive family and an enhanced social 
support network, which are common in southern European countries (Bertani et al., 
2012), or it could reflect the proneness to silence, connected with the feelings of 
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shame and stigma, related to the experience of trauma (Taylor, 2015). Nonetheless, 
comparing our FEP trauma rates (sexual abuse 10.6%, physical abuse 28.6%) with 
those of the Italian general population (sexual abuse 4.2%, physical abuse 6.9%), 
the results confirm at least a two-fold increase and are consistent with findings 
shown previously (Mondelli et al.,2010) .  
 
Affective psychosis and childhood trauma 
In our study, severely sexually abused FEP subjects had a five-fold higher 
likelihood of receiving a diagnosis of affective psychosis. Our results are in line 
with previous studies, which showed an increased presence of psychotic features in 
both unipolar depression and bipolar disorder when the subject was abused 
(Gaudiano & Zimmerman, 2010; Upthegrove et al., 2015; Hammersley et al., 
2003). Affective symptoms could mediate the victimization-psychosis association. 
Our data are consistent with previous studies (Garety et al., 2007; Gracie et al., 
2007), which advocate a significant role of negative beliefs about self and others 
and of depression and anxiety within the pathway from early trauma to psychosis. 
Most interestingly, only sexual abuse, and not physical abuse, has been proven to 
be a strong and specific risk factor for mental disorders, including major depression 
and anxiety disorder (Fergusson et al., 2013), once more supporting our results. A 
recent study described a significant association between sexual abuse and 
depressive symptoms in women but not in men, suggesting that maltreatments may 
have a gender effect on the development of maladaptive self-images and depression 
(Haug et al., 2015) mediated by a gender difference in stress reactivity. Women 
have in fact been shown to be more susceptible to the negative consequences of 
stress in general (Myin-Germeys et al., 2004) and of early traumatic experiences, 
in particular (Myin-Germeys et al., 2007). In contrast, we did not find any effect of 
gender on the association between severe sexual abuse and affective psychosis. Our 
study did not investigate the presence of depressive symptoms but focused on 
diagnostic category; issues other than gender might therefore be involved and 
explain the discrepancy with previous evidence.  
 
Substance use and childhood trauma  
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In our sample, drug use was found to be associated with both severe sexual and 
severe physical abuse. Traumatized FEP subjects and, in particular, those reporting 
severe childhood sexual abuse showed significantly higher lifetime cannabis use.  
The trauma-cannabis-psychosis association could involve several psychosocial 
elements, contributing to an enhanced vulnerability (Houston et al., 2011), and 
various biological factors, including the dopamine neurotransmitter system 
(Kaufman et al., 2000) and the hypothalamic-pituitary-adrenal axis (Mondelli et al., 
2010). First, childhood trauma has been significantly associated with depression, 
which usually precedes the onset of substance dependence among traumatized 
people (Douglas et al., 2010). Consistent with this, abused FEP subjects in our 
sample more frequently received a diagnosis of affective psychosis when compared 
with those who were not abused. We may therefore hypothesize the role of affective 
symptoms as mediators/modulators of the trauma-cannabis-psychosis association. 
Abused people tend to become more frequently depressed and, thus, might more 
frequently use cannabis to alleviate depressive symptoms or could develop 
dysfunctional coping strategies, such as self-medication, to reduce trauma-related 
stress (Houston et al., 2011). Second, social factors might have a meaningful 
influence: disadvantaged environments, where it is easier to get entrapped into 
substance dependence, and social adversities, such as a low socioeconomic status 
and unemployment, have been shown to be significantly associated with both 
psychosis and childhood trauma (Wicks et al., 2005).  
Finally, it is reasonable to hypothesize that abused and non-abused individuals have 
similar drug misuse patterns but that only the former develop psychosis due to a 
pre-existing enhanced vulnerability (Houston et al., 2011; Tosato et al., 2013).  
Biological factors might also be involved. First, and in line with the “sensitization 
hypothesis,” genetically predisposed subjects, whether exposed to environmental 
risk factors (as childhood trauma and cannabis use) or not, have been proven to 
show an increased dopaminergic response to social stressors. It may lead to stable 
changes in the stress-related dopaminergic response system (Collip et al., 2008) and 
eventually to a subsequent enhanced vulnerability for psychosis. Second, animal 
studies have shown an influence of “environmental” stressors on a rat’s ∆THC 
response (Suplita et al., 2008): under stressful housing conditions (i.e., isolation and 
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food deprivation), THC administration resulted in an increased dopamine uptake 
and significant behavioural abnormalities, not observed in control rats (MacLean et 
al., 1977). Finally, early traumatic experiences have been associated with 
permanent hypothalamus-pituitary-adrenal (HPA) axis over-reactivity (higher 
levels of cortisol) to stressors and changes in brain structures (Read et al., 2001).  
Moreover, we found that both sexual and physical severe abuse experiences were 
also significantly associated with heroin lifetime use, while cocaine lifetime use 
appeared to be associated only with severe physical abuse, which is somewhat in 
line with results from other non-FEP studies (Banducci et al., 2014).  
Our findings seem to be in contrast with a recent study (Duhig et al., 2015) that did 
not find any association between childhood trauma and use of cannabis or other 
illicit drugs. This inconsistency might be partially explained by the different time 
frame used when investigating substance use: the present study explored lifetime 
use, while the other investigated substance use in the previous month. 
 
Strengths and limitations 
GET UP PIANO is the first FEP patient trial performed in a large catchment area, 
corresponding to nearly 10 million inhabitants. Over 90% of CMHCs completed 
the study, demonstrating that the subjects were highly representative of the patients 
treated in the community psychiatric services. We used reliable, internationally 
validated instruments and adopted conservative cut-off points, previously applied, 
to identify only the most severe forms of abuse. Moreover, we systematically 
performed adjustments, excluding the gender effect, known to represent a potential 
confounder on the association between trauma and psychosis (Fisher et al., 2009). 
However, some limitations should also be considered. Reliance on the retrospective 
reporting of abuse might increase the risk of recall bias. However, the reliability of 
patients affected by psychosis in referring trauma has been clearly demonstrated 
(Fisher et al., 2011): their reports were independent from symptomatology, stable 
over the course of time, and generally consistent with other sources of information. 
It has also been proven that retrospective recall yields an underestimation of the 
phenomenon, rather than an overestimation (Hardt et al., 2004).  
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Despite clear evidence of association between trauma, cannabis, and psychosis, our 
data do not elucidate whether childhood traumatic experiences and drug misuse 
represent vulnerability factors for psychosis or environmental stressors that trigger 
the disorder acting on a pre-existing vulnerability. Traumatic experiences and drug 
misuses could both be vulnerability agents, which decrease the subject’s resilience 
in response to other stressors (i.e., migration) and lead to psychosis. They might 
represent two different environmental stressors, acting (in an additive or in a 
multiplicative way) on another type (genetic?) of vulnerability. Childhood trauma 
could enhance vulnerability and cannabis use acts as an exacerbating agent, or 
alternatively, vice versa. Finally, because of the relative rarity of abusive 
experiences resulting in small numbers, no further adjustments for social factors 
(such as employment or socioeconomic status) and/or genetic vulnerability 
(familiarity) have been carried out in the analysis. 
In the future, in addition to clarifying whether cannabis and childhood trauma 
represent vulnerability factors or stressors triggering psychosis, studies should also 
analyze this association, taking into account other environmental variables and/or 
biological markers. A population-based, longitudinal prospective study design, 
with long-term follow-up (from infancy to adulthood) would be most appropriate 
(Poulton et al., 2015). 
 
Overall, this study suggests that FEP patients exposed to childhood trauma 
constitute a distinctive subgroup characterized by diverse features in terms of 
nosology and drug use. It has elucidated, albeit partially, to what extent the presence 
of childhood trauma affects FEP features. Finally, this study may provide some 
important hints for specific therapeutic and/or preventive interventions, which 






2.3 CHILDHOOD TRAUMA AND/OR STRESSFUL LIFE EVENTS AND 
METABOLIC DYSFUNCTION IN FIRST-EPISODE PSYCHOSIS  
 
Introduction 
People with severe mental disorders, including schizophrenia and bipolar disorder, 
have increased mortality rates, 2–3 times higher than the general population 
(Reininghaus et al., 2015) turning into a mortality gap of 10–20 years (Lawrence et 
al., 2013). Epidemiological evidence suggests that physical illness, including 
cardiovascular disease and type 2 diabetes, account for the most of the increased 
mortality risk (Olfson et al., 2015). In details, subjects affected by schizophrenia 
(Mitchell et al., 2013a, 2013b) or bipolar disorder (Vancampfort et al., 2013, 2015a) 
are at higher risk to develop metabolic syndrome when compared with the general 
population. Indeed, subjects affected by schizophrenia have twice the risk of 
developing type 2 diabetes compared to general population (Stubbs et al., 2015): 
traditionally, this association has been attributed to the secondary effects of 
antipsychotics (Vancampfort et al., 2015b) or to sedentary life style or unhealthy 
dietary regimen associated with negative symptoms of psychosis (Samele et al., 
2004). Interestingly, accumulating evidence show abnormal glucose metabolism in 
drug-naïve subjects with schizophrenia (Spelman et al., 2007). Indeed, higher levels 
of insulin (Chen et al., 2013, Pillinger et al., 2017), insulin-resistance (Ryan et al., 
2003; Verma et al., 2009; Arranz et al., 2004, Chen et al., 2013, Pillinger et al., 
2017) and an increased levels of insulin-related peptides (Guest et al., 2010; Guest 
et al., 2011) as C-peptide (Wu et al., 2013) were found in drug-naïve subjects with 
first episode of schizophrenia. In bipolar disorder, it has been demonstrated 
increased levels of some adipokines (like leptin and adiponectin) (Barbosa et al., 
2012) and a reduction of glucagon, GLP-1 e ghrelin blood levels associated with 
increased GIP levels (Rosso et al., 2015), when compared with healthy subjects. 
Interestingly, the abnormal levels of GIP, GLP-1 and ghrelin found in these patients 
do not appear to be associated nor with the medications used neither with the 
presence of diabetes, hypertension or metabolic syndrome (Rosso et al., 2015). 
Finally, a recent work of our group reported a decreased levels of ghrelin, glucagon 
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and GLP-1 in first-episode psychosis (FEP) patients at the onset regards to controls 
and an increased PAI-1 levels (Bocchio-Chiavetto et al., 2018).  
Notably, social determinants of health occurring during childhood have been 
documented to increase the risk for the emergence of both psychosis and metabolic 
dysfunction, providing a conceptual framework to explain this association. 
Specifically, the most studied environmental risk factor common to both conditions 
is childhood trauma (Varese et al., 2012a; Danese & Tan, 2014).  Specifically, 
childhood trauma acting as chronic and severe stress could induce the production 
of elevated levels of glucose and insulin in blood (Deppermann et al, 2014). In 
addition, Hypothalamus-Pituitary-Adrenal (HPA) axis interacts with glucose 
metabolism hormones, like insulin, glucagon, gastric inhibitor peptide (GIP) and 
glucagon-like peptide-1 (GLP-1) (Chong et al., 2014; Nussdorfer et al., 2000) 
increasing the likehood to develop metabolic dysfunction. Insulin has an inhibitory 
activity on HPA axis, while glucagon, GIP and GLP-1 have an enhancing one, 
inducing the release of corticotrophin release hormone (CRH)/adrenocorticotrophic 
hormone (ACTH) (Nussdorfer et al., 2000).  
The association between FEP and metabolic abnormalities (Perry et al., 2016) is 
quite well demonstrated as well as the association between childhood trauma and 
the risk to develop psychosis (Varese et al., 2012a). Nonetheless, up to date only 
one study (Veru-Lesmes et al., 2018) has investigated the possible role of childhood 
trauma in the development of glucose metabolism disorders in FEP, finding that 
FEP patients who were physically abused during childhood have higher levels of 
glycated hemoglobin when compared with other patients.  
Moreover, an excess of recent stressful life events in the year prior to psychosis 
onset was reported (Mansueto & Faravelli, 2017). Although stressful life events in 
adulthood have been associated with enhanced vulnerability to develop metabolic 
disorders (Rutters et al., 2015), type 2 diabetes (Maksimovic et al., 2014), the 
underlying biological mechanisms are still poor explored and up to date the 
relationship between recent stressful life events and metabolic disorders in 
psychosis has not been investigated yet.   
Although it is not known whether a different timing in stress exposure could exert 
differential effects and play different roles in the future development of metabolic 
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related dysfunctions, the underlying biological processes have not been identified 
yet.  
In the frame of the available knowledge, briefly summarized above, we performed 
a study to verify, in a large epidemiologically representative sample of FEP patients 
at their first contact with Italian public mental health services serving a 10 million 
inhabitant catchment area, whether FEP patients with an history of childhood 
trauma and/or stressful life events show a different metabolic biomarker profile 
when compared with non-traumatized subjects. 
 
Methods 
This study was conducted within the “Genetics Endophenotypes and Treatment: 
Understanding early Psychosis (GET UP) Research Program. Detailed information 
on the study design, sample recruitment and clinical assessment has been reported 
elsewhere (Ruggeri et al., 2012; 2015). 
Based on the WHO 10-Country study (Jablensky et al., 1992), the initial target 
group comprised people, with potential psychosis, who had had a first contact with 
any community mental health centres (CMHCs) located in two northern Italian 
regions (Veneto and Emilia-Romagna) and the urban areas of Florence, Milan, and 
Bolzano, during the index period (Apr 1, 2010-Mar 31, 2011). Inclusion criteria 
were: (a) age 18–54 years; (b) residence within the catchment areas of CMHCs; (c) 
presence of at least 1 of the following symptoms: hallucinations, delusions, 
qualitative speech disorder, qualitative psychomotor disorder, bizarre, or grossly 
inappropriate behavior; or 2 of the following symptoms: loss of interest, initiative, 
and drive; social withdrawal; episodic severe excitement; purposeless 
destructiveness; overwhelming fear; or marked self-neglect; and (d) first lifetime 
contact with CMHCs, prompted by these symptoms. Exclusion criteria were: (a) 
prescribed antipsychotic medication (>3 months) for an identical or similar mental 
disorder; (b) mental disorders due to general medical condition; (c) moderate-
severe mental retardation assessed by clinical functional assessment; and (d) 
psychiatric diagnosis other than ICD-10 for psychosis. 
Eligible FEP patients, identified as those who reached the clinical stabilization, 
gave written informed consent to be assessed and to give blood sample, after a 
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complete description of the study. The GET UP project was approved by the Ethics 
Committees of the coordinating center (Azienda Ospedaliera Universitaria 
Integrata di Verona) and each participating unit. 
 
Assessment 
A comprehensive set of standardized instruments was used to collect clinical and 
psychosocial information of subjects. In details, psychopathology was assessed by 
the Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987), depressive 
symptoms by the Hamilton Rating Scale for Depression, (HAMD; Hamilton, 1960) 
and symptoms of mania by the Bech-Rafaelsen Mania Rating Scale (BRMRS; Bech 
et al., 1978). Since FEP is generally a phase of high diagnostic instability, the 
specific ICD-10 codes for psychosis (F1x.4; F1x.5; F1x.7; F20–29; F30.2, F31.2, 
F31.5, F31.6, F32.3, F33.3) were assigned at 9 months. The best-estimate ICD-10 
diagnoses were made by consensus by a panel of clinicians by taking into account 
all available information gathered from the point of enrolment into the study, as 
required to apply the Item Group Checklist  (IGC) of the Schedule for Clinical 
Assessment in Neuropsychiatry (SCAN) (Wing et al., 1990). Lifetime and current 
substance use, including several types of drugs, was assessed by the Cannabis 
Experiences Questionnaire (Barkus et al., 2006). Subjects were divided into two 
groups: those who had never tried cannabis and those who had tried at least once in 
their life. 
Information about childhood trauma was obtained using the Childhood Experience 
of Care and Abuse-Questionnaire version (CECA-Q) (Bifulco et al., 2005). It elicits 
information concerning experiences of childhood adversity before age 17, including 
physical and sexual abuse, separation from at least one of the parental figures longer 
than 6 months, and death of a parent. For the purpose of this study, we defined 
childhood trauma (CT) as having experienced at least one event among sexual 
abuse, physical abuse, separation and/or loss.   
The presence of stressful life events (SLEs) were recorded using a semi-structured 
interview derived from Brown et al. (1973), which was adapted to the Italian 
population (Faravelli & Ambonetti, 1983). The semi-structured interview recorded 
the events of the prior year in detail, as well as the timing and the circumstances in 
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which they occurred. On the basis of these accounts, a couple of assessors evaluated 
the following: a) whether a given event corresponded to any of the events listed in 
the Paykel et al. (1971) scale; b) if it was considered severe (i.e., in the top 20 events 
of the Paykel list); and c) if the life event was “dependent” or “independent.” For 
the purpose of this study, we considered the stressful events judged severe and 
occurred in the last 12 months (death of a family member, sexual or physical abuse, 
being accused of having committed a crime, sentence of imprisonment, being 
exposed to war or natural catastrophes, family breakdown, being removed from 
home, sentimental breakdown, severe physical illness). 
Subjects underwent also a detailed medical examination including tobacco use and 
current drug therapies. BMI (kg/m2) was calculated: weight was measured without 
shoes, and in light indoor clothes, using a balance beam scale; height was measured 
without shoes using a fixed stadiometer.  
 
Biomarker analyses  
An anticoagulant-free tube was draw from each subject in the morning after an 
overnight fast (between 07:00 and 10:00). The tubes were kept at room temperature 
for 2 h followed by 1 h at 4 °C before serum separation by centrifugation (3000 g 
for 15 min). Serum samples were then stored at -80 °C until the time of assays.  
The concentrations C-peptide, Ghrelin, GIP, GLP-1, Glucagon, Insulin, Leptin, 
PAI-1 (total), Resistin and Visfatin were analysed by using the Bio-Plex Pro™ 
Human Diabetes kit (Bio-Rad, CA, USA). In brief, 12.5 µl of each sample were 
diluted 1:4 with the sample diluents, and then 50 µl of the diluted sample were 
incubated in a pre-wet filter plate for 1 hour in the dark with the biotinylated 
detection antibody. Each analyte was detected by the addition of a streptavidin-
phycoerythrin solution and quantified using the BioPlex array reader (Bio-Rad, CA, 
USA). Data acquisition and analysis from the reactions were performed using a 
Bio-Plex system reader. Standard curves were obtained using as reference the 
model given by the manufacturer. Single analytes’ concentrations were calculated 
using the Bio-Plex manager software 6.0. All the measurements were double 





Data were described means (standard deviations) for continuous variables and 
frequencies (percentages) for categorical variables. Differences among groups were 
evaluated by ANOVA with Bonferroni post-hoc comparisons in case of continuous 
variables, while Chi-square test was used for categorical variables. The association 
between adverse events and metabolites’ concentrations was performed by linear 
regression models adjusted for confounders. The procedure was repeated after 
deleting extreme outliers or applying the Box-Cox transformation to the 
metabolites’ concentrations in order to check if conclusions change. 
All p-values were two-tailed with a significance level of 0.05. Statistical analyses 
were carried out by Stata 13.0 for Windows.  
 
Description of the sample 
Within the GET UP Research Project, 211 FEP patients out of 444 (47.5%) 
accepted to give blood specimens (Bocchio-Chiavetto et al, 2018). By considering 
the 201 patients for whom it was possible to determine metabolites’ concentrations, 
192 (95.5%) agreed to be assessed with CECA-Q and 143 (71.1%) were 
interviewed about stressful life events in the last 12 months. Overall, 139 (69.1%) 
patients had information on both childhood trauma and stressful life events and 
constituted the sample to be analyzed. No significant differences were found with 
regard to socio-demographic and clinical characteristics between subjects with 
information about metabolites’ concentrations (n=201) and those without (n=243) 
and between subjects assessed with both CECA and stressful life events (n=139) 
and those not assessed (n=62). Moreover, no differences were found between these 
two sub-samples in metabolites’ concentrations (data available from the Authors). 
Socio-demographic features and clinical characteristics of the sample are shown in 





Table 10: Socio-demographic and clinical characteristics (n=139) 
 
 
Variable Mean (sd) or 
N (%) 
Age at first contact with services (years) 29.9 (9.6) 
Gender  
   Male 
 
81 (58.3%) 
Tobacco use (17 missing) 
   Yes 
 
58 (47.5%) 
Cannabis use (18 missing) 
   Yes 
 
17 (14.0%) 
Psychotropic medications (17 missing) 
   Yes 
 
112 (91.8%) 
Body Mass Index (BMI) (25 missing) 23.4 (3.5) 
Diagnosis 
   Affective psychosis 
   Non affective psychosis (No schizophrenia) 





PANSS at BL (after clinical stabilization)  (1 missing) 
   Positive symptoms 
   Negative symptoms 





HAMILTON at BL (after clinical stabilization) 
   No depression 
   Mild depression 
   Moderate depression 






BRMRS at BL (after clinical stabilization) (1 missing) 
   No mania 
   Doubtful mania 
   Hypomania 









Results   
 
The 139 FEP patients assessed with both CECA-Q and stressful life events and with 
metabolites’ blood concentrations were classified with respect to their traumatic 
experiences as follows: nor CT nor severe stressful events (n=41; 31.1%), no CT 
but at least one severe life event (n=12; 9.1%), CT but no severe life event (n=46; 
34.8%), and both CT and at least one severe life event (n=33; 25.0%). For seven 
patients we had no enough information in order to classify them. 
Comparisons among the four sub-groups with respect to age at first contact with 
services, gender, tobacco use, cannabis use, psychotropic medications, BMI, 
diagnosis, psychopathology, depression and mania at baseline did not find 
significant differences (Table 11), with the only exception of tobacco, whose use 
was found significantly more frequent among patients who experienced both CT 





Table 11: Characteristics of patients classified by experienced traumatic events (n=132) 
 
Variable Mean (sd) or N (%)  
 No CT & no 
severe SLEs 
(n=41) 
No CT & severe 
SLEs 
(n=12) 
CT & no severe 
SLEs 
(n=46) 






Age at first contact with services (years) 28.5 (10.9) 31.6 (11.5) 30.6 (9.2) 29.6 (7.5) 0.677 
Gender  











Tobacco use (16 missing) 











Cannabis use (17 missing) 











Psychotropic medications (15 missing) 











Body Mass Index (BMI) (23 missing) 23.2 (3.1) 24.8 (4.5) 23.5 (3.4) 23.7 (3.6) 0.606 
Diagnosis 
   Affective psychosis 
   Non affective psychosis (No schizophrenia) 



















PANSS at BL (after clinical stabilization)  
(1 missing) 
   Positive symptoms 
   Negative symptoms 


























HAMILTON at BL (after clinical stabilization) 16.9 (6.5) 15.4 (6.2) 17.2 (6.9) 18.4 (7.0) 0.580 
BRMRS at BL (after clinical stabilization)  
(1 missing) 







By considering metabolites’ concentrations, only C-peptide and Insulin showed 
significant differences among the four sub-groups. In detail, C-peptide was higher 
in both groups of patients who experienced childhood trauma (with or without 
SLEs) with respect to those ones who did not experience adverse events, while 
Insulin was higher for patients who declared CT without SLEs with respect to those 





Table 12: Metabolites’ concentrations of patients classified by experienced traumatic events (n=132) 
 
Metabolite Mean (sd)  
 
No CT & no 
severe SLEs 
No CT & severe 
SLEs 
CT & no severe 
SLEs 




C-peptide (3 missing) 0.55 (0.30)a,b 0.68 (0.20) 0.85 (0.58)a 0.86 (0.61)b 0.020 
Ghrelin (1 missing) 1.26 (0.57) 1.57 (0.45) 1.26 (0.49) 1.44 (0.44) 0.123 
GIP (4 missing) 0.15 (0.08) 0.30 (0.47) 0.31 (0.86) 0.17 (0.10) 0.490 
GLP-1 (2 missing) 0.35 (0.07) 0.42 (0.06) 0.39 (0.10) 0.39 (0.09) 0.053 
Glucagon (2 missing) 0.90 (0.30) 0.94 (0.21) 0.98 (0.34) 0.90 (0.17) 0.534 
Insulin (2 missing) 0.29 (0.14)c 0.31 (0.12) 0.47 (0.35)c 0.44 (0.31) 0.014 
Leptin (2 missing) 12.17 (10.32) 9.38 (6.71) 10.15 (8.74) 10.09 (8.08) 0.651 
PAI-1 (2 missing) 41.97 (17.45) 38.76 (24.05) 47.29 (26.13) 44.54 (22.45) 0.588 
Resistin (2 missing) 3.68 (2.59) 3.44 (2.36) 3.96 (2.34) 4.07 (1.94) 0.813 
Visfatin (4 missing) 3.91 (2.16) 7.11 (10.21) 4.92 (8.09) 4.66 (3.97) 0.463 







Multivariate linear regression models estimated the association between each 
metabolite and the experienced traumatic events by taking into account age, gender 
and BMI as confounders. They have been chosen by a series of univariate linear 
regression models with each metabolite as the dependent variable and age, gender, 
tobacco use, cannabis use, psychotropic medications, BMI, diagnosis, PANSS, 
Hamilton and BRMRS as independent variables (p<0.10; data available from the 
Authors). The multivariate models showed that experienced traumatic events 
influenced only the levels of C-peptide and Insulin (Table 13, while Leptin was 
associated with gender and BMI. No other metabolites showed significant 
associations with adverse events and the confounders (data available from the 




Table 13: Multivariate linear regression models for metabolites (only those ones significantly associated with at least one 
independent variable shown)  
 
Independent variables#  Coefficient (p-value) 
EXPERIENCED TRAUMATIC EVENTS C-Peptide Insulin Leptin 
No CT & no severe SLEs (Ref.) 
No CT & severe SLEs 
CT & no severe SLEs 













CONFOUNDERS§    
Age at first contact with services (years) -0.010 (p=0.084) -0.008 (p=0.013) 0.005 (p=0.955) 
Male sex (Ref.) -0.105 (p=0.305) -0.065 (p=0.257) -9.407 (p<0.001) 
BMI 0.055 (p=0.001) 0.035 (p<0.001) 0.660 (p=0.011) 
    
Number of observations 107 108 107 
Prob>F 0.005 <0.001 <0.001 
Adj-R-squared 0.116 0.221 0.293 
 
# No significant association (p<0.05) for Ghrelin, GIP, GLP-1, Glucagon, PAi-1, Resistin and Visfatin (data available from the Authors)  
§ only variables which resulted significantly associated (p<0.05) with metabolites in univariate linear regression models (data available from 






Specifically, we found that patients who showed higher C-peptide concentrations 
were those who: (1) experienced CT (with or without SLEs) and (2) had higher 
BMI; these variables accounted for 11.6% of the variance. Patients who showed 
higher Insulin levels were those who: (1) reported CT (with or without SLEs); (2) 
were younger; and (3) had higher BMI. This model accounted for 22.1% of the 
variance. Finally, Leptin was higher for females and for higher levels of BMI, with 
a percentage of variance explained of 29.3.  
A secondary data analysis was performed after having deleted the extreme outliers 
(defined as values more than Q3+3*IQ) for each metabolite (specifically, 2 for C-
peptide, 4 for GIP, 3 for Glucagon, 1 for Leptin, 4 for Resistin and 9 for Visfatin) 
and having re-estimated the regression models. Moreover, another secondary data 
analysis was performed by applying Box-Cox transformations to the metabolites’ 
distributions. In both cases, the results and the significance remained unchanged 
(data available from the Authors).   
 
Discussion 
To our best knowledge, this is the first study to investigate the relationship between 
childhood trauma, stressful life events, and glucose metabolic biomarkers’ levels in 
a large FEP sample. C-peptide and insulin levels were increased in traumatized 
subjects. Indeed, we found that C-peptide was higher in both groups of patients who 
experienced childhood trauma (those with and those without SLEs) with respect to 
subjects who did not experience adverse events, while Insulin was higher for 
patients who declared CT without SLEs with respect to those ones without 
traumatic events. 
The C-peptide is a polypeptide that connects insulin's A-chain to its B-chain in the 
proinsulin molecule; it is processed and stored in secretory vesicles and released, 
together with the mature hormone insulin, by β pancreatic cells in response to 
hyperglycemia. C-peptide physiologic role has not been clarified yet. C-peptide 
seems to possess anti-inflammatory (Haidet et al., 2012), vasodilatory (Wallerath 
et al., 2003) and antioxidant (Giebink et al., 2013) effects, exerted throughout both 
a direct action on endothelial cells and an indirect one on erythrocytes and immune 
system cells. Insulin, in turn, can be considered the main anabolic hormone of the 
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body and regulates the metabolism of carbohydrates, fats, and protein (Voet & 
Voet, 2011) and has been also prove to exert an inhibitory activity on HPA axis 
(Nussdorfer et al., 2000). Our study is fresh evidence evoking an association 
between childhood traumatic experiences (alone or in association with recent 
stressful life events) and C-peptide/insulin levels in a FEP sample. Nonetheless, 
data coming from an animal study (Balasubramanian et al., 2015) showed a 
significant association between prenatal stress and higher levels of c-peptide; 
however, findings were not associated with abnormal calories intake, weight gain 
or increased fat mass and thus failed to demonstrate a significant association 
between prenatal stress and adulthood obesity. As aforementioned, insulin has been 
also prove to exert an inhibitory activity on HPA axis. Studies in psychosis have 
shown an hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis, the 
main biological system involved in mediating the effects of stress (Borges et al., 
2013), particularly evident at the illness onset, which is often described as the most 
distressing time. Several factors have been hypothesized to explain this 
phenomenon, and among them, a primary role appeared to be played by an 
increased rate of childhood trauma in people who suffered from psychosis when 
compared with the general population (Fisher et al., 2009; Nemeroff, 2004; Read et 
al., 2005). The increase of insulin, and of C-peptide that we found in traumatized 
FEP subjects might therefore reflect an attempt, even though dysfunctional, to 
hinder HPA axis hyper activation having insulin an inhibitory activity on HPA axis. 
The chronic activation of the stress response system is in fact associated with 
increased visceral adiposity and lean mass reduction. Moreover, glucocorticoid 
hormones, like cortisol, stimulate gluconeogenesis and facilitate insulin-resistance, 
whereby chronic HPA axis activation might be at the bottom of the development of 
a lacking glycemic control (Charmandari et al., 2005). In turn, the increase of fat 
mass due to glucocorticoids worsens the insulin resistance and the glycemic control, 
determining a vicious circle consisting in hyper-glycaemia, hyperlipidemia and 
insulin-resistance (Charmandari et al., 2005).  This mechanism might at least 
partially explains the higher incidence of cardiovascular disease, metabolic 
abnormalities and immune system dysfunctions in abused subjects (Parvanidou & 
Chrousos, 2012). Stress response system abnormalities might therefore represent a 
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common factor implied in both mental and metabolic disorders: medical conditions, 
so often present in comorbidities with mental disorders, could then be interpreted 
not only as a consequence of the unhealthy life style and the psychotropic 
treatments, but also as early signs of a multi-systemic dysfunction (Leboyer et al., 
2012). Following this model, childhood traumatic experiences (and perhaps recent 
stressful life events) would bring about stress response abnormalities, as HPA axis 
hyper-activation resulting in higher corticosteroids blood levels, and would 
facilitate the development of medical conditions like diabetes and obesity. In turn, 
they would exert their own influence on the HPA axis, picturing a dysfunctional 
vicious circle. Mental disorders and medical conditions appear thus to be associated 
in a complex and bi-directional relationship. They seem to be influenced 
reciprocally, in terms of clinical manifestation and therapeutic options: life 
expectancy of subjects suffering from severe mental illnesses is 30% lower 
comparing with the one of the general population, cause of the high frequency of 
untreated medical comorbidities (Fagiolini et al., 2009). 
The present study has several strengths. First, FEP patients recruited in the 
present study belonged to GET UP PIANO Trial (Ruggeri et al., 2012), performed 
in a large catchment area, corresponding to nearly 10 million inhabitants. Since over 
90% of Community Mental Health Services (CMHCs) completed the study, and 
since no significant differences were found with regard to socio-demographic or 
clinical characteristics between subjects who gave blood and those which did not 
and between subjects with data on childhood trauma and stressful life events and 
those without, our subjects were highly representative of the patients treated in the 
“real world” CMHS, thus our results could be generalized. Second, we used 
reliable, internationally validated instruments and adopted conservative cut-off 
points, previously applied, to identify only the most severe forms of abuse. Thus, 
our study is, to the best our knowledge, the first attempt to investigate the 
association between childhood traumatic experiences, recent stressful life events, 
and glucose metabolic biomarkers’ levels in a FEP sample.  
Some limitations also need to be acknowledged in our study. First, although our is 
the largest sample of FEP subjects in which the relationship between childhood 
trauma, severe stressful life events and metabolic markers has been investigated, 
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the number of subjects with childhood trauma history was relatively small in size, 
and thus our findings should be considered preliminary and need to be replicated in 
larger samples. Second, a substantial number of tests were performed, which means 
that any Bonferroni correction for multiple testing would be large, thus any 
significant p-value should be regarded as nominal. Third, as for the majority of the 
studies on childhood trauma, abuse data rely on retrospective reporting. This 
limitation has been mitigated by the use of a standardized interview as CECA-Q, 
which has good reliability and validity both in general and clinical populations. 
Fourth, it was not possible to explore the full range of variables known to affect 
glucose metabolism; for example, we did not have data on diet regime or daily 
physical activity. Moreover, blood samples were not taken to verify the 
presence/absence of diabetes by an oral glucose tolerance test (OGTT) according 
to criteria from the American Diabetes Association. Finally, there are the possibility 
that the association between childhood trauma and/or recent severe stressful life 
events with plasma levels of glucose related biomarkers could be mediated not only 
by BMI and smoking, but also by other factors, such as psychosocial elements 
including low socio-economic levels. Information about the type of the ongoing 
medication was not considered; concerning this, findings from literature suggest 
that metabolic abnormalities in subjects suffering from psychosis are independent 
from medication and pre-existing the beginning of pharmacological treatment.  
 
Conclusion 
Our results suggest a significant association between childhood traumatic 
experiences, stressful life events, and metabolic abnormalities in the first phase of 
psychosis. Subjects affected by psychosis are known to possess an increased risk to 
develop a metabolic syndrome (De Hert et al. 2011, Fagiolini et al., 2008). 
Childhood trauma might therefore represent an additional risk factor for the 
development of metabolic disorders in patients affected by psychosis. Based on our 
findings, it would be appropriate and recommended to conduct an accurate and 
meticulous medical history, which takes into account the presence of childhood 
trauma, allows settling an early and intensive program of food and nutrition 





















3.1 HEPATITIS C AND DEPRESSION 
 
The association between depression and inflammation has been the object of several 
studies in recent years; many research goals have been achieved, many others are 
still open questions. A central role of peripherally produced pro-inflammatory 
cytokines (as IL-1, IL-6 and TNFa) has been hypothesized. Peripheral pro-
inflammatory cytokines appear in fact to represent among the main mediators of 
the complex interaction between the peripheral inflammation and the central 
nervous system (Krishnadas & Cavanagh, 2012). In response to a chronic and/or an 
abnormal stimulus, the homeostatic purpose of the inflammatory response would 
be lost and the peripheral cytokines would trigger a dis-adaptive phlogistic state at 
central level. Neurons, astrocytes, and glia seem therefore responsible for the 
“conversion” of the peripheral phlogistic state in behavioral outputs (Miller et al., 
2009). The mechanisms hypothesized to be responsible for the translation in 
behavior of biological, biochemical, and molecular alterations include the 
monoaminergic circuit, the hypothalamic-pituitary-adrenal (HPA) axis functioning 
and neuroplasticity (Capuron & Miller, 2011). A behavioral pattern expression of 
an inflammatory state, observed in pre-clinical studies and defined as "sickness 
behavior"(Mellor & Munn, 1999), in consideration of its affinity with the 
depressive syndrome, represents the starting point of this field of research. The 
inflammation-depression hypothesis has been later supported by at least two further 
orders of evidence: first, it has been shown that depressed subjects have higher 
levels of pro-inflammatory cytokines (Dowlati et al., 2010, Liu et al., 2012) and of 
inflammatory indices (PCR) (Krishnadas & Cavanagh, 2012) than the general 
population; second, subjects suffering from chronic inflammatory disease, such as 
chronic HCV-related hepatitis (Fábregas et al., 2012; Fontana et al., 2002), are more 
frequently depressed than healthy subjects. To date, question remains open whether 
inflammation during depression represents a condition of "state", therefore 
secondary to the pathology, or of "trait" and potentially involved in the development 
of the disorder as a predisposing, triggering, and/or maintenance factor. Moreover, 
it is still to be clarified how biological occurrences in genetics (gene sequence), 
epigenetics (gene expression) and/or proteomics turn into psychological and 
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behavioral phenomena. Finally, it remains to be elucidated the intricate network of 
reciprocity among inflammation (and its biological correlates), environment (such 
as childhood traumatic experiences and stressful life events), psychological aspects 
(like stress perception, coping strategies, and level of self-esteem), and depression. 
The prospective longitudinal study "Chronic inflammation and Major Depression 
in patients with Chronic HCV-related Hepatitis" aims to contribute to the 
clarification of these questions. To this end, subjects with chronic HCV-related liver 
disease were recruited and longitudinally assessed prospectively over the course of 
48 weeks, through the collection of both biological and clinical data. The study 
included a comparison between three groups of subjects: group A, which included 
subjects about to start interferon therapy at baseline, group B, comprising 
individuals about to start direct-acting antivirals (DAAs) at baseline, and group C, 
which included subjects who underwent routine controls for monitoring liver 
disease. We aimed to investigate the direction of the inflammation-depression 
association, to explore potentially involved predictors, and elucidate mediation and 
moderation factors of the association itself.  
The term "depression" is not uniquely referable to a single type of depressive 
disorder. Among the different types of depression, the "inflamed" one is 
characterized by the presence of an absence of motivation and invalidating fatigue. 
In this perspective, it is possible that depressed subjects with increased 
inflammatory indices would suffer from a biologically relevant subtype of 
depression, in which the immune system (peripheral and central) play a key 
pathogenic role (Raison & Miller 2011).  
 
Inflammation and Depression 
As said before, the role of the inflammation, both peripheral and central, in the 
pathogenesis of depression has been the subject of several investigations in the last 
two decades. There is now evidence that proves an important role of the 
inflammation in the development of depression (Patel, 2013) and that demonstrates 
an intricate network of interactions between the immune system and the central (the 
brain) and peripheral nervous system (Krishnadas & Cavanagh, 2012). 
Inflammatory cytokines, including IL-1, IL-6 and TNFa, seem to represent the main 
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mediators of this complex interactive network. Cytokines are in fact believed to be 
responsible not only for the organization of the cellular response to the pathogenic 
stimulus, but also for the behavioral changes necessary to healing. 
In physiological conditions, following a pathogenic stimulus, the cytokine-
mediated pro-inflammatory response is temporary and strictly regulated by a 
balanced anti-inflammatory mechanism. Indeed, under normal conditions, in 
reaction to an inflammatory stimulus, a neuro-immuno-endocrine anti-
inflammatory response develops (involving the sympathetic and parasympathetic 
peripheral nervous system, the immune system and the endocrine-hormonal 
system). An adaptive behavioral response also takes place; it is usually temporary 
and placed under the control of the central nervous system (CNS). 
However, whether the phlogistic stimulus becomes chronic and/or excessive it can 
lead to an out-of-control reaction of the inflammatory system, resulting in the 
development of immune-endocrine disorders (eg excessive production of 
proinflammatory cytokines and/or in a malfunction of the hypothalamic-pituitary-
adrenal axis) and contributing to the occurrence of non-functional behaviors. They 
therefore lose their adaptive purpose and sometimes become clinically relevant and 
attributable to psychiatric syndromes of various kinds, including depression 
(Krishnadas & Cavanagh, 2012). 
Cytokines are relatively large proteins that do not pass the blood-brain barrier 
(BBB) freely. Nevertheless, there is evidence that they are able to reach the brain 
through humoral, neural and cellular mechanisms (Capuron & Miller, 2011). So far, 
there are at least five mechanisms identified, not mutually exclusive, by which 
cytokines would reach the CNS: 
 
1) Through the BBB at regions characterized by a greater permeability, such as the 
choroid plexus and the circumventricular organ (Quan & Banks, 2007; Konsman et 
al., 2002); 
2) Through the BBB, active transported by cytokine-specific transporters located 
on the endothelium (Plotkin et al., 1996; Quan & Banks, 2007; Rivest et al., 2000); 
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3) Through activation of endothelial cells, with the release of  second messengers, 
such as prostaglandin E2 (PGE2) and nitric oxide (NO), at the level of the cerebral 
parenchyma (Quan & Banks, 2007); 
4) Through the activation of afferent nervous fibers, such as those of the Vagus 
nerve, which would transmit the cytokine-mediated pro-inflammatory signal 
(Watkins et al., 1995; Quan & Banks, 2007; Konsman et al., 2002); 
5) Through the entrance into the cerebral parenchyma of activated peripheral 
monocytes (D'Mello et al., 2009). 
 
The activation of these specific mechanisms appears to spread the effect of 
peripherally produced cytokines on the CNS. The inflammatory cellular network in 
the brain, consisting of different elements such as neurons, microglia and 
astrocytes, is therefore activated and an inflammatory state is established. These 
neural inflammatory subjects, organized in complex systems, seem therefore 
potentially involved in the development of psychiatric syndromes (Miller et al., 
2009). 
How a peripheral inflammatory state could result into a mental disorder such as 
depression through brain inflammation is still a matter of investigation. Several 
studies have focused on the monoaminergic neurotransmitter system (tryptophan, 
serotonin and dopamine in the first instance), on the neuroendocrine activity (with 
a primary role of the hypothalamus-pituitary and adrenal axis functioning), and on 
neuroplasticity (Capuron & Miller, 2011). Regarding the action of cytokines on 
monoaminergic neurotransmitters, the "hypothesis of tryptophan depletion" 
(Mellor & Munn, 1999) postulated that there is a relationship between reduced 
levels of tryptophan and the development of depression. A subsequent study 
(Raison et al., 2010b), however, demonstrated the absence of a statistically 
significant difference in terms of liquor levels of tryptophan between subjects with 
depression and healthy subjects. An alternative hypothesis has therefore been 
developed, known as the "neurotoxic hypothesis". According to the latter, the 
activation of the enzyme indoleamin 2,3-dioxygenase (IDO), due to a long-term or 
uncontrolled inflammatory stimulus, would provoke an imbalance of the use of 
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tryptophan in the endothelial cells of BEE favoring the production of Kinurenina 
(Kyn) (at the expense of the production of serotonin, 5-HT).  
IDO is highly inducible by pro-inflammatory cytokines, including interferon-γ 




Figure 6: Degradation of tryptophan through the kynurenine pathway. 
 




Kynurenine, is readily transported across the blood–brain-barrier into the brain 
where it can be further metabolized in perivascular macrophages, microglia and 
astrocytes to generate neuroactive compounds. Kynurenine is degraded along one 
of two catabolic branches, leading to the formation of either 3-hydroxykynurenine 
(3-HK) and quinolinic acid (QA) or kynurenic acid (KA) (Krishnadas & 
Cavanagh,2012). QA is an N-methyl-D-aspartate (NMDA) receptor agonist, it is 
preferentially produced by microglia and can cause oxidative stress and lipid 
peroxidation. By contrast, KA is an NMDA receptor antagonist produced by 
astrocytes and it has been speculated to be neuroprotective (Schwarcz & Pellicciari, 
2002). An increased production of QA together with an enhanced production of 
microglial glutamate (Schwarcz & Pellicciari, 2002), would cause an increase in 
oxidative stress, with a cytotoxic and a calcium mediated apoptotic effect in the 
CNS (McNally et al., 2008). An imbalance of kynurenine pathway metabolites 
might underlie inflammation-associated depressive disorders. Furthermore, 
cytokines have been shown to influence dopamine (DA) synthesis, release, and re-
uptake. In animal studies, intrathecal administration of kinurenic acid (KA) 
produced a dramatic reduction of extra cellular DA at the striated body (Wu et al., 
2007), whereas IFN-a administration resulted in a reduction of tetrahydro-biopterin 
(4HB) and DA concentration in association with an increase in nitric oxide (NO) 
(Kitagami et al., 2003). 4HB is a cofactor necessary for the synthesis of both NO 
and DA. Therefore, an increased synthesis of NO, occurring under an inflammatory 
drive, could reduce the availability of 4HB and consequently limit the production 
of DA in significant brain regions. 
 
Regarding the action of the cytokines on the neuroendocrine system, the acute 
(short duration) administration of cytokines is able to determine the activation of 
the hypothalamic-pituitary-adrenal (HPA) axis: corticotrophin releasing hormone 
(CRH) is synthetized in the hypothalamic paraventricular nucleus (PVN). Once 
released into the portal circulation, it reaches the pituitary gland and activates the 
secretion of adrenocorticotropic hormone (ACTH), which finally stimulates the 
secretion of cortisol from adrenal glands. Cortisol in turn binds its receptors (GR 
and MR) in multiple target tissues, including also the HPA axis itself; at this level, 
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it is responsible for a negative feedback of both ACTH and CRH secretion (Pariante 
& Lightman, 2008). 
In case, however, of prolonged stimulation this homeostatic mechanism may fail. 
A flattening of the daily curve of cortisol values was observed with a significant 
increase in the evening values in association to a chronic stimulation by pro-
inflammatory cytokines (Raison et al., 2010a). A chronic stimulation of the HPA 
axis can be responsible for its malfunction through an inhibitory effect on 
glucocorticoid (GR) receptors. It has been demonstrated that pro-inflammatory 
cytokines can reduce the functionality of glucocorticoid (GR) receptors: cytokines 
were shown to inhibit both cytoplasm-nucleus translocation and DNA binding, and 
were proven to influence the expression of receptors’ isoforms, stimulating the 
production of a relatively inert isoform (Pace et al., 2007). It would result in 
increased levels of circulating corticosteroid hormones, due to an altered HPA 
cortisol-axis negative feedback mechanism and mediated, at least in part, by 
glucocorticoid receptor resistance. 
 
To conclude, cytokines also appear to exert an effect on neuronal plasticity 
(neurogenesis) and to influence neuronal circuits. In a context of chronic stress, the 
levels of pro-inflammatory cytokines has been significantly associated with a 
decreased production of neuronal growth factors and with a reduced neurogenesis, 
especially in the hippocampus (Duman & Monteggia 2006). Neuro-imaging studies 
have also extensively demonstrated how pro-inflammatory cytokines influence 
neuronal circuits in both cortical and subcortical levels, including an action at the 
basal ganglia and anterior cingulate cortex (ACC). The former play a fundamental 
role in determining motor activity and motivating force, while the latter is involved 
in the modulation of affective responses (such as anxiety and depression), alertness 
and vigilance (Capuron & Miller 2011). 
 
In summary, it has been hypothesized that peripheral pro-inflammatory cytokines 
would affect the brain by one or more of the aforementioned mechanisms, which in 
turn would lead to poorly adaptive behavioral changes. The presence of 
psychomotor retardation, reduction of appetite and body weight, sleep disturbances, 
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increased perception of pain, inability to experience pleasure, have been observed 
in animals affected by microbial infection, and therefore characterized by a chronic 
inflammatory state a long time ago (Hart, 1988). This set of behavioral 
characteristics was given the name of "sickness behavior". The "sickness behavior” 
could be reliably reproduced in the laboratory by the administration of pro-
inflammatory cytokines and its effects were reversible through the administration 
of cytokine antagonists or anti-inflammatory cytokines (such as IL-10) (Dantzer et 
al., 2008). The "sickness behavior" represented a reliable experimental model that 
seemed to share some characteristics with the depressive syndrome and led to the 
hypothesis of a role of inflammation in the pathogenesis of depression (Raison et 
al., 2006). 
This hypothesis was subsequently supported by at least three further orders of 
evidence: 
1) Subjects suffering from Major Depressive Disorder (MDD) (even in the absence 
of a medical comorbidity) had mean levels of inflammatory indexes significantly 
higher than healthy subjects did. Specifically, higher concentrations of pro-
inflammatory cytokines were found, such as sIL-2R, IL-6 and TNF-α (Dowlati et 
al., 2010; Liu et al, 2012) in subjects with MDD, both in peripheral blood and in 
cerebral-spinal fluid. 
In addition, approximately one third of those with MDD showed elevated 
inflammatory indices (PCR) compared to the general population. These increases 
were usually modest (2-3 times the values observed in the general population) and 
often within the normal range (Krishnadas & Cavanagh, 2012). 
 
2) Patients suffering from chronic medical conditions characterized by an 
inflammatory pattern, such as HCV-related chronic liver disease, had a much higher 
prevalence of psychiatric comorbidity, including depression, when compared to the 
general population (Fontana et al ., 2002). 
MDD is an event that occurs 5-10 times more frequently in individuals with chronic 
organic disease than in the general population, it worsens prognosis and increases 
disability (Krishnadas & Cavanagh, 2012). The inflammatory state in a context of 
organic disease can therefore facilitate the onset of depression in vulnerable and 
105 
 
predisposed subjects (genetically and not only), acting as a precipitating factor 
(Krishnadas & Cavanagh, 2012). 
 
3) Patients suffering from different organic conditions, which were treated with 
cytokines (including subjects with chronic HCV-related liver disease undergoing 
interferon treatment), had a significant risk of developing depression during 




Interferon treatment was proven to be responsible for the onset of two distinct 
behavioral syndromes (Figure 7): a neuro-vegetative syndrome and an affective-
cognitive syndrome, characterized by different symptomatology and diverse 




Figure 7: The Neuro-vegetative and the Affective-cognitive Syndromes 
 
Capuron & Miller, 2011 
 
The neuro-vegetative syndrome is characterized by the presence of fatigue, 
psychomotor retardation, loss of appetite and sleep disorders. It occurs early during 
treatment, already during the first weeks and persists for the entire duration of 
therapy. It is not responsive to treatment with antidepressants and has been 
associated with changes in the functioning of basal ganglia and with alterations in 
DA metabolism. 
The affective-cognitive syndrome is characterized by the presence of depressed 
mood, anxiety, memory and attentional deficit and occurs later in the course of 
treatment, approximately between 4 and 12 weeks, especially in vulnerable 
subjects. It is usually well responsive to treatment with antidepressant and it has 
been associated with tryptophan/serotonin metabolism alterations (Capuron & 
Miller, 2011). 
No one feels better during interferon treatment. However, the same dose of drug, 
taken following the same therapeutic scheme, produces a wide variability of clinical 
response, ranging from mild malaise with increased fatigue to cases of severe 
depression with suicidal ideation. This clinical variability suggests that there are 
other factors potentially involved. Several so-called vulnerability factors (or 
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immune response amplifiers) associated with the development of depression during 
interferon-treatment have been identified, including: 
(1) increased serum concentration of TNF-α and / or IL-6 (Wichers et al., 2007); 
(2) Reduced diurnal variation of the hypothalamic-pituitary-adrenal axis function 
(with a flattened cortisol curve) (Raison et al., 2010a); 
(3) Increased cortisol levels in the evening (Raison et al., 2010a); 
(4) Reduced sensitivity of glucocorticoid (GR) receptors to the negative feedback 
mechanism by glucocorticoids (Raison & Miller, 2011); 
(5) Reduced plasma concentration of BDNF (Wichers et al., 2007), 
(6) Reduced plasma concentration of tryptophan (Capuron et al., 2002b), 
(7) Increased plasma and liquor concentrations of Kinurenine and quinoline acid 
(Capuron et al., 2002a). 
 
Therefore, subjects with alterations in the inflammatory system appear to be the 
subjects that, from a strictly biological point of view, are more at risk of developing 
depression during interferon-treatment (Raison & Miller, 2011). Moreover, from a 
clinical point of view, female subjects with low education, with a personal history 
of depression or other psychiatric disorders and subthreshold depressive symptoms 






3.2 THE RESEARCH PROJECT 
 
Aims 
The research project "Chronic inflammation and Depression”, still ongoing, 
evaluates a sample of subjects with chronic hepatitis C, following them for a period 
of 48 weeks, and aims to elucidate clinically relevant predictors of depression and 
to better understand the molecular mechanisms involved. 
 
In details, the study aims: 
1. To explore the basal inflammatory profile of patients with chronic HCV-related 
liver disease; 
2. To explore whether patients who develop depression during the follow up period 
would show significantly higher levels of inflammatory bio-markers in comparison 
with patients not developing depression ("state" bio-markers). 
3. To examine whether clinical predictors (including antiviral drug therapy, 
childhood traumatic experiences, and stressful life events over the last 6 months), 
genetics, and/or epigenetics would be associated with both changes over time of 




This is a prospective longitudinal study, evaluating subjects with HCV-related liver 
disease. Patients considered eligible have been proposed to participate in the study 
by the attending infectious disease doctor during a routine visit. Those who have 
agreed to take part to the study have been then evaluated, using a longitudinal 
perspective design.  
After baseline assessment, subjects were divided into three groups: 
- GROUP A: subjects with hepatitis C eligible for the treatment with peg-IFN-α  of 
24 (most of the time), 36 or 48 weeks duration.  
 
- GROUP B: subjects with hepatitis C eligible for the treatment with DAAs of 8 or 




- GROUP C: subjects with chronic HCV related liver disease, not about to start any 
treatment. 
  
Patients about to start antiviral therapy (GROUP A and B) have been evaluated at 
baseline, before the begin of the treatment, after 4 weeks of treatment,  at week 12 
(the “end of therapy” time-point for most of the subjects included in group B), at 
week 24 (only group A, and it was the “end of therapy” time-point for most of the 
subjects included in this group), and finally at 6 months after the end of the 
treatment (6-month FU). In case of patients undergoing disease monitoring 
(GROUP C), the evaluations were made accordingly to the clinical practice and 
therefore at baseline, 24, and 48 weeks. 
Researchers with a clinical background (psychiatrists and psychologists) performed 
clinical assessments during the regular visits to which patients attended at the 
Infectious Diseases Department, outpatients Clinic. During these visits blood 
sampling was also performed. 
 
Subjects 
Recruitment process began on October 2013 at the Infectious Diseases Department 
of the Verona University Hospital and it will terminate on October 2019. 
 
Inclusion criteria 
- Patients suffering from chronic HCV-related liver disease who had/had not 
undergone antiviral treatments previously; 
- Age> 18 years 
 
Exclusion criteria 
- Patients receiving HAART (Highly Active Anti-Retroviral Therapy) for HIV 
- Patients in pregnancy or breastfeeding 
- Patients with autoimmune diseases, acute infections or other hepatic diseases of 
different origin from chronic HCV infection 
- Cirrhosis with Child-Pugh B or C stage 
110 
 
- Esophageal varices> F1 
- Unstable cardiac pathology 
- Pharmacologically not controlled epilepsy 
- Current drug addiction or alcoholism  
- Patients with current severe depression (ICD-9 296.23 / 296.24 / 296.33 / 296.34 
/ 296.53 / 296.54) or current psychotic disorder (ICD9 295/297/298) 
- Patients with known Cognitive Impairment (MMSE <24/30) 
 
Assessment 
Severity of symptomatology 
 Depressive and anxious symptomatology were assessed by the Inventory of 
Depressive Symptomatology (IDS) (Rush et al., 1996) and by the Hospital 
Anxiety and Depression Scale (HADS) (Zigmond et al., 1983). The IDS is 
a 30-items self-administered scale that focuses on mood, sleep quality, 
appetite, psychomotricity, cognitive performance, and sexual interest 
changes in the last week. The HADS is also a self-administered instrument, 
validated in a hospital setting, which allows a more general investigation 
with respect to anxiety-depressive symptomatology; 
 Manic symptoms (sleep, appetite, sexual activity, mood quality, 
psychomotority) were evaluated by the Bech-Rafaelsen Mania Rating Scale 
(BRMRS) (Bech et al., 1978); 
 Fatigue levels were evaluated using the Chalder Fatigue Questionnaire 
(CFQ) (Chalder et al., 1993). Levels of tiredness, weakness and/or lack of 
energy in the last month were estimated; 
 Health status was investigate by the Standard health status questionnaire 
(SF-36 V1) (Ware & Sherbourne, 1992) aiming to detect the subject's 
opinion about his general health. 
 
Socio - demographics and risk factors 




 An anamnestic file was applied to register any current and/or previous 
pharmacological treatments; 
 Family History for Genetic Studies (FIGS) (NIMH, 1992) assessed the 
family psychiatric history; 
 The presence of stressful life events (SLEs) in the previous year was 
determined using a modified version of the Life Events Scale Life (Paykel 
et al., 1971); 
 The Perceived Stress Scale (PSS) (Cohen et al., 1983) was used to measure 
the perception of stress in the last month; 
 The Childhood Experiences of Care and Abuse (CECA) (Bifulco et al., 
2005) questionnaire assessed the presence of childhood traumatic 
experiences and concerned adversity before age 17, including physical and 
sexual abuse, separation from at least one of the parental figures longer than 
6 months, death of a parent, antipathy, and neglect; 
 The Beliefs about Medication Questionnaire (BMQ) (Horne et al., 1999): 
explored convictions about the received treatments and opinions regarding 
medicines in general; 
 Social functioning was estimated by the Global Assessment of Functioning 
Scale (GAF) (APA, 1994); 
 The Italian version of the Coping Orientation to Problems Experienced 
inventory (COPE) (Carver et al., 1989), a self-administered questionnaire, 
accounted different coping modalities: positive reinterpretation and growth, 
mental disengagement, focus on and venting of emotions, use of 
instrumental social support, active coping, denial, religious coping, humor, 
behavioral disengagement, restraint, use of emotional social support, 
substance use, acceptance, suppression of competing activities, and 
planning; 
 The Rosenberg self-esteem scale (Rosenberg, 1979) assessed self-esteem: it 
is a one-dimensional measurement questionnaire of global self-esteem.  
 
Diagnosis (including Substance Use Disorder) 
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 Any Axis I psychiatric disorder was explored by the Mini International 
Psychiatric Interview (MINI) (Sheehan et al., 1998); 
 The use of alcohol in the last 12 months was evaluated by the Use of alcohol 
Alcohol Use Disorder Identification Test AUDIT (Babor et al., 1992); 
 Lifetime cannabis use was investigated by the Cannabis Experience 
Questionnaire (CEQ) (Barkus et al., 2006); 
 Questionnaire on Nicotine Addiction (Heatherton et al., 1991) explored the 
habits of smoking tobacco. 
 
Biological Investigation 
 One DNA tube was collected only at baseline to analyze candidate genes’ 
variants. They will include IL-6, IL-10, TNF-α genes and genes of the 
soluble interleukin receptors IL-2, IL-6, INF-α. 
 One paxgene tube was collected at baseline, at week 4 (only in group A), 12 
(only in groups A and B), 24 (only in group A and C), and 48 (or 6 months 
after the end of the treatment) to analyze gene expression (mRNA). The 
investigation of both candidate genes and “whole genome” gene-expression 
will be performed. 
 One serum tube was collected at baseline, at week 4 (only in group A), 12 
(only in groups A and B), 24 (only in group A and C), and 48 (or 6 months 
after the end of the treatment). Serum cytokine concentrations will be 
evaluated. 
 One plasma tube was collected at baseline, at week 4 (only in group A), 12 
(only in groups A and B), 24 (only in group A and C), and 48 (or 6 months 
after the end of the treatment). Plasma analyzes of polyunsaturated fatty 
acids PUFA will be performed. The plasmatic lipid profile was also 
estimated. 
 Routine test tubes for hemoglobin and total white blood cells, T3, T4, TSH, 
AST, ALT, viremia (HCV-RNA), creatinine, cryoglobulins and 
autoantibodies were collected according to the clinical routine.  
 Salivary cortisol levels were measured using Salivettes (Sarstedt, Leicester, 
UK) at baseline. Subjects were instructed to wake up before 10 am, to 
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collect saliva samples by chewing the cotton roll for 2 min, immediately 
after awakening (0 min) while still in bed, and 15, 30 and 60 min after 
awakening. Having breakfast and teeth brushing were to be avoided during 
the first hour of awakening. Saliva samples were collected again at noon 
and at 8 pm and subjects were recommended not to eat in the 30 min before 
sampling. Subjects were instructed to store salivary samples at 4°C. On the 
arrival to the laboratory, salivary samples were immediately centrifuged at 
3000 rpm per ten minutes and stored at -20°C until the assay. Cortisol was 
measured using a commercially available ELISA kit (Enzo Life Sciences, 
Farmingdale, NY, USA), following the manufacturer’s instruction. All 
samples were assessed in duplicate. Diurnal cortisol levels and the Cortisol 
Awakening Response (CAR) were measured using the Area Under the 
Curve (AUC) respected to the ground calculation (Pruessner,et al., 2003): 
for the former were taken into account levels at 0 min, 15min, 30min, 
60min, noon and 8 pm, while for CAR levels at 0 min to 15, 30, and 60 min 
after awakening were considered. 
 
As mentioned above, this Research Project is still ongoing. Nonetheless, we have 
already conducted some preliminary investigation, whose results have been 
recently presented in the Symposium “Clinical pathways: a tool for improving 
mental health outcomes in medical settings” at the 6° Annual Scientific Conference 
of the European Association of Psychosomatic Medicine (EAPM) 27th-30th June 





3.3 RESILIENCE AND VULNERABILITY FOR DEPRESSION IN 
HEPATITIS C PATIENTS 
 
Aims 
We conducted a study on a sample of patients affected by Hepatitis C, paying 
particular attention to resilience and vulnerability factors for depression. In details, 
we aimed: 
 To estimate baseline levels of depression, anxiety, fatigue, and perceived 
stress; 
 To explore whether subjects under INF would show higher levels of 
depression, anxiety, fatigue, and/or perceived stress than subjects under 
DAAs at week 12 and 48 or patients not in treatment, at week 24 and 48; 
 To explore whether at week 12, 24 or 48, levels of depression, anxiety, 
fatigue, and/or perceived stress would be associated with childhood 
traumatic experiences, substance or alcohol use, recent stressful life events 




After giving a written consent, eligible subjects have been evaluated, using a 
longitudinal perspective study design up to 48 weeks. Inclusion and exclusion 
criteria are reported above. After baseline assessment, they were divided into three 
groups: 
 
- GROUP A: subjects with hepatitis C eligible for the treatment with peg-IFN-α  of 
24 (most of the time), 36 or 48 weeks duration.  
 
- GROUP B: subjects with hepatitis C eligible for the treatment with DAAs of 8 or 
12 (most of the time) weeks duration. 
 






 Patient Information Sheet (PIS) allowed to collect socio-epidemiological 
data;  
 Depressive and anxious symptomatology were assessed by the IDS (Rush 
et al., 1996) and the HADS (Zigmond et al., 1983). IDS score can range 
from 0 to 84, with scores categorized as follows: normal (0-13), mild (14-
25), moderate (26-38), severe (39-48), and very severe (49-84). HADS 
score for each subscale (anxiety and depression) can range from 0 to 21 with 
scores categorized as follows: normal (0-7), mild (8-10), moderate (11-14), 
severe (15-21). Scores for the entire HADS scale (emotional distress) range 
from 0-42 (with higher scores indicating more distress). 
 Fatigue levels were evaluated using the CFQ (Chalder et al., 1993); This 
scale was scored “bimodally” with columns representing 0, 0, 1 & 1 and a 
range from 0 to 11, with a total of 4 or more qualifying for “caseness”. 
 The PSS-10 (Cohen et al., 1988) was used to measure the perception of 
stress; each item is rated on a 5-point scale ranging from never (0) to almost 
always (4). PSS-10 scores are obtained by reversing the scores on the four 
positive items (4, 5, 7, and 8 ) and then summing across all 10 items. Scores 
around 13 are considered average. Scores of 20 or higher are considered 
high stress. 
 The CECA-Q (Bifulco et al., 2005) assessed the presence of childhood 
traumatic experiences. It comprises information concerning experiences of 
childhood adversities before age 17, including physical punishments, sexual 
unwanted experiences, parental separation and loss. Separation has been 
defined as a detachment from at least one of the relatives, longer than 6 
months; whereas, loss was determined whether one or both parents died 
during subjects’ childhood. Childhood trauma (CT) was defined as the 
experience of at least one among physical punishments, sexual unwanted 
experiences and parental loss/separation. The questionnaire also assessed 
the presence of lack of parental care (neglect; cut-off: mother >=22, father 
>=24) and hostile or cold parenting (antipathy; cut-off mother or father 
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>=25). Therefore, childhood traumatic experiences (CTE) involve 
childhood trauma (CT),(including physical punishments, sexual unwanted 
experiences, parental separation and loss), neglect, and antipathy. 
 Lifetime cannabis use was investigated by the Cannabis Experience 
Questionnaire (CEQ) (Barkus et al., 2006): current and lifetime use of 
cannabis, cocaine and heroin were investigated; 
 The use of alcohol in the last 12 months was evaluated by the AUDIT, 
(Babor et al., 1992); 
 The presence of stressful life events (SLEs) in the previous year was 
determined using a modified version of the Life Events Scale (LES) (Paykel 
et al., 1971). Based on a previous works (Lopizzo et al., 2017; Ira et al., 
2014), only "severe life events" (i.e. death of a family member, sexual or 
physical abuse, being accused of having committed a crime, sentence of 
imprisonment, being exposed to war or natural catastrophes, family 
breakdown, being removed from home, sentimental breakdown, severe 
physical illness) were taken into account. 
 Any Axis I psychiatric disorder was explored by the Mini International 
Psychiatric Interview (MINI) (Sheehan et al., 1998); 
 The FIGS, (NIMH, 1992) assessed the family psychiatric history: only first 
degree family history was taken into account; 
 The Italian version of the COPE-NVI (Carver et al., 1989; Sica et al., 2008) 
accounted different coping modalities, as described above. Higher means 
meant more frequent use.  
 
Patients in GROUP A have been evaluated at baseline, before beginning the 
treatment, after 4 weeks of treatment, at week 12, at week 24 (it was the “end of 
therapy” time-point for most of the subjects included in this group), and finally at 
6 months after the end of the treatment (48 weeks).  
Patients in GROUP B have been evaluated at baseline, before beginning the 
treatment, after 4 weeks of treatment, at week 12 (it was the “end of therapy” time-
point for most of the subjects included in this group), and finally at 6 months after 
the end of the treatment (48 weeks).  
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In case of patients undergoing disease monitoring (GROUP C), the evaluations 
were made accordingly to the clinical practice and therefore at baseline, 24, and 48 
weeks. 
 
Table 14 summarizes the assessments at each time points for the three groups.  
 
No biological investigation were performed for the purpose of this study. 
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Table 14: Assessment plan  
 
Instruments 
GROUP A GROUP B GROUP C 
BL W4 W12 W24 W48 BL W4 W12 W24 W48 BL W4 W12 W24 W48 
PIS X ---- ---- ---- ---- X ---- ---- ---- ---- X ---- ---- ---- ---- 
IDS X X X X X X X X ---- X X ---- ---- X X 
HADS X X X X X X X X ---- X X ---- ---- X X 
CFQ X X X X X X X X ---- X X ---- ---- X X 
PSS X X X X X X X X ---- X X ---- ---- X X 
CECA Q X ---- ---- ---- ---- X ---- ---- ---- ---- X ---- ---- ---- ---- 
CEQ X ---- ---- ---- ---- X ---- ---- ---- ---- X ---- ---- ---- ---- 
AUDIT X ---- ---- ---- ---- X ---- ---- ---- ---- X ---- ---- ---- ---- 
LES X ---- ---- ---- X X ---- ---- ---- X X ---- ---- ---- X 
MINI X ---- ---- ---- ---- X ---- ---- ---- ---- X ---- ---- ---- ---- 
FIGS X ---- ---- ---- ---- X ---- ---- ---- ---- X ---- ---- ---- ---- 








Description of the sample 
Socio-demographic characteristics of the sample 
To date, 50 subjects affected by Hepatitis C have been included in the study.  
The majority of individuals lived with partners and/or offspring (N=35, 70.0%), 
while 12.0% and 10.0% of them lived alone and with the family of origin, 
respectively. The remaining 8.0% reported other types of housing arrangements. 
Socio-demographical characteristics of the sample are shown in table 15.
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Table 15: Socio-demographic characteristics of the sample 
  





Group C  
(N=18) p-value 
Mean or N (SD) or % Mean or N (SD) or % Mean or N (SD) or % Mean or N (SD) or % 
Age (years) 49.6 (13.3) 45.4 (1.8) 58.6 (13.1) 48.9 (14.1) 0.02 
Gender, (Male) 22 44.0 13 61.9 4 36.4 5 27.8 ns 
Marital status: 
- unmarried 
- married/in a stable relation 
- separated/divorced 











































- low (primary/secondary school) 





































































Clinical profile at baseline 
Exploring baseline levels of depression, anxiety, fatigue, and perceived stress, we 
analysed the caracteristics of the whole sample and then of three groups.  
 
In the whole group, we found that, when assessed by IDS, 33.3% and 4.8% of the 
subjects showed mild and moderate levels of depression, respectively, while 61.9% 
scored within the range of normality. When applying the HADS, non-significant 
levels of depression were found in the vast majority of our sample (90.2%), and 
only 9.8% resulted mildly/moderately depressed. None of the participants was 
under antidepressant treatment. Similarly, mild to severe anxiety was detected in 
7.2% of participants, while 92.7% of them did not report anxious symptomatology. 
Significantly higher levels of fatigue in the last month, in comparison with the 
“usual wellbeing”, were reported by 39.0% of subjects. Finally, almost one subjects 
out of two (47.5%) referred high levels of stress in the last month.  
No significant difference was found among groups in terms of levels of depression, 




Table 16: baseline levels of depression, anxiety, fatigue and perceived stress in the whole sample and in groups A, B, and C 
 
1 IDS score can range from 0 to 84, with scores categorized as follows: normal (0-13), mild (14-25), moderate (26-38), severe (39-48), and very severe (49-84).  
2 HADS score for each subscale (anxiety and depression) can range from 0 to 21 with scores categorized as follows: normal (0-7), mild (8-10), moderate (11-14), severe 
(15-21). Scores for the entire HADS scale (emotional distress) range from 0-42, (with higher scores indicating more distress). 
3 a total of 4 or more qualifying for “caseness”. 




Whole sample (N=50) Group A (N=21) Group B (N=11) Group C (N=18) 
p-value 
Mean  (SD) Mean  (SD)  Mean  (SD)  Mean  (SD)  









































CFQ3 3.2 (3.9) 2.3 (3.1) 2.2 (2.7) 4.9 (4.9) ns 






Risk and resilience factors profile  
 
Childhood traumatic experiences 
Overall, 41.7% of the subjects included in the study had at least one childhood 
traumatic experience among physical punishment (14.6%), sexual unwanted 
experiences (4.5%), parental loss or/and separation (31.3%). Parental antipathy and 
neglect were reported by 21.3% and 40.4% of participants, respectively. Mother 
and father antipathy were detected in 12.2% and 12.8% of individuals, while mother 
and father neglect were detected in 18.4% and 29.8%, respectively. No significant 
difference was found among groups in terms of childhood trauma (or mother/father 
antipathy or neglect) rates. 
 
Substance and alcohol use 
In terms of lifetime substance use, 48.0% of subjects reported cannabis use, 32.0% 
referred cocaine use, and 36.7% recalled heroin use. Current use rates were 
extremely low, and only a few subjects (two for cannabis, one for cocaine, and three 
for heroin) admitted current, but sporadic consumption and none of them presented 
a related disorder or was in charge to a dedicated unit.  
Subjects reported to consume alcohol more frequently than once in a month in 
38.0% of cases (18.0% had drunk almost daily in the last year). Another 38.0% 
described themselves as non-drinkers, while 24.0% of subjects referred to drink 
alcohol less than once in a month. Among subjects admitting to drink, 10.0% 
reported that people around them (family, physician, or friends) had shown 
apprehension and expressed concerns regarding their alcohol consumption at some 
point of their lives. None of the subjects suffered from an alcohol use disorder when 
included in the study.  
No significant difference was found among groups in terms of substance or alchol 
use rates.  
 
Severe stressful life events 
Almost one subjects out of two (47.9%) recalled a severe stressful life events in the 
last year. No significant difference was found among groups (57.1% in group A, 
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36.4% in group B, and 43.8% in group C) regarding the frequency of severe 
stressful life events in the last year.  
 
Personal or family psychiatric history 
Subjects recalling at least one episode of Major Depression in their lives were the 
24.0% of the sample. No significant difference was found among groups (26.3% in 
group A, 18.2% in group B, and 29.4% in group C) in terms of personal history.  
Twenty (40.0%) participants out of 50 reported a positive family psychiatric 
history, having at least one first-degree relative affected. No significant difference 
was found among groups in terms of family psychiatric history. 
 
Coping strategies 
Coping strategy profiles for both the whole sample and the three groups are 








Group A (N=21) Group B (N=11) Group C (N=18) 
p-value 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Positive reinterpretation 
and growth 
11.5 (3.0) 11.4 (2.5) 11.4 (4.1) 11.6 (3.2) ns 
Mental disengagement 7.4 (7.4) 7.8 (2.6) 6.0 (2.4) 7.9 (2.1) ns 
Focus on and venting of 
emotions 
7.8 (2.9) 7.4 (2.5) 7.9 (3.2) 8.4 (3.5) ns 
Use of instrumental 
social support 
10.4 (3.0) 9.7 (3.3) 11.0 (3.0) 11.1 (2.7) ns 
Active coping 10.9 (2.1) 0.9 (1.9) 11.6 (2.4) 10.5 (2.3) ns 
Denial 5.8 (2.5) 6.2 (3.1) 4.6 (1.1) 5.8 (1.9) ns 
Religious coping 9.0 (4.1) 7.8 (3.8) 10.2 (3.8) 10.2 (4.6) ns 
Humor 7.6 (2.7) 8.1 (2.8) 8.0 (3.6) 6.5 (1.7) ns 
Behavioral 
disengagement 
5.6 (1.9) 5.8 (1.8) 4.4 (0.5) 6.3 (2.6) ns 
Restraint 9.5 (2.8) 9.5 (2.8) 9.8 (2.9) 9.2 (2.8) ns 
Use of emotional social 
support 
9.7 (3.7) 9.0 (3.9) 9.5 (2.2) 11.0 (4.0) ns 
Substance use 4.6 (1.7) 4.9 (1.7) 4.2 (0.6) 4.6 (2.2) ns 
Acceptance 11.2 (2.9) 10.5 (2.6) 13.6 (2.5) 10.4 (2.6) 0.006 
Suppression of 
competing activities 
9.7 (2.7) 9.3 (2.6) 10.6 (3.5) 9.6 (2.3) ns 






Levels of depression, anxiety, fatigue, and perceived stress at follow-ups 
 
Group A in comparison with group B at week 12 and 48 
As expected (figure 8), we found within group A an increase in depression rates 
during the treatment with interferon-alpha, especially at week 12 (IDS mean=17.1, 
sd=7.8; range= 7-29), while no such change was observed in group B (IDS 
mean=10.7, sd=5.7; range= 4-20), whose levels of depression actually dropped, 
although the difference between groups did not reach significance. At baseline, 
62.5% of subjects of group A reported no significant symptoms of depression (vs 
72.7% in group B), while 31.3% and 6.3% referred mild and moderate 
symptomatology, respectively (vs 27.3% and 0.0% in group B, respectively). At 
week 12, only 33.3% of subjects in group A was not depressed at all (vs 66.7% in 
group B), while 50.0% and 16.7% resulted affected by mild and moderate 
depression, respectively (vs 33.3% and 0.0% in group B, respectively).  At week 48 
(6 months after the end of the treatment), rates of mild depression in group A were 
equal to 46.7% (vs 16.7% in group B), while 53.3% of participants were non 
depressed (vs 83.3% in group B). Differences between groups did not reach 
significance. 
 


























When looking at HADS scores for depression (figure 9), we confirmed the increase 
in depressive symptomatology at week 12 only in group A (mean=3.8, sd=4.7; 
range= 0-12 vs mean=2.2, sd=1.7; range= 0-4 in group B), but even in this case the 
difference did not reach significance. 
 
Figure 9: depression levels (HAD score) in group A vs group B 
 
 
With regards to anxiety symptomatology (see figure 10), levels remained 
substantially stable during and after the treatment in both groups and did not differ 
significantly between groups.   
 































































Significant levels of fatigue (including feeling tired, weak or lacking in energy) at 
week 12 were reported by 45.5% and 33.3% of subjects in group A and B, 
respectively. At six months after the end of the treatment, levels were decreased in 
both groups (33.3% in group A and 16.7% in group B) with mean CFQ scores equal 
to 2.8 (sd=3.6) and 1.3 (sd=2.2) ad shown in figure 11. Difference did not reach 
significance. 
 
Figure 11: Levels of fatigue in group A vs group B 
 
 
Finally, we found that levels of perceived stress gradually decreased in group B: 
mean values were equal to 20.7 (sd=3.2) at baseline, and diminished to 19.5 
(sd=4.4) and to 18.3 (sd=3.7) at 12 and 48 weeks, respectively. In group A level of 
stress remained substantially stable and low (figure 12). No significant difference 



























Figure 12: Perceived stress in group A vs group B 
 
 
Group A in comparison with group C at week 24 and 48 
We did not find any significant difference in terms of levels of depressive 
symptomatology between group A and group C at both 24 and 48 weeks FU. 
Similarly, no difference was found at both time points between group A and C in 
terms of anxiety, fatigue levels, or perceived stress. 
 
Risk and resilience factors 
Finally, we wanted to explore whether at week 12, 24 or 48, levels of depression, 
anxiety, fatigue, and/or perceived stress would be associated with childhood 
traumatic experiences, substance or alcohol use, recent stressful life events (SLEs), 
personal or family psychiatric history, or coping strategies. 
 
Childhood traumatic experiences 
Childhood trauma (i.e. at least one among physical punishments, sexual unwanted 
experiences, loss, or separation) was found significantly associated with high levels 
of depressive and anxious symptomatology at week 24. Traumatized subjects 
showed higher IDS scores (mean=20.1, sd=10.2, p=0.017), and higher HADS 
depression (mean=3.9, sd=3.1, p=0.042) and anxiety (mean=5.4, sd=4.1, p=0.012) 
sub-scores, and higher HADS total score (mean=9.3, sd=5.1, p=0.001) in 


























ds=3.1; HADS depression sub-score: mean=1.5, sd=1.6; HADS anxiety sub-score: 
mean=1.8, sd=1.1; HADS total score: mean=3.4, sd=1.4). Conversely, any 
significant association was found between childhood trauma and levels of 
depression or anxiety when looking at week 12 or 48, or between trauma and fatigue 
or perceived stress, regardless the investigated time point. 
 
Exploring different types of trauma, we found that subjects with a history of 
physical punishments demonstrated significantly increased levels of depression, 
emotional distress, and fatigue at week 24 in comparison with subjects not recalling 
such a history. The IDS mean score at week 24 in subjects physically punished 
when children was equal to 25.6, sd=7.5 vs a mean of 13.1, sd=4.7 (p=0.000) found 
in non-punished. Similarly, HADS depression sub-score resulted significantly 
higher in association with physical punishments (mean=5.8, sd=3.1 in punished vs 
mean=1.7, sd=1.7 in non-punished, p=0.001). A greater emotional distress was also 
found in association with physical punishments at week 24: the HADS total score 
was higher in subjects recalling punishments (mean=10.4, sd=3.8) in comparison 
with that of subjects non reporting such a history (mean=4.5, sd=4.2, p=0.017). 
Finally, physical punishments were found significantly associated with higher 
levels of fatigue (mean CFQ score in cases was equal to 6.8, sd=4.9 vs a mean of 
2.9, sd=2.8, p=0.04).  
 
An even stronger association was found between sexual unwanted experiences 
(SUE) and levels of depression, anxiety, and emotional distress at different time 
points as shown in figure 13. Any association was instead found between sexual 




Figure 13: Sexual unwanted expericences (SUE) and levels of depression and 
anxiety 
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Subjects recalling loss or separation did not differ significantly in terms of levels of 
depression, anxiety, fatigue or perceived stress regardless the investigated time 
points when compared with individuals without parental loss or separation. 
 
Parental antipathy was significantly associated with higher levels of depression 
(IDS mean score in cases was equal to 30.5, sd=10.6 vs mean=13.6, sd=5.8, 
p=0.002), anxiety (IDS anxiety mean sub-score in cases was equal to 8.5, sd=0.7 vs 
mean=3.1, sd=3.2, p=0.03),  and emotional distress (HADS mean total score in 
cases was equal to 13.0, sd=4.2 vs mean=5.1, sd=4.4, p=0.025) at week 24. 
 
Finally, parental neglect was found associated with higher levels of perceived stress 
(PSS mean score in cases was equal to 21.6, sd= 3.9 vs mean=17.9, sd=2.8, 
p=0.043) at week 12 and higher levels of depression at week 24 (IDS mean score 
in cases was equal to 23.8, sd=12.8 vs mean=13.2, sd=4.7, p=0.012; HADS 
depression mean sub-score in cases was equal to 4.8, sd=3.9 vs mean=1.7, sd=1.7, 
p=0.022). 
 
Substance or alcohol use 
Any significant association was found between cannabis or heroin lifetime use, or 
alcohol use and levels of depression, anxiety, fatigue, or perceived stress regardless 
the investigated time point. Cocaine lifetime use was found conversely significant 
associated with higher levels of depression at week 24 (IDS mean score in cases 
was equal to 24.0, sd=12.8 vs mean=14.4, sd=6.1, p=0.040).  
 
Recent severe stressful life events (SLEs) 
Any significant association was found between recent severe stressful life events 
and levels of depression, anxiety, fatigue, or perceived stress regardless the 
investigated time point 
 
Personal or family psychiatric history 
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We found that having at least one Episode of Major Depression (EMD) in the past 
was significantly associated with higher levels of depression, anxiety, fatigue, and 
perceived stress at several time points, as shown in figure 14. 
 
Conversely, any significant association was found between family psychiatric 
history and levels of depression, anxiety, fatigue, or perceived stress regardless the 




Figure 14: Personal psychiatric history and levels of depression and anxiety 
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When investigating coping strategies, we found that some (Focus on and venting of 
emotions, Denial, and Substance use) were significantly associated with higher 
levels of depression, anxiety, fatigue, and stress, while some others appeared to act 
as resilience factors (specifically, Mental disengagement and Humor) and were 
related to lower levels of levels of depression, anxiety, fatigue, and stress at several 
time points. 
In details, Focus and venting of emotions coping strategy resulted associated with 
higher levels of depression (correlation coefficient =0.469, p=0.037), anxiety 
(correlation coefficient =0.541, p=0.014), and emotional distress (correlation 
coefficient=0.471, p=0.036) at week 24. Similarly, Denial coping strategy was 
associated with increased levels of fatigue at week 48 (correlation coefficient 
=0.363, p=0.041), and with higher level of depression at week 12 (correlation 
coefficient =0.469, p=0.049). Substance use coping strategy was also found to 
enhance both depression levels (correlation coefficient =0.481, p=0.032) and 
perceived stress correlation coefficient =0.448, p=0.048) at week 24.  
Conversely, Mental disengagement and Humor coping strategies were found to play 
a protective role. Mental disengagement coping strategy and lower levels of 
perceived stress were found associated at week 24 (correlation coefficient= -468, 
p=0.037). Humor coping strategy was significantly associated with lower levels of 
depression at both 24 and 48 weeks (correlation coefficient = -0.605, p=0.005 for 
HADS depression score at week 24; correlation coefficient =   -0.451, p=0.010 for 
IDS score at week 48). A reduction in levels of anxiety at week 48 (correlation 
coefficient = -0.363, p=0.041) was also found in association with humor as a coping 
strategy.  Similarly, reduced emotional distress was found associated with Humor 
coping strategy at both week 24 and 48 (correlation coefficient = -0.449, p=0.047, 
and correlation coefficient = -0.354, p=0.047, respectively).  Finally, decreased 
level of fatigue at week 12 and 24 (correlation coefficient = -0.604, p=0.010, 
correlation coefficient = -0.562, p=0.012, respectively), and reduced perceived 
stress at week 48 (correlation coefficient = -0.397, p=0.027) and Humor coping 





In a sample of subjects affected by chronic Hepatitis C followed up for 48 weeks, 
we explored levels of depression, anxiety, fatigue, and perceived stress at baseline 
and at several time points. As expected, we found an increase in depression rates 
during the treatment with interferon-alpha (group A), especially at week 12, while 
no such change was observed in subjects treated with DAAs (group B), whose 
levels of depression actually dropped, although the difference between groups did 
not reach significance. Similarly, no significant difference was found with regards 
to levels of anxiety, fatigue, or perceived stress between group A and B (or C, not 
in treatment) during the 48 weeks of follow up. Our findings appear to be in line 
with the literature that points out an “illness-effect”: patients suffering from chronic 
medical conditions characterized by an inflammatory pattern, such as HCV-related 
chronic liver disease, had a higher prevalence of psychiatric comorbidity, including 
depression, when compared to the general population (Fontana et al., 2002). 
Although patients undergoing interferon therapy showed increasing levels of 
depression during the treatment, differences with subjects undergoing DAAs 
treatment or with subjects not in treatment did not reach significance. On one side, 
these results appear to support the prevailing of the illness-effect on the treatment-
effect. On the other side, they might be ascribable to the small sample size, and thus 
further investigation could be required. 
Risk and resilience factors were also assessed, including childhood traumatic 
experiences, drug and alcohol use, psychiatric history, and coping strategies, and 
their influence on subjects’ well being was explored during the follow up. We 
wanted to explore whether levels of depression, anxiety, fatigue, and/or perceived 
stress would be associated with risk/resilience factors. We found that overall, 41.7% 
of the subjects had at least one childhood traumatic experience among physical 
punishment, sexual unwanted experiences, parental loss or/and separation. Parental 
antipathy and neglect were reported by 21.3% and 40.4% of participants, 
respectively. Mother and father antipathy were detected in 12.2% and 12.8% of 
individuals, while mother and father neglect were detected in 18.4% and 29.8%, 
respectively. When compared to data from the Italian National Survey (CISMAI-
TDH, 2015), which found that almost one children out of 100 (9.5‰) is victim of 
137 
 
maltreatments in Italy, these findings, although descriptive, evoke an increased rate 
of maltreatments in our sample of subjects affected by Hepatitis C. Moreover, if 
looking at our own data collected in a sample of healthy subjects (Tomassi et al., 
under revision), the difference appears even more significant: 28.2% (vs 41.7%) of 
healthy subjects included had at least one childhood traumatic experience. Mother 
and father antipathy were detected in 7.7% (vs 12.2%) and 10.8% (vs 12.8%) of 
healthy individuals, while mother and father neglect were detected in 10.3% (vs 
18.4%) and 10.8% (29.8%), respectively. An association between suffering from 
Hepatitis C in adulthood and childhood trauma is suggested. However, a proper 
case-control study is warrant. We found that childhood trauma (i.e. at least one 
among physical punishments, sexual unwanted experiences, loss, or separation) 
was significantly associated with higher levels of depressive and anxious 
symptomatology and with greater emotional distress at week 24. Exploring 
different types of trauma, we found that subjects with a history of physical 
punishments demonstrated significantly increased levels of depression, emotional 
distress, and fatigue at week 24 in comparison with subjects not recalling such a 
history. An even stronger association was found between sexual unwanted 
experiences and levels of depression, anxiety, and emotional distress. Parental 
antipathy was significantly associated with higher levels of depression, anxiety, and 
emotional distress at week 24. Finally, parental neglect was found associated with 
higher levels of perceived stress at week 12 and higher levels of depression at week 
24. Our findings are mostly in line with the literature and confirm a significant role 
for childhood traumatic experiences in predisposing subjects to develop depression 
and anxiety (Buckman et al., 2018, Tunnard et al, 2014, Nanni et al., 2011, 
Gaudiano & Zimmerman., 2010). However, to our best knowledge, it is the first 
study investigating childhood trauma as a potential vulnerability factor for 
depression, anxiety, and fatigue in a sample of Hepatitis C patients. The effect of 
childhood trauma in increasing the risk of depressive and anxious symptomatology 
appears substantially independent from other factors, including HCV treatments. 
However, further analyses will be needed to validate and corroborate these results. 
Finally, it is worth reminding, that the study is still ongoing. Several biological 
investigations have also been conducted, and specimens are now under process. 
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Thus, we will be soon able to deep our exploration with regards to risk/resilience 
factors, specifically childhood traumatic experiences, in terms of genetics, 
epigenetics and proteomics. Any significant association was found between drug 
lifetime use, alcohol use, or recent severe stressful life events and levels of 
depression, anxiety, fatigue, or perceived stress regardless the investigated time 
points. Subjects recalling at least one Episode of Major Depression in their lives 
were the 24.0% of the sample. We found that having at least one episode of Major 
Depression in the past was significantly associated with higher levels of depression, 
anxiety, fatigue, and perceived stress at several time points. These findings are in 
line with previous literature (Buckman et al., 2018; Raison et al., 2005) and support 
the need of specific psychosocial and/or pharmacological interventions in this 
subsample of patients. Conversely, any significant association was found between 
family psychiatric history and levels of depression, anxiety, fatigue, or perceived 
stress regardless the investigated time point. 
Finally, when investigating coping strategies, we found that some (Focus on and 
venting of emotions, Denial, and Substance use) were significantly associated with 
higher levels of depression, anxiety, fatigue, and stress, while some others appeared 
to act as resilience factors (specifically, Mental disengagement and Humor) and 
were related to lower levels of levels of depression, anxiety, fatigue, and stress at 
several time points. Once again, our findings appear coherent with the available 
evidence (Hardeveld et al., 2010, Beshai et al., 2011, Conradi et al., 2008), support 
the association between poor coping skills and depression, and extend that notion 
to subjects affected by Hepatitis C. In addition, our results evoke a potentially 
increased resilience in a sub-sample of these subjects and support a further 
investigation, along with the routine medical caring, of the coping strategies profile.  
Our study has several strengths. First, it has a longitudinal perspective design, with 
a follow up period 48 weeks long, which provide an appropriate time-window for 
the evaluation of the subjects. Second, the presence of the group of hepatitis C 
subjects in the phase of stationary disease (C, not in therapy) represents an element 
of methodological accuracy. The comparison between the groups A vs C has 
allowed in fact to estimate the prevalence of depression during interferon treatment, 
distinguishing it from the prevalence of depression in the course of chronic hepatitis 
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C. Similarly, the presence of group B represents one of the major innovation of this 
study in comparison with previous literature on the field that to our best knowledge 
has never before investigated DAAs as we did. Third, the study has a collaborative 
nature: in fact, it has been being conducted in collaboration with the Section of 
Infectious Diseases of the Verona University Hospital. This aspect has allowed the 
integration skills, the sharing of knowledge, has ensured the accuracy of the data 
collected, and has applied in research a collaboration between medical disciplines 
already tested in the clinic. Finally, subject has been assessed using internationally 
validated scales by expert researchers with a clinical background (psychiatrists and 
psychologists).  
Some limitations must also be addressed. First, these are preliminary findings and 
descriptive results obtained in a relatively small sample and therefore should not be 
interpreted as hypothesis generating. Second, retrospective reporting of abuse might 
increase the risk of recall bias, although the reliability of referring trauma has been 
previously demonstrated (Schäfer & Fisher, 2011): reports were consistent with 
other sources of information and stable over time. Third, the presence of personality 
disorders was not investigated. It is honest to admit that personality could play a 
central role in a sample whose rates of substance use disorder as well as the rates of 
childhood traumatic experiences appear higher than in non-hepatitis C subjects. 
However, we decided to maintain the focus on severe mental disorders rather than 
to include a complex element such as personality traits. Childhood trauma and 
personality disorder represents in fact a wide, different, and quite diffused field of 
research.  
 
To conclude, among clinical vulnerability factors for depression, anxiety, and 
fatigue in Hepatitis C subjects, childhood traumatic experiences must be considered 
to play a significant role. It appears therefore of primary importance to 
systematically investigate the presence of a history of childhood traumatic events. 
It could help the clinician to identify the most appropriate therapeutic interventions 
to offer the patient, which can be both pharmacological and psychosocial (Larkin 

























4.1 THE HEALTHY SUBJECTS GROUP 
 
Background 
Clinical and social outcomes of psychosis represent a challenge for clinical practice. 
Psychoses are characterized by high clinical heterogeneity and wide treatment 
response variability, in association with individual factors of neuro-psychological, 
genetic, and environmental nature.  
 
The GxE model 
In the last two decades, several studies have tried to elucidate how genetics and 
psycho-social elements interact with each other in determining the onset and the 
evolution of psychosis. Despite the effort, a causal association between genetic 
variants and psychosis has not been demonstrated yet (Allen et al., 2009). On the 
other hand, epidemiological studies have established the existence of non-genetic 
risk factors that can contribute to enhance the vulnerability for psychosis, leading 
to the development of the disorder. Among biological factors, malnutrition (Penner 
& Brown, 2007), obstetric complications (Cannon et al., 2002;), paternal age at the 
time of conception (Ek et al., 2015), and maternal infections (Khandaker GM et al., 
2013) were investigated. Psychosocial factors were also explored: childhood 
trauma (Read et al., 2005), stressful life events (Mansueto & Faravelli, 2017), 
migration to another country (Cantor-Graae & Selten, 2005), urbanity (Padhy et al., 
2014) and cannabis use (Henquet et al., 2005) were found to play a role in 
increasing the vulnerability for psychosis. Psychotic disorders seem therefore to 
represent "multi-factorial" disorders, in which the genetic and non-genetic factors 
play an equally important role in determining vulnerability (Van Os & Rutten, 
2008). 
In this scenario, the gene-environment (GxE) model for psychosis postulates that 
neither genes nor environmental risk factors are sufficient to determine the onset of 
the disease, but that their synergistic co-action is necessary. According to this 
model, the risk of developing a psychotic disorder in response to a certain type of 
environmental stimulus would be influenced by the GxE interaction. It seems then 
relevant to note that even the healthy general population shares with psychotic 
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patients numerous factors that have been considered risky for the development of 
psychosis, including cannabis use and stressful life events (e.g. childhood trauma). 
In healthy subjects, however, these predisposing factors were not sufficient to 
determine the illness onset. Which are the key-factors necessary for an individual 
to exceed the vulnerability threshold and to develop the disorder? What is the role 
of genetic factors and biological modifiers? 
 
Endophenotypes: Neurological Soft Signs and neuro-cognitive evaluations 
A further promising approach of investigation is based on endophenotypes. An 
endophenotype (also known as intermediate phenotype) is a quantitative biological 
trait. It is reliable in reflecting the function of a discrete biological system and is 
reasonably heritable, and as such is more closely related to the root cause of the 
disease than the broad clinical phenotype (Gottesman & Gould, 2003; Cannon & 
Keller, 2006;). This term refers not to symptoms or signs of specific psychiatric 
disorders, but rather to components of the disease itself, such as alterations in 
cognitive abilities, cerebral neuroanatomy, and behavior (Mazzoncini et al, 2009). 
Endophenotypes lay between the genetic variants and the clinical expression of the 
disorder and can be found at any intermediate level of the pathophysiological 
process that links the genotype to the final diagnosis (Cannon & Keller 2006). In 
psychiatry research, the accepted criteria, which a biomarker must fulfill to be 
called an endophenotype, include (Beauchaine, 2009): 
 An endophenotype must segregate with illness in the population. 
 An endophenotype must be heritable. 
 An endophenotype must not be state-dependent (i.e., manifests whether 
illness is active or in remission). 
 An endophenotype must co-segregate with illness within families. 
 An endophenotype must be present at a higher rate within affected families 
than in the population. 
 An endophenotype must be amenable to reliable measurement, and be 




Consequently, due to their intrinsic characteristics, it is not uncommon to find 
endophenotypes even in healthy individuals of the general population. Their 
prevalence in healthy subjects is however not adequately documented. At the 
theoretical level, such endophenotypes could be neutral or even beneficial (Keller 
and Miller 2006), for example conferring a particular selective advantage under 
certain circumstances. The endophenotypes that in literature have been associated 
with psychosis and which were also found in healthy subjects are numerous and 
heterogeneous. These include neurological abnormalities, such as Neurological 
Soft Signs (NSS) (Chan & Gottesman 2008), and neurocognitive deficits, such as 
memory functions, processing speed, attention, verbal reasoning, resolution of 
visual-spatial problems (Reichenberg et al., 2010). 
 
Aim 
The Healthy Subjects Research Project leaded by Tosato S. et collaborators aims to 
investigate, in a sample of healthy subjects belonging to the general population, a 
set of environmental, biological, and neuropsychological variables, including 
endophenotypes, known to be involved in the development of psychosis. The 
project, once completed, will allow the execution of one, or more, case-control 
studies, whose results will enrich, with a scientifically relevant contribution, the 
knowledge concerning psychosis already acquired in the Psychosis Incident Cohort 
Outcome Study (PICOS) (Lasalvia et al., 2012) and the “GET-UP PIANO – 
Psychosis: early Intervention and assessment of Needs and Outcome” (Ruggeri et 




The project, still ongoing, aims to recruit 435 subjects belonging to general 
population. Assessments takes place at the Psychiatry Section of the Verona 
University Hospital. Subjects are recruited on a voluntary base, through leaflets and 
word of mouth. 
 
The inclusion criteria are: 
144 
 
1) Age >= 18 years 
 
The exclusion criteria are: 
1) History of psychotic disorder (schizophrenic spectrum disorders, bipolar I 
disorder, manic episode, depression with psychotic symptoms) 
2) Known intellectual disability (IQ<70);  
3) History of neurological disease (eg epilepsy, dementia, cerebrovascular or 
infectious diseases, trauma or brain tumors); 
4) Family history of psychosis (first-degree relative affected). 
 
Eligible subjects receive a full explanation of the aims of the study. Once a written 
consent is obtained, subjects are assessed through the administration of clinical 
scales and a battery of neuropsychological/neurological tests, and blood is sampled. 
Partial participation is foreseen and for this reason, enrolled subjects are allowed to 
choose whether to carry out the whole assessment (clinical-epidemiological and 






Socio-demographic data are collected according to a subject information sheet, 
including information about: gender, age, ethnicity, employment, marital status, 
living status, medical conditions and use of medication. Table 18 shows the 





Table 18: Instruments used in the socio-demo and clinical assessment 
Instruments Investigated area 
Mini International Neuropsychiatric Interview (MINI) (Sheehan et al., 1998)  Psychiatric disorder in Axis I 
Alcohol Use Disorders Identification Test (AUDIT) (Babor et al, 1992) Alchool use 
Cannabis Experience Questionnaire (CEQ) (Barkus et al., 2006) Drug use 
Questionnaire on Nicotine Addiction (Heatherton et al., 1991)  Smoking tobacco 
Childhood Experience of Care and Abuse Questionnarie (CECA-Q) (Bifulco et al., 2005) Childhood traumatic experiences 
The Community Assessment of Psychic Experiences (CAPE) (Stefanis et al., 2002) Psychotic-like Experiences 
Parental Bonding Instrument (PBI) (Parker, 1979) Parenting style 
Life Events Scale (Paykel et al., 1971) Stressful life events 
Lewis-Murray Obstetric Complications Scale (Lewis et al., 1989) Obstetric complications 
The Level of Expressed Emotion Scale (LEE) (Cole & Kazarian, 1988) Expressed Emotion Levels 
Hamilton Rating Scale for Depression (HAM-D) (Hamilton, 1960) Depressive symptomatology 
Bech-Rafaelesen Mania Rating Scalen (BRMRS) (Bech et al., 1978) Manic symptomatology 
Manchester Short Assessment of Quality of life (MANSA) (Priebe et al., 1999) Quality of life 








A full neuro-psychological evaluation is also conducted (details not shown). 
 
Biological Investigation 
Subjects are also blood sampled: one DNA tube (for sequencing), one paxgene tube 
(to investigate gene expression and epigenetics), one serum and one plasma tube 
(aiming to explore proteomics and glucose/lipid profiles, respectively) are 
collected. Optionally, salivary cortisol levels are also measured (to evaluate salivary 
cortisol levels) using Salivettes (Sarstedt, Leicester, UK). 
 
Some studies have been already performed exploring the available data form the 
Healthy Subjects Research Project. With reference to childhood traumatic 
experiences, and for the purpose of this thesis, the effects of early adversity were 
investigated in healthy individuals in terms of psychotic-like experiences, salivary 
cortisol levels and lifetime cannabis use (Tomassi et al., under review), gene 
expression and leukocyte telomere length (Lopizzo et al., 2017), and glucose 
metabolism (Tosato et al., under review). In this PhD thesis, I will report the two 






4.2 CHILDHOOD TRAUMA AND PSYCHOTIC-LIKE EXPERIENCES IN 
HEALTHY SUBJECTS 
 
Psychosis might be considered a dimensional phenotype, also expressed at non-
clinical levels. The psychosis continuum implies that symptoms usually reported 
by subjects affected by psychosis can be experienced also by non-clinical samples 
(Linscott & Van Os, 2013). Indeed, a median annual incidence rate equal to 2.5% 
and a median prevalence rate of 7.2% of psychotic experiences were found in the 
general population (Linscott & Van Os, 2013). Then, considering psychosis as a 
quantitative trait (Stefanis et al., 2002) it is possible to affirm that psychotic-like 
experiences (PLEs) exist along a continuum in the general population, may 
similarly be measurable, and share similar risk factors with psychotic disorders, 
including, among others, childhood traumatic experiences (Kessler et al., 2010; 
Linscott and Van Os, 2013). Within environmental risk factors, childhood traumatic 
experiences double the risk of developing psychosis (Bonoldi et al., 2013; Borges 
et al., 2013; Varese et al., 2012a). Nevertheless, the biological, psychological or 
environmental mechanisms underlying the association between being traumatized 
as a child and developing a psychosis or psychotic like experiences later in life are 
still a matter of debate. A primary role for the stress response system, including the 
hypothalamic-pituitary-adrenal (HPA) axis, has been hypothesized. Both HPA axis 
hyper- and hypo-activation (Lupien et al., 2009) and hyper- (Heim et al., 2000) and 
hypo-reactivity to stress (Klaassens et al., 2009; Carpenter et al., 2007) have been 
associated to childhood trauma. On the other hand, HPA-axis dysfunction has been 
significantly associated to psychosis: HPA-axis hyperactivity, characterized by 
high cortisol levels in basal condition, and a blunted HPA axis response to stress 
(hypo-reactivity) have been observed in psychosis (Borges et al., 2013). However, 
whether HPA axis dysfunction mediates the trauma-psychosis association or 
represents a trait of illness is still unclear. Moreover, HPA axis functioning may be 
influenced by numerous factors, including age, gender and tobacco (Adam & 
Kumari, 2009) which could play a confounding role. Smoking cannabis represents 
another element, which potentially mediates the association between childhood 
traumatic experiences and psychosis (Tomassi et al., 2017). In fact, the association 
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between cannabis consumption and psychotic symptoms is well known, even in the 
general population (Henquet et al., 2005.; Moore et al., 2007; Rössler et al., 2011). 
Moreover, subjects recalling childhood trauma are more prone to use substances, 
including cannabis: they may develop depressive symptoms and try to self-
medicate themselves (Houston et al., 2011) and they often live in disadvantaged 
environments, where it is easier to get addicted to substance (Wicks et al., 2005).  
Based on the aforementioned knowledge, we conducted a study, to explore the 
association between childhood traumatic experience and PLEs in a sample of 
healthy subjects, investigating potentially mediating factors like HPA axis 
functioning (in terms of both activity and reactivity) and cannabis use. We 
hypothesized that subjects with a history of childhood traumatic experiences would 
have more frequent and/or more distressful PLEs, show different saliva cortisol 
levels, and higher rates of lifetime cannabis use when compared to subjects without 
childhood traumatic experiences. 
 
Methods 
Subjects and questionnaires  
Healthy subjects were recruited through notices posted at the Verona University 
Hospital, Verona (Italy). Individuals presenting a history of neurological or 
psychiatric diseases, prior traumatic brain injury, or intellectual disability (IQ<70); 
being pregnant or breastfeeding or under current medications were excluded from 
the study. The Mini International Neuropsychiatric Interview (Sheehan et al., 1998) 
was used to exclude any psychiatric disorder in Axis I; and the Structured Clinical 
Interview for DSM disorders (First et al., 1997) was applied to exclude any 
psychiatric disorder in Axis II. Information about self-reported BMI and tobacco 
use were also collected.  
The presence of childhood traumatic experiences (CTE) was assessed by the 
CECA-Q scale (Bifulco et al., 2005). It comprises information concerning 
experiences of childhood adversities before age 17, including physical 
punishments, sexual unwanted experiences, parental separation and loss. 
Separation has been defined as a detachment from at least one of the relatives, 
longer than 6 months; whereas, loss was determined whether one or both parents 
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died during subjects’ childhood. Childhood trauma (CT) was defined as the 
experience of at least one among physical punishments, sexual unwanted 
experiences and parental loss/separation. The questionnaire also assessed the 
presence of lack of parental care (neglect; cut-off: mother >=22, father >=24) and 
hostile or cold parenting (antipathy; cut-off mother or father >=25). Therefore, 
childhood traumatic experiences (CTE) involve childhood trauma (CT),(including 
physical punishments, sexual unwanted experiences, parental separation and loss), 
neglect, and antipathy.  
The Community Assessment of Psychic Experiences (CAPE) (Stefanis et al., 2002), 
a 42-items instrument, collected information about lifetime psychotic-like 
experiences, with regards to both frequency (1 never, 2 sometimes, 3 often, 4 nearly 
always) and related distress (1 not distressed, 2 a bit distressed, 3 quite distressed, 
4 very distressed). Scores were estimated for the positive (20 items), negative (14 
items), and depressive (8 items) dimensions by adding up single item scores and 
weighting for the number of valid answers.  
The Cannabis Experiences Questionnaire (Barkus et al., 2006) assessed lifetime 
cannabis use. Subjects were divided in two groups: those who had never used 
cannabis and those who had used cannabis at least once in their life. 
The investigation was carried out in accordance with the latest version of the 
Declaration of Helsinki (World Medical Association et al., 2013). Written informed 
consent of the participants was obtained after the nature of the procedures had been 
fully explained. The study design was reviewed and approved by the ethic 
committee of the Verona University Hospital.  
 
Salivary cortisol assessment 
Salivary cortisol levels were measured using Salivettes (Sarstedt, Leicester, UK). 
Subjects were instructed to wake up before 10 am, to collect saliva samples by 
chewing the cotton roll for 2 min, immediately after awakening (0 min) while still 
in bed, and 15, 30 and 60 min after awakening. Having breakfast and teeth brushing 
were to be avoided during the first hour of awakening. Saliva samples were 
collected again at noon and at 8 pm and subjects were recommended not to eat in 
the 30 min before sampling. Subjects were instructed to store salivary samples at 
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4°C. On the arrival to the laboratory, salivary samples were immediately 
centrifuged at 3000 rpm per ten minutes and stored at -20°C until the assay. Cortisol 
was measured using a commercially available ELISA kit (Enzo Life Sciences, 
Farmingdale, NY, USA), following the manufacturer’s instruction. The analysis 
was performed by Dr. Brondino, with the supervision of Professor Politi, at The 
University of Pavia. All samples were assessed in duplicate. The sensitivity of the 
assay was 56.72 pg/ml, while the intra- and inter-assay coefficients of variation 
were 6.6% and 7.8%, respectively. Diurnal cortisol levels and the Cortisol 
Awakening Response (CAR) were measured using the Area Under the Curve 
(AUC) respected to the ground calculation (Pruessner et al., 2003): for the former 
were taken into account levels at 0 min, 15min, 30min, 60min, noon and 8 pm, 
while for CAR levels at 0 min to 15, 30, and 60 min after awakening were 
considered.  
 
Statistical analysis  
Comparisons between the groups of subjects reporting trauma and no trauma, 
respectively, were performed by t test in case of continuous variables and Fisher’s 
exact test in case of categorical dummy variables. Linear regressions models were 
estimated to compare the outcomes of interest between these groups of individuals 
when putative confounders were taken into account. All tests were bilateral at 
p<0.05. Analyses were performed by using SPSS 22.0 for Windows. 
 
Results 
Description of the sample 
We recruited 39 subjects from the general population. Socio-demographics and life 





Table 19: Socio-demographics and life style characteristics with respect to 
childhood trauma (at least one among physical punishment, sexual unwanted 















Age (years), mean (sd) 39.1 (11.0) 41.8 (10.1) 38.0 (11.3) 0.335 
Sex 









Current tobacco Use 









Lifetime cannabis use 














Overall, 28.2% of the subjects included in the study had at least one childhood 
traumatic experience among physical punishment, sexual unwanted experiences, 
parental loss or/and separation. Mother and father antipathy were detected in 7.7% 
and 10.8% of individuals, while mother and father neglect were detected in 10.3% 
and 10.8%, respectively (data not shown). No significant differences were found 
between people who experienced childhood trauma (or mother/father antipathy or 
neglect) and those ones who did not with respect to socio-demographics and life 
style characteristics. 
Frequencies of psychotic-like experiences and the associated levels of distress are 
summarized in table 20. 
Cortisol Awakening Response (CAR) and Diurnal Cortisol (DC) levels (measured 





Table 20: Lifetime psychotic-like experiences: frequency and related distress 
(CAPE) with respect to childhood trauma (at least one among physical punishment, 




Childhood trauma  










Frequency score (1-4) 
   Positive 
   Negative 

















Distress score (1-4) 
   Positive 
   Negative 



















Table 21: Cortisol Awakening Response (CAR) and Diurnal Cortisol levels with 
respect to childhood trauma (at least one among physical punishment, sexual 




Childhood trauma  










71.8 (25.8) 79.2 (37.2) 68.9 (19.9) 0.270 














Childhood traumatic experiences and PLEs 
Regarding the lifetime frequency of PLEs (Table 20), a significantly higher lifetime 
frequency of positive symptomatology was found in subjects reporting CT (1.35 sd 
0.25) in comparison with those not recalling such experience (1.19 sd 0.20) (t test, 
p=0.050). Conversely, traumatized and non-traumatized subjects did not differ 
significantly in terms of lifetime frequency of negative or depressive 
symptomatology. 
No significant difference between traumatized and non-traumatized subjects was 
found for lifetime distress caused by PLEs.  
By exploring a history of parental antipathy or neglect, we found that subjects 
reporting maternal antipathy showed a significantly lower lifetime frequency of 
negative symptoms than individuals who did not recall such experience (1.19 ds 
0.11 vs 1.55 sd 0.28; t test, p=0.037) and significantly lower levels of distress in 
association with depressive symptoms (1.89 sd 0.84 vs 2.65 sd 0.61; t test, p=0.05). 
Father antipathy and father or mother neglect did not show any significant 
association with lifetime frequency and distress levels of PLEs (data not shown). 
 
Childhood Traumatic Experiences and saliva cortisol levels 
We did not find any significant difference regarding cortisol levels (both CAR and 
diurnal cortisol levels) between subjects who recalled a history of CT and those 
who did not (Table 21). By exploring the most severe type of childhood trauma (i.e. 
sexual unwanted experiences), we found a significant difference for the levels of 
CAR, which were higher in subjects with sexual unwanted experiences than in those 
without such experiences (112.8 sd 74.5 vs 69.6 sd 21.3; t test, p=0.019). 
Parental antipathy and neglect did not show any significant association with saliva 
cortisol levels (data not shown).  
 
Childhood Traumatic Experiences and lifetime cannabis use 
Lifetime cannabis use did not differ significantly between traumatized and non-
traumatized, although 54.5% of people reporting trauma had used cannabis at least 
once in their life vs 39.3% of those ones without trauma (Table 19).  
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Parental antipathy and neglect did not show any significant association with lifetime 
cannabis use (data not shown).  
 
Association of childhood traumatic experiences with PLEs adjusted for 
putative confounders 
 
Cortisol levels (both CAR and diurnal levels) and cannabis lifetime use were 
explored as potential confounders of the association between CT or mother 
antipathy and PLEs. 
 
CT and the frequency of positive symptoms   
Subjects who reported at least one CT showed significantly higher lifetime 
frequency of positive symptoms in comparison with subjects without a history of 
CT. The aforementioned association remained significant only when it was adjusted 
for CAR (Beta coefficient for CT=0.341, p=0.039), although CAR did not 
significantly affect the frequency of positive symptoms (Beta coefficient for CAR=-
0.141, p=0.382).  
 
Maternal antipathy and the frequency of negative symptoms or the distress levels 
of depressive symptoms  
Subjects with a history of maternal antipathy had a significantly lower lifetime 
frequency of negative symptoms in comparison with individuals not reporting such 
experience. When adjusting for CAR, diurnal cortisol levels or lifetime cannabis 
use, this association remained significant (Beta coefficient for mother antipathy was 
-0.346 with p=0.034, -0.338 with p=0.038 and -0.333 with p=0.041, respectively), 
although CAR, diurnal cortisol levels or lifetime cannabis use did not significantly 
affect the frequency of negative symptoms (data not reported).  
Moreover, subjects with a history of maternal antipathy had significantly lower 
levels of distress in response to depressive symptoms with respect to individuals 
not reporting such experience. After adjusting for CAR, this association remained 
significant (Beta coefficient for mother antipathy=-0.322, p=0.050), while it lost 
significance after adjusting for diurnal cortisol levels (Beta coefficient for mother 
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antipathy=-0.312, p=0.052) or cannabis lifetime use (Beta coefficient for mother 
antipathy=-0.313, p=0.056). CAR, diurnal cortisol levels or lifetime cannabis use 
did not result associated with the magnitude of distress associated with lifetime 
depressive symptoms (data not reported). 
 
Sexual unwanted experiences and CAR  
Subjects with a history of sexual unwanted experiences had significantly higher 
levels of CAR in comparison with individuals not reporting such experiences. 
When adjusting for possible confounders (sex, age and current tobacco use), this 
association remained significant (Beta coefficient for sexual unwanted experiences 
was 0.371 with p=0.021, 0.387 with p=0.023 and 0.358 with p=0.027, respectively), 




To the best of our knowledge, this is the first study aiming to explore the effect of 
childhood traumatic experiences and their association with psychotic-like 
experiences (PLEs) in a sample of healthy subjects, taking into account the potential 
confounder effect of HPA axis activity and lifetime cannabis use. We found that 
subjects with a history of childhood trauma, including at least one among physical 
punishment, sexual unwanted experiences, loss and separation, showed higher 
lifetime frequency of positive symptoms. In psychosis, childhood adversities were 
found significantly associated with both auditory hallucinations and paranoid 
ideation (Bentall et al., 2012; Dvir et al., 2013). Our findings are in line with the 
available knowledge and extend the notion that childhood trauma is associated with 
PLEs (especially positive symptoms), at a non-clinical level. Unfortunately, the 
association was no more significant after adjusting for diurnal cortisol levels or 
lifetime cannabis use, while CAR showed no effect. HPA-axis dysfunction was 
proven significantly associated to both childhood trauma (Carpenter et al., 2007.; 
Lupien et al., 2009) and psychosis (Borges et al., 2013). In contrast, in our sample 
we did not observed an association between salivary cortisol levels and CT or 
lifetime occurrence of positive symptomatology. Interestingly, we found that sexual 
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unwanted experiences were significantly associated to higher CAR, in line with 
previous findings (Mondelli et al., 2010; Weissbecker et al., 2006). Trauma 
spectrum disorders (i.e. psychosis and PTSD) have frequently shown an association 
with an altered regulation of the HPA axis (Frodl and O’Keane, 2013; Schalinski et 
al., 2015). As we recruited healthy subjects from the general population, thus 
without any mental disorder related to trauma, our finding suggests the role of 
environmental programming for the HPA axis and hints that environmental 
stressors, such as sexual unwanted experiences, can be significantly related to the 
neuroendocrine phenotype.  
In contrast with previous studies (Houston et al., 2011; Moore et al., 2007; Rössler 
et al., 2011; Tomassi et al., 2017) we also found that lifetime cannabis use rates did 
not differ significantly between traumatized and non-traumatized subjects and that 
no association existed between lifetime cannabis use and lifetime frequency of 
positive symptoms. There are several explanations for this finding. Firstly, there is 
evidence that protective factors can modify the negative effects of early adverse life 
circumstances leading people to select functional environments (Werner, 2004, 
1992). These factors can be attributed to the individual itself, as temperamental 
characteristics that easily elicit positive responses from caregivers and/or good 
communication and problem solving skills, or lie within the family (substitute 
caregivers providing positive role models) and in the community (teachers, caring 
neighbors elder mentors and peers) (Werner, 2004). A primary role has also been 
theorized for contextual and cultural factors (Ungar, 2013) and resilience has been 
defined as the capacity of both individuals and their environments to interact to 
overcome childhood adversities (Ungar and Liebenberg, 2011). Political processes, 
funding, and cultural norms contribute significantly to make it more or less likely a 
positive adaptation (Leadbeater et al., 2005). Secondly, we used a cross sectional, 
lifetime-framed investigation for cannabis use and PLEs, preventing any further 
exploration in terms of temporal association between cannabis consumption and 
symptoms. Moreover, prospective studies have previously determined that the risk 
of psychotic outcomes is specifically increased in those who use cannabis very 
frequently (Moore et al., 2007). We could not differentiate subjects that used 
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cannabis frequently, and thus more prone to experience symptoms, from those who 
just tried a few times or even once in their lives. 
Finally, we found that maternal antipathy was significantly associated to lower 
lifetime frequency of negative symptoms and lower levels of distress in response to 
depressive symptoms. Once again, it is possible to postulate that subjects that 
endured mother hostility, whether surrounded by a supportive relational and social 
context, also coped with it in an adaptive way (Ungar, 2013; Ungar and Liebenberg, 
2011). While the first association remained significant when adjusted for salivary 
cortisol levels and lifetime cannabis use, both considered potential confounders, the 
second lost significance when adjusted: however we did not find any significant 
difference regarding cortisol levels or lifetime cannabis use between subjects who 
reported a history of mother antipathy and those who did not. It is possible to 
assume that dysfunctional parenting styles and their consequences, in terms of both 
offspring’s vulnerability and resilience, maybe mainly influenced by psychological 
(e.g. attachment styles, coping strategies, temperamental characteristics,) and 
environmental (e.g. supportive teachers, religion and faith, peers’ relationships) 
factors (Werner et el., 1992) rather than biological ones, like HPA axis functioning 
and cannabis use. 
Our study has some important limitations. First, because of the study’s explorative 
nature, due to the small sample size, findings should be considered as preliminary 
and should be replicated in larger samples. Second, the results do not survive 
multiple testing corrections, which may be due to the small sample size; so they 
should not be interpreted as hypothesis generating. Third, the cross-sectional study 
design precludes any claims of causality. Finally, retrospective reporting of abuse 
might increase the risk of recall bias, although the reliability of referring trauma has 
been previously demonstrated (Schäfer and Fisher, 2011): reports were consistent 
with other sources of information and stable over time.  
The principal strengths of our study rely on the sound methodology applied at 
different levels (study design, subjects recruitments, and data collection and 
analysis) and on the use of internationally validated scales to assess subjects along 
with an accurate clinical evaluation by expert researchers with a clinical 





Our explorative study suggests significant effects of childhood traumatic 
experiences in terms of both symptomatology frequency and related distress in a 
non-clinical sample. Varying degrees of stress sensitivity possibly mediate how 
childhood traumatic experiences affect the frequency of PLEs and their related 
distress. Well-designed, population-based, prospective longitudinal studies are 
desirable to disentangle this lifelong multi-factors (biological, psychological and 
environmental) bundle. Optimistically, studies should follow traumatized children, 
collecting information about potentially involved factors (such as cannabis or other 
drugs consumption), taking into account biological determinants (including 
genetics, epigenetics and proteomics) and explore resilience factors (individual’s, 
family, and cultural). Even though traumatized children do not develop a clinically 
significant disorder in the majority of cases (Matheson et al., 2013), the association 
between CTE and mental disorders is well known and appear strong (Varese et al., 
2012a). On one side, our study confirms a detrimental effect of trauma, even at non-
clinical level. On the other side, our findings evoke a potential increased resilience 
in subjects with a history of CTE, therefore suggesting an alternative starting point 
for future research on childhood adversities, which should be more positively 





4.3 CHILDHOOD TRAUMA, RECENT SEVERE LIFE EVENTS, AND 
BIOMARKERS RELATED TO GLUCOSE METABOLISM IN HEALTHY 
SUBJECTS. 
 
There is strong evidence indicating that stressful experiences during critical periods 
of brain development, such as childhood, can cause long-term, persistent effects on 
behaviour, increasing the likelihood to negative health outcome. In details, 
childhood trauma, encompassing physical and sexual abuse, increases the 
vulnerability for mental disorders, including depression and psychosis (Li et al., 
2016; Trotta et al., 2015) but also for several medical conditions, including 
cardiovascular diseases, type 2 diabetes and metabolic disorders (Huffhines et al., 
2016, Miller et al., 2011).  
The physiological response to stress involves the activation of multiple biological 
systems, comprising the endocrine, cardiovascular, metabolic, and immune 
systems; moreover, whereas the acute stress activate adaptive mechanisms, 
(McEwen, 2003) the long term exposure to stress is associated with long lasting 
physiological dysregulation, eventually leading to enhanced vulnerability to several 
kind of diseases (Juster et al., 2010). 
Confirming the long-term effects of early life stress on the body, several studies 
(Danese et al., 2009; Dich et al., 2015) have linked childhood trauma to detrimental 
changes in physiological functions. For instance, it has been shown that victims of 
childhood sexual and physical abuse are more likely to be obese or to show three 
or even more symptoms of metabolic syndrome when compared with non-victims 
(Danese & Tan, 2014). Moreover, it was showed that exposure to maltreatment is 
associated with higher levels of several biomarkers related to metabolism, such as 
the inflammation marker C-reactive protein (hs-CRP) and clustering of metabolic 
markers, including high glycated hemoglobin, at age 32 (Danese et al., 2009). 
Moreover, Evidence suggests that subjects who reported an exposure of childhood 
trauma had an increased risk of the 32% to develop later in life type 2 diabetes 
(Huang et al., 2015) and of the 20-50% to develop obesity (Thomas et al., 2008). 
One of the possible biological mechanisms underlying the association between 
childhood trauma exposure and the later development of metabolic disorders is 
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represented by glucose metabolism (Deppermann et al., 2014). In fact, childhood 
trauma acting as chronic and severe stress could induce the production of elevated 
levels of glucose and insulin in blood. Moreover, the hypothalamic-pituitary-
adrenal (HPA) axis and inflammatory systems, which are both influenced by 
childhood trauma, interact with other stress mediators, including hormones 
involved in the glucose metabolism, like insulin, glucagon, secretin, gastric 
inhibitory polypeptide (GIP) and glucagone-like peptide 1 (GLP-1) (Nussdorfer et 
al., 2000) to further regulate HPA axis homeostasis. For example, insulin 
physiologically exerts an inhibitory action on HPA axis tone (Takao et al., 2000), 
while glucagon, secretin, GLP-1 and GIP enhance its function, stimulating the 
hypothalamus-pituitary CRH/ACTH release (Nussdorfer et al., 2000). However, 
only one study (Anderson et al, 2018) analysed the association between childhood 
trauma and biomarkers plasma levels related to glucose metabolism, specifically 
insulin, and found no association with physical and sexual abuse. In this context, 
up to now, as compared to the plenty of the literature proving a role of childhood 
trauma in enhancing the individual vulnerability to develop a wide range of 
illnesses, only a few studies have investigated the impact of recent severe stressful 
life events on health outcomes in the adulthood. Nonetheless, although stressful life 
events in adulthood have been associated with enhanced vulnerability to develop 
metabolic disorders (Rutters et al., 2015), type 2 diabetes (Maksimovic et al., 2014), 
the underlying biological mechanisms are still poor investigated.  
Moreover, although it is not known whether a different timing in stress exposure 
could exert differential effects and play different roles in the future development of 
metabolic related dysfunctions, the underlying biological processes involved have 
not been identified yet.  
Based on this, in the present pilot study, we aimed to investigate the effect of stress 
occurred in different periods of time (childhood and adulthood) on a panel of 
biomarkers related to glucose metabolism. In detail, we measured the plasma levels 
of Insulin, C-peptide, GIP, PAI-1, Visfatin, GLP-1, Ghrelin, Glucagon, Leptin, and 
Resistin in a group of subjects characterized for exposure to childhood trauma or to 
severe stressful life events occurred recently in life. We also explore whether BMI 
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and smoking may mediate the association between stress exposures and alterations 




Participants and Clinical Assessments 
Healthy subjects, aged between 19 and 54 years, were recruited through notices 
posted at the Verona University Hospital, Verona (Italy). Individuals presenting a 
history of any physical or psychiatric diseases, prior traumatic brain injury, or 
intellectual disability (IQ<70) were excluded from the study. Additionally, being 
pregnant or breastfeeding represented exclusion criteria. The absence of any 
psychiatric disorder was ascertained via two schedules: the Mini International 
Neuropsychiatric Interview (M.I.N.I. Plus, Sheehan et al., 1998), to exclude any 
psychiatric disorder in Axis I; and the Structured Clinical Interview for DSM 
disorders (SCID-II, Spitzer et al., 1992, 1993) to exclude any psychiatric disorder 
in Axis II. Moreover, depressive symptoms were assessed by the Hamilton Rating 
Scale for Depression (HAMD, Hamilton, 1960), and symptoms of mania by the 
Bech-Rafaelsen Mania Rating Scale (BRMRS, Bech et al., 1978). Subjects were 
asked regarding present physical illness including tobacco use. Weight was 
measured in Kg, wearing minimal clothing, with a floor scale; height was measured 
in m, without shoes and using a measuring tape. Then, BMI was calculated as body 
weight (Kg)/square of their height (m2). Written informed consent was obtained by 
participants after receiving a complete description of the study, which has been 
approved by the Ethic Committee of the Verona University Hospital (Prog. N. 1995 
approved on 31/08/2011; Prog. N. 1816 approved on 29/05/2013).  
The presence of childhood trauma was assessed by the CECA-Q scale (Bifulco et 
al., 2005). It elicits information concerning experiences of childhood adversity 
before age 17, including physical and sexual abuse, separation from at least one of 
the parental figures longer than 6 months, and death of a parent. Based on previous 
literature (Tomassi et al., 2017, Bifulco et al., 2005), the severity of each 
maltreatment variable was dichotomized into severe and non-severe categories. 
Physical abuse was defined as repeated exposure to physical violence from parental 
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figures. To be considered “severe”, these incidents had to meet at least two of the 
following criteria: the abuse consisted of being hit with a belt or stick or being 
punched or kicked; the abuse resulted in an injury, including broken limbs, black 
eyes or bruising; the perpetrator was considered to be out of control. Sexual abuse 
was considered among unwanted sexual experiences. It was defined as “severe” if 
at least two of the following criteria were met: the individual knew the perpetrator; 
the perpetrator was a relative; the perpetrator lived in the same household; the 
unwanted sexual experience occurred more than once; the perpetrator touched 
child’s genitals; the perpetrator forced the child to touch his/her genitals; the abuse 
involved intercourse. Separation was defined as a detachment from at least one of 
the parental figures longer than 6 months; whereas, loss was determined whether 
one or both parents died during subjects’ childhood. Childhood trauma was defined 
as having experienced at least one among severe physical abuse, severe sexual 
abuse and loss/separation. The presence of stressful life events (SLEs) was 
collected using a modified version of the Life Events Scale (Paykel et al., 1971), 
which lists 56 commonly encountered life stressors. Subjects were asked to indicate 
and date events that had occurred in the 6 months preceding the assessment. Based 
on a previous work (Lopizzo et al., 2017; Ira et al., 2014), only "severe life events" 
(i.e. death of a family member, sexual or physical abuse, being accused of having 
committed a crime, sentence of imprisonment, being exposed to war or natural 
catastrophes, family breakdown, being removed from home, sentimental 
breakdown, severe physical illness) were taken into account. 
Finally, the variable “childhood trauma and severe life events” was calculated for 
subjects who had experienced both childhood trauma and severe life events in the 
last 6 months.  
 
Metabolism biomarkers plasma levels 
Fasting blood samples were collected in the morning from each subject involved in 
the study. The tubes were kept at room temperature for 2 hours, then processed for 
plasma separation by centrifugation (1.620 x g for 15min). Plasma samples were 
then stored at -80 °C until they were processed for biochemical analyses. The 
concentrations of C-peptide, Ghrelin, GIP, GLP-1, Glucagon, Insulin, Leptin, PAI-
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1, Resistin and Visfatin were determined using Bio-PlexPro™ Human Diabetes 
Assays on a Bio-Plex 200 System array reader (Bio-Rad, CA, USA), following the 
manufacturer's instructions. Each sample was diluted 1:4, by using a kit sample 
diluent, and incubated in a pre-wet filter plate with biotinylated detection antibody. 
Each captured analyte was detected by the addition of streptavidin–phycoerythrin 
and quantified using the BioPlex array reader. Standard curves were generated 
using the reference standard specimens supplied by the manufacturer. The different 
analytes concentrations were calculated using the Bio-Plex Manager software. All 
the measurements were performed in duplicates and all the samples with different 
clinical features and negative control samples were run together in the same plates. 
 
Statistical analysis  
Continuous variables were described by using the means (standard deviations) and 
categorical variables were expressed as n (%). Normality of biomarkers plasma 
levels was confirmed by Kolmogorov-Smirnov tests. In case of non-normal 
distributions, a secondary data analysis was performed after applying Box-Cox 
transformations. 
Univariate linear regression models were estimated to test the association of each 
trauma exposure [childhood trauma, physical abuse, severe physical abuse, sexual 
abuse, severe sexual abuse, loss/separation, severe stressful events (last 6 months), 
childhood trauma and severe stressful life events (last 6 months)] with each of the 
metabolism related biomarkers. Multivariate linear regression analyses were 
performed to test these associations, adjusting for sex and age. Separate mediation 
effect of BMI and smoking on the association of trauma exposure with each 
biomarker was tested by a series of linear regression models after controlling for 
the aforementioned confounders. Although several design frameworks for 
mediation effect have been proposed to date, the classic work by Baron and Kenny 
(1986) is still the most prevalent approach. Mediation is demonstrated when the 
following steps are met: (1) the main independent variable (i.e. trauma) is 
significantly associated with the main dependent variable (i.e. biomarker). This step 
establishes that there is an overall direct effect that may be mediated; (2) the 
independent variable (i.e. trauma) is significantly related with the mediating 
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variable (i.e. BMI and  smoking); (3) the mediating variable (i.e. BMI and smoking) 
is significantly associated with the dependent variable (i.e. biomarker) when the 
independent variable (i.e. trauma) is controlled for. Note that it is not sufficient just 
to regress the mediator only on the biomarker; the mediator and the biomarker can 
be related because they are both caused by the trauma/life events. So, the trauma/life 
events must be controlled in establishing the effect of the mediator on the 
biomarker. Combined mediation analysis through a structural equation model 
including all biomarkers has not been conducted due to the fact that the number of 
parameters to be estimated was too high with respect to the available sample size. 
The procedure was repeated after applying the Box-Cox transformation (Fox, 1997) 
to the biomarkers plasma levels in order to check if conclusions change. All p values 
were two-tailed with an accepted significance level of 0.05. No multiple testing 
correction was applied due to the exploratory nature of the study. Analyses were 
performed by SPSS 22.0 for Windows.  
 
Results 
Clinical and biological characteristics of the sample 
We approached 91 subjects: overall, 72 (79.1%) people were included in the study. 
Of the other 19 subjects, 7 (36.8%) were excluded because under antidepressant 
treatment and 12 (63.2%) because affected by physical chronic diseases. The 
sample characteristics and the presence of childhood trauma and severe life events 
in the last 6 months are shown in Table 22. 
  
In details, 22.2% of participants reported childhood trauma and 29.2% reported 
severe stressful life events in the last 6 months. By considering childhood trauma 
and severe stressful life events in the last 6 months, 8.3% declared to have 
experienced both events.  
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Table 22: Socio-demographics, life style characteristics, childhood trauma and stressful 
life events (last 6 months) (n=72) 
 
Variable Mean (sd) or N (%) 
Age (years) 37.9 (12.4) 
Gender 












   Yes 
 
25 (34.7%) 
Body Mass Index (BMI) 
   Underweight (<18.5) 
   Normal (18.5-24.9) 
   Overweight (25.0-29.9) 
   Obesity (Class I 30.0-34.9) 
   Obesity (Class II 35.0-39.9) 








Bech-Rafaelsen Mania Rating Scale (BRMRS) 
   No mania (≤6) 
 
72 (100.0%) 
Hamilton Rating Scale for Depression (HAM-
D) 


















   Yes 
 
14 (19.4%) 
Severe Physical Abuse 




   Yes 
 
5 (6.9%) 
Severe Sexual Abuse 




   Yes 
 
10 (13.9%) 
Severe Life Events° (last 6 months) 
   Yes 
 
21 (29.2%) 
Childhood Trauma and Severe Life Events (last 
6 months) 





* at least one among loss/separation, severe physical abuse and/or severe sexual abuse 
° death of a family member, sexual or physical abuse, being accused of having committed a crime, sentence 
of imprisonment, being exposed to war or natural catastrophes, family breakdown, being removed from 




Effects of childhood trauma and/or severe stressful life events on metabolism 
biomarkers 
First, we wanted to investigate any effect of childhood trauma and/or severe recent 
stressful life events on the panel of biomarkers that we measured. Univariate linear 
regression models showed that stressful life events are influencing only the levels 
of GIP; we also found that specific childhood trauma exposures and childhood 
trauma plus severe recent stressful life events were associated with the levels of 
Insulin, Visfatin, GIP, PAI-1, C-Peptide and GLP1 (see Table 23), thus suggesting 
that there was an overall direct effect that could be mediated (first step for 
mediation). Only Ghrelin, Glucagon, Leptin and Resistin levels were not found 
significantly associated with trauma (data not showed). Also, when we took into 
account gender and age as cofounders, multivariate linear regression analyses 
confirmed the associations found between exposure to trauma and the above-
mentioned biomarkers (data not showed). 
 
Mediation of BMI and smoking on the association between childhood trauma 
and/or severe stressful life events on metabolism biomarkers  
Subsequently, in order to evaluate possible mediation effects of BMI and smoking 
on the association between childhood trauma and/or severe stressful life events on 
metabolism biomarkers, multivariate linear regression models were performed and 
each biomarker was used as the dependent variable. When found significantly 
associated in the univariate models, we considered age, gender, BMI and smoking 
as independent variables (GIP and GLP1 were associated with only trauma 
exposure, so multivariate models were not estimated) (see Table 24).   
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TRAUMA EXPOSURE Insulin Visfatin GIP PAI-1 C-Peptide GLP1 





















































































(0.517; 0.6%) (0.781; 0.1%) (0.028; 5.4%) (0.432; 0.9%) (0.321; 1.4%) (0.388; 0.0%) 










































      



































Table 24: Multivariate linear regression models for metabolism biomarkers (only biomarkers significantly associated with at least 
one trauma exposure variable and one confounder and/or mediator) (n=72)  
 
  Coefficient 
(p-value; adj-R2%) 
 
Independent variables# Insulin C-Peptide Visfatin PAI-1 





- - 0.381 
(0.001; 
15.4%) 
- - - 
Severe Physical Abuse 
(Ref. Yes) 




Severe Sexual Abuse (Ref. 
Yes) 
- - - 0.279 
(0.014; 
3.9%) 
- - - - - 
Severe Life Events (last 6 
months) (Ref. Yes) 




Childhood Trauma and 
Severe Life Events (last 6 
months) (Ref. Yes) 
- 0.279 
(0.010; 9.8%) 
- - 0.328 
(0.004; 
12.0%) 
- - - 0.267 
(0.011; 
9.2%) 
















Sex (Ref. Male) - - - - - - - - 0.214 
(0.041; 
5.7%) 




























We found that participants who showed higher Insulin levels were those who: (1) 
experienced at least one childhood trauma and one severe life event in the last 6 
months; (2) had higher BMI and these variables accounted for 24.2% of the 
variance. Subjects who showed higher PAI-1 levels were those who: (1) reported at 
least one childhood trauma and one severe life event in the last 6 months; (2) were 
males; (3) had higher BMI with an overall effect of the 27.5% of the variance.  
Subjects who experienced higher C-Peptide levels were those who: (1) declared 
childhood physical abuse or severe sexual abuse or at least one childhood trauma 
and one severe life event in the last 6 months; (2) had higher BMI. Overall, these 
models accounted for 16.5%, 10.6% and 17.8% of the variance, respectively. 
Finally, For Visfatin, participants who experienced higher levels were those who 
declared physical abuse during childhood with an effect that accounted the 15.4% 
of the variance.   
The different pathways that could explain the effect of trauma on Insulin, PAI-1 
and C -Peptide were explored by mediation models (see the path diagrams of Figure 
15). BMI was found significantly associated with only physical abuse (=0.235, 
p=0.049), while severe sexual abuse (=-0.004, p=0.972) and childhood trauma 
plus severe life events (=0.135, p=0.261) were not. Smoking was not associated 





Figure 15: Mediation models: A) Insulin; B) PAI-1; C) C-Peptide (Kenny approach) 
(n=72) (only models involving childhood trauma and/or severe stressful life events in the 








When we considered Insulin (diagram paths A), we found that BMI completely 
mediated the association with physical abuse during childhood, while childhood 
trauma plus severe life events in the last 6 months and BMI gave independent 
contributions. For PAI-1 (path diagram B), childhood trauma plus severe life events 
in the last 6 months, gender (being male) and BMI gave independent contributions. 
Finally, when we considered C-Peptide (path diagrams C), we found that BMI 
completely mediated the association with physical abuse, while severe sexual abuse 
or childhood trauma plus severe life events in the last 6 months and BMI 
independently contributed to C-Peptide levels.   
The distribution of biomarkers showed a departure from normality for all of them 
(Kolmogorov-Smirnov test), with the exception of C-Peptide (p=0.071), Glucagon 
(p=0.200) and Resistin (p=0.095), thus, a secondary data analysis was performed 
after applying Box-Cox transformations, however, the results and the significance 
remained unchanged (data not showed).   
 
Discussion 
This is the first study reporting that stress occurring in different periods of life can 
exert distinct effects on markers related to metabolism. In particular, here we 
explored, in a pilot study, the impact of childhood trauma and/or recent severe life 
events on several biomarkers, related to glucose metabolism, measured in plasma 
samples of 72 healthy subjects drawn from the Italian general population. 
Specifically, we have tried to dissect the pathways that could explain the effect of 
childhood trauma and/or recent severe life events on a panel of biomarkers related 
to glucose metabolism (Insulin, C-peptide, GIP, PAI-1, Visfatin, GLP-1, Ghrelin, 
Glucagon, Leptin, and Resistin) by exploring indirect effects given by specific 
mediators (sex, age, BMI and tobacco).  
We found that subjects that have been exposed to childhood physical abuse or 
childhood trauma in addition to experience recent severe life events showed higher 
plasma levels of Insulin. Moreover, we found that BMI completely mediates the 
association between insulin levels and physical abuse, while childhood trauma plus 
recent severe life events and BMI gave independent contributions.  
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It is well known that stress influences our body functions and several evidences 
have indeed showed that subjects exposed to stress early in life, such as childhood 
trauma, are more vulnerable to develop obesity in adulthood (Harding et al., 2014; 
Block et al., 2009) as well metabolic dysfunctions such as insulin-resistance and 
diabetes (Huffhines et al., 2016). In line with this, we found that BMI completely 
mediates the association between physical abuse and insulin levels, suggesting that 
physical abuse can cause an increase in BMI, which later can, in turn, entail a rise 
in insulin levels. Our finding is also in line with previous works that showed a 
significant association between physical abuse and obesity (Rehkopf et al., 2016; 
Danese & Tan, 2014). This effect may occur through the stimulation of different 
biological mechanisms and among them, there is the activation, due to the stress, of 
the neuroendocrine and inflammatory pathways, which are known to directly 
increase fat accumulation (Davis et al., 2014), promote visceral adiposity (Wardle 
et al., 2011) and the release of appetite hormones with increased food consumption 
(Bjorntorp, 2001). Conversely, we found that childhood trauma plus recent severe 
life events and BMI give independent contributions to insulin levels, indicating that 
the association between childhood trauma and at least one recent severe life events 
and higher levels of insulin is, in our sample, independent from the BMI. The 
occurrence of stressful life events later in life could represent a sort of “second hit”, 
which may lead to an even more dysfunctional response by the stress response 
system. Insulin has been proven to exert an inhibitory activity on HPA axis (Takao 
et al., 2000), thus, increased levels of insulin, observed in association with 
childhood trauma and severe life events, could then imply an attempt to reduce HPA 
activity, denoting a compensatory, albeit dysfunctional, mechanism.  
We also found that physical abuse was associated with higher levels of C-Peptide, 
but BMI completely mediates this association; conversely, severe sexual abuse or 
childhood trauma plus recent severe life events and BMI independently contribute 
to C-Peptide levels. C-peptide is a biologically active peptide, stored with insulin 
in the secretory vesicles until stimulation of the pancreatic β-cells by elevations in 
extracellular glucose concentration. C-peptide does not appear to directly alter 
glucose metabolism (Wahren & Larsson, 2015) even although there is evidence that 
C-peptide and insulin-initiated signalling cascades interact each other; thus, this 
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interaction is important for the normal functioning of both peptides, particularly in 
erythrocytes (Richards et al., 2013). No physiological or pathophysiological 
situation exists in which cells in vivo are exposed to C-peptide in the absence of 
insulin, and thus the precise role of C-peptide in physiological condition is difficult 
to ascertain. C-peptide likely exerts anti-inflammatory (Haidet et al., 2012) and 
vasodilatory (Wallerath et al., 2003) effects in the vascular endothelium through 
both direct actions on the endothelial cells and indirectly through interaction with 
erythrocytes and immune cells. As suggested (Yosten and Kolar, 2015), C-peptide 
plays a physiologically relevant role in the tuning of insulin signaling and in 
endothelial physiology, that could account for the microvascular dysfunction 
observed in diabetes. To date there are no evidence reporting altered C-peptide 
levels in adult subjects exposed to childhood trauma, although there are data in an 
animal model of stress early in life, the prenatal stress model (PNS). In particular, 
higher levels of C-peptide were observed in adult animals exposed to PNS, although 
this increase in C-peptide was not accompanied by alterations in caloric intake, 
body weight gain or fat mass (Balasubramanian et al., 2015). Our findings are 
partially in line with these preclinical data (Balasubramanian et al., 2015). Indeed, 
in our sample, the association between physical abuse and C-peptide is completely 
mediated by BMI, whereas the association between severe sexual abuse or 
childhood trauma plus severe life events and C-peptide is BMI-independent. This 
could suggest different and specific roles for physical and severe sexual abuse on 
the C-peptide levels. Results concerning C-peptide basically overlap with those in 
reference to insulin. Given the strong link between C-peptide and insulin plasma 
levels, the formers could be seen as a consequence of the latter. It stands then 
possible the “second hit” hypothesis with reference to the association between 
childhood trauma plus severe life events and C-peptide levels.   
In our sample, we also found that childhood trauma plus recent severe life events, 
gender (being male) and BMI give independent contributions to PAI-1 levels. PAI-
1 prevents plasmin generation and is considered a primary inhibitor of fibrinolysis, 
playing a primary role in balancing coagulation and fibrinolysis (Savoy et al., 
2017). PAI-1 represents also an important contributor to obesity and it has been 
found associated with the Metabolic Syndrome in several studies (Kraja et al., 2007; 
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Hanley et al., 2004). Our result of the contribution of BMI to PAI-1 levels is in line 
with the fact that PAI-1 is lowered by weight loss and drugs that improve insulin 
sensitivity (Kursawe & Santoro, 2014). Moreover, PAI deficient mice were found 
resistant to diet-induced obesity, explained by increased energy expenditure (Liang 
et al, 2006). Furthermore, PAI-1 has been proven potentially implicated in emotion, 
stress appraisal and response (Savoy et al., 2017). PAI-1 gene expression is 
mediated by pro-inflammatory cytokines, such as TNF-a and IL-1, and both PAI-1 
expression and protein synthesis are increased by acute systemic inflammation 
(Ekström et al., 2012). In turn, systemic PAI-1 may cross the brain-blood barrier 
and, once in the medial and central amygdala, can regulate stress-related neural 
modelling (Pawlak et al., 2003). Because this brain region strongly projects onto 
the hypothalamus, PAI-1 potentially play a role in regulating the physiological 
response to external stress via the HPA axis. These findings could suggest a bridge 
between the childhood trauma/life events-induced inflammation and elevated PAI-
1 concentration.  
The present study has several strengths. First, reliable, internationally validated 
instruments and adopted conservative cut-off points, previously applied, to identify 
also the most severe forms of abuse were used. Second, since childhood 
maltreatment is an important predictor of depression over the life-course (Nanni et 
al., 2011) and depression is prospectively associated with obesity (Luppino et al, 
2010), we have recruited subjects without a positive psychiatric history and without 
current diagnosis of depression, to exclude a factor mediating the effect of 
childhood maltreatment on obesity.  
Some limitations also need to be acknowledged in our study. First, although our is 
the largest sample of healthy subjects in which the relationship between childhood 
trauma, severe stressful life events and metabolic markers has been investigated, 
the number of subjects with childhood trauma history was relatively small in size, 
and thus our findings need to be replicated in larger samples. Second, a substantial 
number of tests were performed, which means that any Bonferroni correction for 
multiple testing would be large, thus any significant p-value should be regarded as 
nominal. Third, as for the majority of the studies on childhood trauma, abuse data 
rely on retrospective reporting. This limitation has been mitigated by the use of a 
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standardized interview as CECA-Q which has good reliability and validity both in 
general (Smith et al., 2002) and clinical populations (Bifulco et al., 2005). Fourth, 
although we selected a group of healthy subjects with negative physical and 
psychiatric history, none of these participants had evidence of metabolic disease 
other than obesity and none is under any systemic disease or medication use, we do 
not have information about their diet style. Moreover, blood samples were not taken 
to verify the presence/absence of diabetes by an oral glucose tolerance test (OGTT) 
according to criteria from the American Diabetes Association. Finally, there are the 
possibility that the association between childhood trauma and/or recent severe 
stressful life events with plasma levels of glucose related biomarkers could be 
mediated not only by BMI and smoking, but also by other factors, such as 
psychosocial elements including low socio-economic levels (Dich et al, 2015). 
 
Conclusions 
In conclusion, our results suggest that a history of childhood trauma and/or recent 
severe stressful life events increase the plasma levels of a panel of biomarkers 
related to glucose metabolism, and this could underlie the possible enhanced risk to 
develop poorer health outcomes. These findings suggest that children with 
childhood trauma history and/or adult with recent severe stressful life events may 
benefit from specific interventions. For example, the stability and permanency in 
safe, in some cases also foster, care place could help maltreated children in 
developing secure attachment and recovering from the psychological effects of 
abuse. In these interventions, attention should be paid also to the metabolic effects 
of the abuse, thus, teaching them a correct life style and dietary regime in order to 
prevent the later development of metabolic disorders. Up to now, only few studies 
(Isasi et al., 2015, Davis et al., 2014, Sinha et al., 2013) have investigated possible 
differential effects exerted on obesity and metabolism by stressful events occurring 
more recent in life as compared to events occurred during childhood. More recent 
in life and short-lasting stress exposure, may not entail gain of weight, while early 
traumatic experiences, especially if occurring for a prolonged amount of time 
during development, may lead to the activation of biological and behavioural 
patterns that lead to obesity and other pathologies related to metabolism (Isasi et 
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al., 2015). Our study provides important insights on the extent to which effects of 
childhood traumatic experiences persist over time influencing important markers 






Findings of this PhD thesis confirmed the importance of early life experiences in 
influencing adult health outcomes.  
 
On one side, they corroborated the detrimental effect of childhood traumatic 
experiences. To begin with, First Episode Psychosis patients exposed to childhood 
trauma appeared to constitute a distinctive subgroup characterized by diverse 
features in terms of nosology and drug use. Our study has elucidated, albeit 
partially, to what extent the presence of childhood traumatic experiences can affect 
early psychosis features. Findings therefore provide some important hints for 
specific therapeutic and/or preventive interventions, which might carry within 
themselves an enhanced impact on illness course, outcomes, and prognosis. 
Moreover, our results suggest a significant association between childhood traumatic 
experiences, stressful life events, and metabolic abnormalities in the first phase of 
psychosis. Childhood trauma appears to represent an additional risk factor for the 
development of metabolic disorders in patients affected by psychosis. It is therefore 
recommended to conduct an accurate and meticulous medical history, which would 
allow settling an early and intensive program of food and nutrition education, and 
would guide the choice of medication.  
Second, childhood traumatic experiences were found significantly associated in 
Hepatitis C patients with greater emotional distress and higher levels of depression, 
anxiety, and fatigue. It appears then of primary importance to systematically 
investigate the presence of a history of childhood traumatic events in these patients. 
It could help the clinician to identify, along with the routine medical caring, the 
most appropriate therapeutic interventions, which can be both pharmacological and 
psychosocial, to offer to the patient (Larkin & Read, 2008). Third, early adverse 
experiences were found associated, even in a non-clinical sample made by healthy 
adult subjects, with higher lifetime frequency of positive psychotic-like 
experiences. Finally, a significant difference was found between 
traumatized/stressed and non-exposed healthy subjects in terms of glucose 
metabolism. These findings suggested that children with childhood trauma history 
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and/or adult with recent severe stressful life events could benefit from specific 
interventions regarding general health. In these interventions, attention should be 
paid also to the metabolic effects of the abuse, thus, teaching them a correct life 
style and dietary regime in order to prevent the later development of metabolic 
disorders.  
 
Well-designed, population-based, prospective longitudinal studies are desirable to 
disentangle the lifelong multi-factors (biological, psychological, and 
environmental) bundle, which most likely mediates the association between 
childhood traumatic experiences and health outcomes. Optimistically, studies 
should follow traumatized children, in comparison with a group of control, collect 
information about potentially involved mediators, and explore risk and resilience 
factors for health outcomes.  
 
On the other side, we found that healthy subjects with a history of maternal 
antipathy were less likely to experience negative symptoms lifetime and reported 
lower levels of distress in association to depressive symptomatology. I would like 
therefore to close my thesis, stressing the knowledge that, even though the negative 
impact of early adverse experiences on mental health is well-established (Varese et 
al., 2012a), traumatized children do not develop a clinically significant disorder in 
the majority of cases (Matheson et al., 2013). Our findings, evoking a potential 
increased resilience in subjects with a history of childhood traumatic experiences, 
suggest an alternative starting point for future research on childhood adversities, 
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